ZeeJay的个人主页 - 老虎社区

ZeeJay

ZeeJay

暂无个人介绍

IP属地：未知

6关注

4粉丝

0主题

0勋章

2021-11-12

[Smile]

外媒头条：市值突破千亿！Rivian上市次日再度飙升

2021-11-06

[Miser]

抱歉，原内容已删除

2021-11-03

🤧

Hertz Says It’s Already Receiving Teslas; Doesn’t Address Musk Tweet

2021-09-03

Apple performces has already plateaued in recents years, so unless some new big thing can reignite sales, never say never..

Bear Attack: Could Apple Stock Really Drop 40%?

2021-07-14

Feels too speculative for comfort..

10 Companies Are About To Post Blowout 1,000%+ Profit Growth

2021-07-08

Another one riding on a high..

抱歉，原内容已删除

2021-07-08

Too much speculation on healthcare and biotech.. Wait fornsome stability before plunging.

3 Biotechs to Avoid Like the Plague in July

2021-07-06

Risk of Chinese mobile app businesses..

抱歉，原内容已删除

2021-07-03

Hope its real tips..

3 Stocks Cathie Wood Is Selling That Could Still Make You Rich

2021-07-01

Buy buy buy!!

This Dividend King Is About to Get a Big Boost From Reopening

2021-06-29

Robotics with loads of potential ridingnon hype of automation..

抱歉，原内容已删除

2021-06-28

Buy buy buy

抱歉，原内容已删除

2021-06-28

Apple strategies are very short term. Need longer term view for future growth.

抱歉，原内容已删除

2021-06-28

NIO

Ford Or NIO? The Final Verdict

2021-06-28

Pure speculation

抱歉，原内容已删除

去老虎APP查看更多动态

{"i18n":{"language":"zh_CN"},"userPageInfo":{"id":"4087711343938000","uuid":"4087711343938000","gmtCreate":1624608442137,"gmtModify":1624685102188,"name":"ZeeJay","pinyin":"zeejay","introduction":"","introductionEn":null,"signature":"","avatar":"https://static.tigerbbs.com/36dbec811e59c06f4aea5df6c06ea26f","hat":null,"hatId":null,"hatName":null,"vip":1,"status":2,"fanSize":4,"headSize":6,"tweetSize":15,"questionSize":0,"limitLevel":999,"accountStatus":4,"level":{"id":1,"name":"萌萌虎","nameTw":"萌萌虎","represent":"呱呱坠地","factor":"评论帖子3次或发布1条主帖（非转发）","iconColor":"3C9E83","bgColor":"A2F1D9"},"themeCounts":0,"badgeCounts":0,"badges":[],"moderator":false,"superModerator":false,"manageSymbols":null,"badgeLevel":null,"boolIsFan":false,"boolIsHead":false,"favoriteSize":0,"symbols":null,"coverImage":null,"realNameVerified":null,"userBadges":[{"badgeId":"e50ce593bb40487ebfb542ca54f6a561-1","templateUuid":"e50ce593bb40487ebfb542ca54f6a561","name":"出道虎友","description":"加入老虎社区500天","bigImgUrl":"https://static.tigerbbs.com/0e4d0ca1da0456dc7894c946d44bf9ab","smallImgUrl":"https://static.tigerbbs.com/0f2f65e8ce4cfaae8db2bea9b127f58b","grayImgUrl":"https://static.tigerbbs.com/c5948a31b6edf154422335b265235809","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2022.11.21","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1001},{"badgeId":"518b5610c3e8410da5cfad115e4b0f5a-1","templateUuid":"518b5610c3e8410da5cfad115e4b0f5a","name":"实盘交易者","description":"完成一笔实盘交易","bigImgUrl":"https://static.tigerbbs.com/2e08a1cc2087a1de93402c2c290fa65b","smallImgUrl":"https://static.tigerbbs.com/4504a6397ce1137932d56e5f4ce27166","grayImgUrl":"https://static.tigerbbs.com/4b22c79415b4cd6e3d8ebc4a0fa32604","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.21","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1100}],"userBadgeCount":2,"currentWearingBadge":null,"individualDisplayBadges":null,"crmLevel":2,"crmLevelSwitch":0,"location":"未知","starInvestorFollowerNum":0,"starInvestorFlag":false,"starInvestorOrderShareNum":0,"subscribeStarInvestorNum":0,"ror":null,"winRationPercentage":null,"showRor":false,"investmentPhilosophy":null,"starInvestorSubscribeFlag":false},"baikeInfo":{},"tab":"post","tweets":[{"id":879335689,"gmtCreate":1636681323341,"gmtModify":1636681677573,"author":{"id":"4087711343938000","authorId":"4087711343938000","name":"ZeeJay","avatar":"https://static.tigerbbs.com/36dbec811e59c06f4aea5df6c06ea26f","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4087711343938000","authorIdStr":"4087711343938000"},"themes":[],"htmlText":"[Smile]&nbsp;","listText":"[Smile]&nbsp;","text":"[Smile]","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/879335689","repostId":"2182606257","repostType":2,"repost":{"id":"2182606257","kind":"news","pubTimestamp":1636666860,"share":"https://www.laohu8.com/m/news/2182606257?lang=&edition=full","pubTime":"2021-11-12 05:41","market":"fut","language":"zh","title":"外媒头条：市值突破千亿！Rivian上市次日再度飙升","url":"https://stock-news.laohu8.com/highlight/detail?id=2182606257","media":"新浪财经","summary":"全球财经媒体昨夜今晨共同关注的头条新闻主要有：\n\n1、为什么经济学家低估了美国通胀的爆发力和耐力？\n\n\n2、美债市场遍布地雷 凶险程度达到疫情爆发以来之最\n\n\n3、又一波新冠疫情来袭 美国中西部医院I","content":"<p><b>全球财经媒体昨夜今晨共同关注的头条新闻主要有：</b></p>\n<blockquote>\n <b>1、为什么经济学家低估了美国通胀的爆发力和耐力？</b>\n</blockquote>\n<blockquote>\n <b>2、美债市场遍布地雷 凶险程度达到疫情爆发以来之最</b>\n</blockquote>\n<blockquote>\n <b>3、又一波新冠疫情来袭 美国中西部医院ICU人满为患</b>\n</blockquote>\n<blockquote>\n <b>4、“<a href=\"https://laohu8.com/S/TSLA\">特斯拉</a>杀手”Rivian上市次日再度飙升逾20% 市值突破千亿超越<a href=\"https://laohu8.com/S/GM\">通用汽车</a></b>\n</blockquote>\n<blockquote>\n <b>5、改善居住条件叠加回城上班刚需 推动曼哈顿房租创纪录上涨</b>\n</blockquote>\n<blockquote>\n <b>6、<a href=\"https://laohu8.com/S/DIS\">迪士尼</a>股价创18个月最大跌幅 因流媒体服务业务放缓</b>\n</blockquote>\n<p><img src=\"https://static.tigerbbs.com/5dbc3fa747a5e8746ac0c3f61f34757e\" tg-width=\"550\" tg-height=\"339\" referrerpolicy=\"no-referrer\" width=\"100%\" height=\"auto\"></p>\n<p><b>为什么经济学家低估了美国通胀的爆发力和耐力？</b></p>\n<p>卷土重来的疫情、脆弱的全球供应网络和刺激政策充实的消费者荷包，共同推动美国物价涨幅远超华尔街和决策者的预期。经济学家也明白了该谦虚的时候要谦虚。</p>\n<p>本周三发布的最新通胀数据显示，10月份消费物价同比上涨6.2%，高于所有预测。以前的物价上涨更多因为经济重新开放，而10月的数据却显示了广泛的通胀压力。</p>\n<p><a href=\"https://laohu8.com/S/DB\">德意志银行</a>首席美国经济学家Matthew Luzzetti说，过去一年，预测通胀“非常具有挑战性，”未来也依然很难。“现在这个时候，谁都别以为自己已经考虑了足够的价格压力，通胀前景的风险仍然偏向上行。”</p>\n<p>自年初以来，经济学家被迫提高了对消费价格涨幅的预测。曾经，通胀被视为某种幻觉，是所谓的基期效应扭曲了数字。但结果证明，这是个更加长期的问题。</p>\n<p><img src=\"https://static.tigerbbs.com/0de9807e60befbc92e727c2b27cd2f47\" tg-width=\"550\" tg-height=\"364\" referrerpolicy=\"no-referrer\" width=\"100%\" height=\"auto\"></p>\n<p><b>美债市场遍布地雷 凶险程度达到疫情爆发以来之最</b></p>\n<p>美国国债市场过去一个月已成为雷区。</p>\n<p>随着全球债券交易员努力迫使央行出手应对高通胀，债市异常的震荡让他们自己也损失不小。由此仿佛陷入一个恶性循环，不愿入市令债市流动性减少，价格更易大幅波动，这进而又阻止了人们入市的脚步。</p>\n<p>美国政府证券流动性指数显示，美国国债目前的交易状况为2020年3月以来最糟。该指数衡量收益率偏离公允价值模型的程度。至于预期波动率，跟踪美国国债的ICE<a href=\"https://laohu8.com/S/BAC\">美国银行</a>MOVE指数目前接近2020年4月以来最高水平。</p>\n<p>美联储11月3日宣布计划每月减少购买800亿美元美国国债，目标是到明年年中结束购债行动。主席鲍威尔重申该减码时间表对于加息时间没有指示意义，必要情况下联储会果断对“通胀”采取行动。周三美国公布的10月CPI涨幅超过预期，美债市场遭遇2月以来最大抛盘。</p>\n<p><img src=\"https://static.tigerbbs.com/17bb143298d36f6743808a411697ad14\" tg-width=\"550\" tg-height=\"349\" referrerpolicy=\"no-referrer\" width=\"100%\" height=\"auto\"></p>\n<p><b>又一波新冠疫情来袭 美国中西部医院ICU人满为患</b></p>\n<p>美国部分地区的医院已经开始看到新冠疫情秋季浪潮的影响，这个最新迹象表明，即使是在疫苗接种率相对较高的地区，医疗系统仍然面临来自新冠病毒的巨大压力。</p>\n<p>在12个州，Covid-19患者使用的重症监护床位比两周前有所攀升，这些州大多数位于南起亚利桑那州和新墨西哥州，北至明尼苏达州，跨越北美大平原的连续地带上。在西部几个州，许多医生和护士还没有从上一轮感染高峰中缓过气来。</p>\n<p>“我们已经满负荷运转，（直到几天前）都无法让病人转院，” 科罗拉多州偏远的Moffat县农村地区医院Memorial Hospital的手术副总裁Jennifer Riley说。“很难相信疫情已经持续了这么久。”该医院有大约25张床位。</p>\n<p>美国未来数月面临着不确定性，随着传统的冬季病毒传染高峰期来临，德尔塔变异毒株仍在全国范围内蔓延。美国许多地区也经历了异常温暖的秋季，尚未看到当寒冷的天气促使人们更多呆在室内、病毒更容易传播时会发生什么状况。</p>\n<p><img src=\"https://static.tigerbbs.com/1558ffa4bade529e0653078064a84267\" tg-width=\"550\" tg-height=\"309\" referrerpolicy=\"no-referrer\" width=\"100%\" height=\"auto\"></p>\n<p><b>“特斯拉杀手”Rivian上市次日再度飙升逾20% 市值突破千亿超越通用汽车</b></p>\n<p>电动汽车初创公司Rivian股价周四继续攀升，在上市一天后再度大涨约23%。</p>\n<p>这家<a href=\"https://laohu8.com/S/AMZN\">亚马逊</a>和福特支持的公司的市值已经超过<a href=\"https://laohu8.com/S/F\">福特汽车</a>和通用汽车，目前超过1000亿美元。不过这仍然远远落后于特斯拉逾1万亿美元的市值。</p>\n<p>截至发稿，通用汽车的市值为888亿美元，而福特的市值为776亿美元。</p>\n<p>Rivian当前的市值意味着亚马逊在该公司20%的股份现价值约210亿美元，而福特持有的12%股份价值超过120亿美元。</p>\n<p>鉴于Rivian还没有成熟的商业模式，并预计三季度营收最高仅为100万美元，因此该股两日的涨幅尤其惊人。该公司在招股说明书中表示，预计当季亏损将高达12.8亿美元。</p>\n<p>Rivian凭借全电动皮卡在市场上击败了竞争对手，但尚未大规模生产其车辆。</p>\n<p><img src=\"https://static.tigerbbs.com/703c35767cc066ea313d043ed964d5ae\" tg-width=\"550\" tg-height=\"309\" referrerpolicy=\"no-referrer\" width=\"100%\" height=\"auto\"></p>\n<p><b>改善居住条件叠加回城上班刚需 推动曼哈顿房租创纪录上涨</b></p>\n<p>曼哈顿的公寓租金正在以创纪录速度上涨，因为准备重返办公室的人们纷纷在曼哈顿寻找条件更好的住所。</p>\n<p>评估公司Miller Samuel Inc．和中介公司Douglas Elliman Real Estate在周四的一份报告中表示，10月份租金中位数达到3382美元，同比上涨18%。这是10年前有数据以来最大同比涨幅；不过，租金中位数绝对值仍低于2019年10月的3409美元。</p>\n<p>Miller Samuel总裁Jonathan Miller说，那些无缘在郊区购房的公寓租户发现，他们可以转而在市内租下更好的房子。还有人则在办公室附近找到房子，为最终不得不回办公室上班做准备。</p>\n<p>“越来越多的人理解了自己想要住的地方和雇主希望他们工作的地方之间的关系，”Miller说。</p>\n<p><img src=\"https://static.tigerbbs.com/4a8b70e558184105f6ced2b1ee484691\" tg-width=\"533\" tg-height=\"300\" referrerpolicy=\"no-referrer\" width=\"100%\" height=\"auto\"></p>\n<p><b>迪士尼股价创18个月最大跌幅 因流媒体服务业务放缓</b></p>\n<p>迪士尼股价创疫情爆发以来最大跌幅，之前该公司报告流媒体用户增长低于预期，引发投资者对连续两年火爆之后增长放缓的担忧。</p>\n<p>迪士尼股价周四早盘一度下跌9.2%，为2020年3月以来最大盘中跌幅。此番下跌导致该公司市值低于竞争对手Netflix&nbsp;Inc．。流媒体的不足只是该公司各业务部门当季普遍令人失望的缩影。</p>\n<p>该公司周三公告称，Disney+在第四财季新增210万用户，其用户总数达到1.181亿。接受彭博调查的分析师预测为1.196亿。这是该服务两年前推出以来的最小季度增幅。</p>\n<p>迪士尼已将这个家庭流媒体产品作为未来几年增长的重点，管理层重申了到2024年拥有2.6亿用户的目标。11月12日是月费8美元的Disney+上线两周年纪念日，该公司正在举行庆祝活动，在全公司范围内推出新电影和促销活动。</p>","source":"sina","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>外媒头条：市值突破千亿！Rivian上市次日再度飙升</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n外媒头条：市值突破千亿！Rivian上市次日再度飙升\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-11-12 05:41 北京时间&nbsp;&nbsp;&nbsp;<a href=https://finance.sina.com.cn/stock/usstock/c/2021-11-12/doc-iktzscyy5039074.shtml><strong>新浪财经</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>全球财经媒体昨夜今晨共同关注的头条新闻主要有：\n\n1、为什么经济学家低估了美国通胀的爆发力和耐力？\n\n\n2、美债市场遍布地雷 凶险程度达到疫情爆发以来之最\n\n\n3、又一波新冠疫情来袭 美国中西部医院ICU人满为患\n\n\n4、“特斯拉杀手”Rivian上市次日再度飙升逾20% 市值突破千亿超越通用汽车\n\n\n5、改善居住条件叠加回城上班刚需 推动曼哈顿房租创纪录上涨\n\n\n6、迪士尼股价创18个月最大跌幅...</p>\n\n<a href=\"https://finance.sina.com.cn/stock/usstock/c/2021-11-12/doc-iktzscyy5039074.shtml\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"https://static.tigerbbs.com/37d8ba54faa1a9d08aed79d6e8240d1f","relate_stocks":{"RIVN":"Rivian Automotive, Inc.",".DJI":"道琼斯",".SPX":"S&P 500 Index",".IXIC":"NASDAQ Composite"},"source_url":"https://finance.sina.com.cn/stock/usstock/c/2021-11-12/doc-iktzscyy5039074.shtml","is_english":false,"share_image_url":"https://static.laohu8.com/b0d1b7e8843deea78cc308b15114de44","article_id":"2182606257","content_text":"全球财经媒体昨夜今晨共同关注的头条新闻主要有：\n\n1、为什么经济学家低估了美国通胀的爆发力和耐力？\n\n\n2、美债市场遍布地雷 凶险程度达到疫情爆发以来之最\n\n\n3、又一波新冠疫情来袭 美国中西部医院ICU人满为患\n\n\n4、“特斯拉杀手”Rivian上市次日再度飙升逾20% 市值突破千亿超越通用汽车\n\n\n5、改善居住条件叠加回城上班刚需 推动曼哈顿房租创纪录上涨\n\n\n6、迪士尼股价创18个月最大跌幅 因流媒体服务业务放缓\n\n\n为什么经济学家低估了美国通胀的爆发力和耐力？\n卷土重来的疫情、脆弱的全球供应网络和刺激政策充实的消费者荷包，共同推动美国物价涨幅远超华尔街和决策者的预期。经济学家也明白了该谦虚的时候要谦虚。\n本周三发布的最新通胀数据显示，10月份消费物价同比上涨6.2%，高于所有预测。以前的物价上涨更多因为经济重新开放，而10月的数据却显示了广泛的通胀压力。\n德意志银行首席美国经济学家Matthew Luzzetti说，过去一年，预测通胀“非常具有挑战性，”未来也依然很难。“现在这个时候，谁都别以为自己已经考虑了足够的价格压力，通胀前景的风险仍然偏向上行。”\n自年初以来，经济学家被迫提高了对消费价格涨幅的预测。曾经，通胀被视为某种幻觉，是所谓的基期效应扭曲了数字。但结果证明，这是个更加长期的问题。\n\n美债市场遍布地雷 凶险程度达到疫情爆发以来之最\n美国国债市场过去一个月已成为雷区。\n随着全球债券交易员努力迫使央行出手应对高通胀，债市异常的震荡让他们自己也损失不小。由此仿佛陷入一个恶性循环，不愿入市令债市流动性减少，价格更易大幅波动，这进而又阻止了人们入市的脚步。\n美国政府证券流动性指数显示，美国国债目前的交易状况为2020年3月以来最糟。该指数衡量收益率偏离公允价值模型的程度。至于预期波动率，跟踪美国国债的ICE美国银行MOVE指数目前接近2020年4月以来最高水平。\n美联储11月3日宣布计划每月减少购买800亿美元美国国债，目标是到明年年中结束购债行动。主席鲍威尔重申该减码时间表对于加息时间没有指示意义，必要情况下联储会果断对“通胀”采取行动。周三美国公布的10月CPI涨幅超过预期，美债市场遭遇2月以来最大抛盘。\n\n又一波新冠疫情来袭 美国中西部医院ICU人满为患\n美国部分地区的医院已经开始看到新冠疫情秋季浪潮的影响，这个最新迹象表明，即使是在疫苗接种率相对较高的地区，医疗系统仍然面临来自新冠病毒的巨大压力。\n在12个州，Covid-19患者使用的重症监护床位比两周前有所攀升，这些州大多数位于南起亚利桑那州和新墨西哥州，北至明尼苏达州，跨越北美大平原的连续地带上。在西部几个州，许多医生和护士还没有从上一轮感染高峰中缓过气来。\n“我们已经满负荷运转，（直到几天前）都无法让病人转院，” 科罗拉多州偏远的Moffat县农村地区医院Memorial Hospital的手术副总裁Jennifer Riley说。“很难相信疫情已经持续了这么久。”该医院有大约25张床位。\n美国未来数月面临着不确定性，随着传统的冬季病毒传染高峰期来临，德尔塔变异毒株仍在全国范围内蔓延。美国许多地区也经历了异常温暖的秋季，尚未看到当寒冷的天气促使人们更多呆在室内、病毒更容易传播时会发生什么状况。\n\n“特斯拉杀手”Rivian上市次日再度飙升逾20% 市值突破千亿超越通用汽车\n电动汽车初创公司Rivian股价周四继续攀升，在上市一天后再度大涨约23%。\n这家亚马逊和福特支持的公司的市值已经超过福特汽车和通用汽车，目前超过1000亿美元。不过这仍然远远落后于特斯拉逾1万亿美元的市值。\n截至发稿，通用汽车的市值为888亿美元，而福特的市值为776亿美元。\nRivian当前的市值意味着亚马逊在该公司20%的股份现价值约210亿美元，而福特持有的12%股份价值超过120亿美元。\n鉴于Rivian还没有成熟的商业模式，并预计三季度营收最高仅为100万美元，因此该股两日的涨幅尤其惊人。该公司在招股说明书中表示，预计当季亏损将高达12.8亿美元。\nRivian凭借全电动皮卡在市场上击败了竞争对手，但尚未大规模生产其车辆。\n\n改善居住条件叠加回城上班刚需 推动曼哈顿房租创纪录上涨\n曼哈顿的公寓租金正在以创纪录速度上涨，因为准备重返办公室的人们纷纷在曼哈顿寻找条件更好的住所。\n评估公司Miller Samuel Inc．和中介公司Douglas Elliman Real Estate在周四的一份报告中表示，10月份租金中位数达到3382美元，同比上涨18%。这是10年前有数据以来最大同比涨幅；不过，租金中位数绝对值仍低于2019年10月的3409美元。\nMiller Samuel总裁Jonathan Miller说，那些无缘在郊区购房的公寓租户发现，他们可以转而在市内租下更好的房子。还有人则在办公室附近找到房子，为最终不得不回办公室上班做准备。\n“越来越多的人理解了自己想要住的地方和雇主希望他们工作的地方之间的关系，”Miller说。\n\n迪士尼股价创18个月最大跌幅 因流媒体服务业务放缓\n迪士尼股价创疫情爆发以来最大跌幅，之前该公司报告流媒体用户增长低于预期，引发投资者对连续两年火爆之后增长放缓的担忧。\n迪士尼股价周四早盘一度下跌9.2%，为2020年3月以来最大盘中跌幅。此番下跌导致该公司市值低于竞争对手Netflix Inc．。流媒体的不足只是该公司各业务部门当季普遍令人失望的缩影。\n该公司周三公告称，Disney+在第四财季新增210万用户，其用户总数达到1.181亿。接受彭博调查的分析师预测为1.196亿。这是该服务两年前推出以来的最小季度增幅。\n迪士尼已将这个家庭流媒体产品作为未来几年增长的重点，管理层重申了到2024年拥有2.6亿用户的目标。11月12日是月费8美元的Disney+上线两周年纪念日，该公司正在举行庆祝活动，在全公司范围内推出新电影和促销活动。","news_type":1},"isVote":1,"tweetType":1,"viewCount":847,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":842248013,"gmtCreate":1636188538148,"gmtModify":1636188538301,"author":{"id":"4087711343938000","authorId":"4087711343938000","name":"ZeeJay","avatar":"https://static.tigerbbs.com/36dbec811e59c06f4aea5df6c06ea26f","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4087711343938000","authorIdStr":"4087711343938000"},"themes":[],"htmlText":"[Miser]&nbsp;","listText":"[Miser]&nbsp;","text":"[Miser]","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":9,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/842248013","repostId":"1176171748","repostType":4,"isVote":1,"tweetType":1,"viewCount":980,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":841700354,"gmtCreate":1635939499588,"gmtModify":1635939749648,"author":{"id":"4087711343938000","authorId":"4087711343938000","name":"ZeeJay","avatar":"https://static.tigerbbs.com/36dbec811e59c06f4aea5df6c06ea26f","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4087711343938000","authorIdStr":"4087711343938000"},"themes":[],"htmlText":"🤧","listText":"🤧","text":"🤧","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/841700354","repostId":"1115803721","repostType":4,"repost":{"id":"1115803721","kind":"news","pubTimestamp":1635863791,"share":"https://www.laohu8.com/m/news/1115803721?lang=&edition=full","pubTime":"2021-11-02 22:36","market":"us","language":"en","title":"Hertz Says It’s Already Receiving Teslas; Doesn’t Address Musk Tweet","url":"https://stock-news.laohu8.com/highlight/detail?id=1115803721","media":"Bloomberg","summary":"Hertz Global Holdings Inc. said it’s already receiving cars under its plan to add 100,000 Tesla elec","content":"<p>Hertz Global Holdings Inc.&nbsp;said it’s already receiving cars under its plan to add 100,000 Tesla electric vehicles through 2022, without responding directly to a market-moving tweet from billionaire Elon Musk that said there’s been no signed contract between the companies yet.</p>\n<p>The rental-car company unveiled its EV initiative last week, a deal with potential to change the industry and speed consumers’ adoption of EVs. Shares of&nbsp;Tesla Inc.&nbsp;fell in early trading Tuesday after Musk, its chief executive officer, tweeted there was no contract yet and reiterated that Hertz wouldn’t get any special pricing.</p>\n<p>“As we announced last week, Hertz has made an initial order of 100,000 Tesla electric vehicles and is investing in new EV charging infrastructure across the company’s global operations,” Hertz said in an emailed statement Tuesday. “Deliveries of the Teslas already have started. We are seeing very strong early demand for Teslas in our rental fleet, which reflects market demand for Tesla vehicles.”</p>\n<p>Hertz, which trades over the counter ahead of a re-listing on the Nasdaq Stock Market, climbed 38% through Monday since Bloomberg News first reported the Tesla-rental plan on Oct. 25. The plan has pushed up the Estero, Florida-based rental company’s market valuation to about $16.1 billion -- just four months out of bankruptcy.</p>\n<p>In his Monday night tweet, Musk said that because Tesla has demand for more vehicles than it can produce, the deal with Hertz “has zero effect on our economics.” Teslasharesslumped as much as 6.9% before the start of regular trading Tuesday, after soaring 56% during the past month to give the EV-maker a market valuation above $1 trillion.</p>","source":"lsy1584095487587","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Hertz Says It’s Already Receiving Teslas; Doesn’t Address Musk Tweet</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nHertz Says It’s Already Receiving Teslas; Doesn’t Address Musk Tweet\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-11-02 22:36 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.bloomberg.com/news/articles/2021-11-02/hertz-says-already-receiving-teslas-doesn-t-address-musk-tweet><strong>Bloomberg</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Hertz Global Holdings Inc. said it’s already receiving cars under its plan to add 100,000 Tesla electric vehicles through 2022, without responding directly to a market-moving tweet from billionaire ...</p>\n\n<a href=\"https://www.bloomberg.com/news/articles/2021-11-02/hertz-says-already-receiving-teslas-doesn-t-address-musk-tweet\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"TSLA":"特斯拉","HTZ":"赫兹租车","HTZZ":"Hertz Global Holdings, Inc."},"source_url":"https://www.bloomberg.com/news/articles/2021-11-02/hertz-says-already-receiving-teslas-doesn-t-address-musk-tweet","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1115803721","content_text":"Hertz Global Holdings Inc. said it’s already receiving cars under its plan to add 100,000 Tesla electric vehicles through 2022, without responding directly to a market-moving tweet from billionaire Elon Musk that said there’s been no signed contract between the companies yet.\nThe rental-car company unveiled its EV initiative last week, a deal with potential to change the industry and speed consumers’ adoption of EVs. Shares of Tesla Inc. fell in early trading Tuesday after Musk, its chief executive officer, tweeted there was no contract yet and reiterated that Hertz wouldn’t get any special pricing.\n“As we announced last week, Hertz has made an initial order of 100,000 Tesla electric vehicles and is investing in new EV charging infrastructure across the company’s global operations,” Hertz said in an emailed statement Tuesday. “Deliveries of the Teslas already have started. We are seeing very strong early demand for Teslas in our rental fleet, which reflects market demand for Tesla vehicles.”\nHertz, which trades over the counter ahead of a re-listing on the Nasdaq Stock Market, climbed 38% through Monday since Bloomberg News first reported the Tesla-rental plan on Oct. 25. The plan has pushed up the Estero, Florida-based rental company’s market valuation to about $16.1 billion -- just four months out of bankruptcy.\nIn his Monday night tweet, Musk said that because Tesla has demand for more vehicles than it can produce, the deal with Hertz “has zero effect on our economics.” Teslasharesslumped as much as 6.9% before the start of regular trading Tuesday, after soaring 56% during the past month to give the EV-maker a market valuation above $1 trillion.","news_type":1},"isVote":1,"tweetType":1,"viewCount":964,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":815183172,"gmtCreate":1630656079296,"gmtModify":1632468291157,"author":{"id":"4087711343938000","authorId":"4087711343938000","name":"ZeeJay","avatar":"https://static.tigerbbs.com/36dbec811e59c06f4aea5df6c06ea26f","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4087711343938000","authorIdStr":"4087711343938000"},"themes":[],"htmlText":"Apple performces has already plateaued in recents years, so unless some new big thing can reignite sales, never say never..&nbsp;","listText":"Apple performces has already plateaued in recents years, so unless some new big thing can reignite sales, never say never..&nbsp;","text":"Apple performces has already plateaued in recents years, so unless some new big thing can reignite sales, never say never..","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/815183172","repostId":"1131318558","repostType":4,"repost":{"id":"1131318558","kind":"news","pubTimestamp":1630591645,"share":"https://www.laohu8.com/m/news/1131318558?lang=&edition=full","pubTime":"2021-09-02 22:07","market":"us","language":"en","title":"Bear Attack: Could Apple Stock Really Drop 40%?","url":"https://stock-news.laohu8.com/highlight/detail?id=1131318558","media":"Thestreet","summary":"One of two Wall Street analysts that had a sell rating on Apple stock threw in the towel. The other still thinks that AAPL shares could drop 40%. Is the sizable downside risk realistic?On the first day of September, one of the rare Wall Street bears on Apple stock  finally gave in and dropped his sell rating. The last remaining one still sees shares dropping to a price target of $90, representing risk of loss of around 40%.Could New Street’s Pierre Ferragu, the last remaining Apple bear on Wall ","content":"<p>One of two Wall Street analysts that had a sell rating on Apple stock threw in the towel. The other still thinks that AAPL shares could drop 40%. Is the sizable downside risk realistic?</p>\n<p>On the first day of September, one of the rare Wall Street bears on Apple stock&nbsp;(<b>AAPL</b>)&nbsp;finally gave in and dropped his sell rating. The last remaining one still&nbsp;sees&nbsp;shares dropping to a price target of $90, representing risk of loss of around 40%.</p>\n<p>Could New Street’s Pierre Ferragu, the last remaining Apple bear on Wall Street, be right about his downside call? The Apple Maven looks a bit closer at the argument.</p>\n<p><b>Why bearish on Apple?</b></p>\n<p>The core of Pierre’s bearish argument&nbsp;seems to be the iPhone. The analyst has called the upcoming device launch a “12S cycle”, arguing that the best of Apple’s iPhone upgrade wave,the so-called 5G super cycle, has been left in the rearview mirror.</p>\n<p>New Street subscribes to the view that the strong iPhone 12 cycle has pulled forward smartphone sales, leaving a gap in demand going forward. Interestingly, this is exactly the&nbsp;opposite opinion of bullish Wedbush analyst Dan Ives, who said the following during an interview with the Apple Maven:</p>\n<blockquote>\n “What the Street underestimates is how massive and elongated this super cycle is. […] 5G does not get fully embraced for the next two or three years, until the networks are built out. In China [where the 5G infrastructure is further ahead], the iPhone 12, especially the larger Pro versions, really sold extremely well.”\n</blockquote>\n<p>Still on the iPhone, Mr. Ferragu laid out his expectations for 2022 back in April (I am unaware of revisions since then). He believes that iPhone shipments will reach 190 million units, suggesting segment revenues of around $150 billion – a modest annual increase of 5% from COVID-19 levels.</p>\n<p><b>Could AAPL sink 40%?</b></p>\n<p>Now, let’s put pen to paper. For Apple stock to be valued at $90 apiece, one of two things would need to happen: either financial performance would need to lag consensus expectations, or valuations would need to contract (or a combination of both).</p>\n<p>On results,Wall Street currently sees&nbsp;fiscal 2022 EPS landing at $5.63, roughly flat against a 2021 that has been impressive so far. For AAPL to drop 40% in price, therefore, next-year earnings would need to miss consensus substantially, by at least a couple of dollars. I find this highly unlikely.</p>\n<p>On valuations, AAPL currently trades at a fiscal 2021 earnings multiple of 27 times. Assuming consensus-matching results in the future, this multiple would need to drop to about 16 times for AAPL shares to sink to $90. The stock’s forward P/E has not been this low in years.</p>\n<p><b>The Apple Maven’s take</b></p>\n<p>I find it very improbable, if not virtually impossible, for Apple to ever be valued at $90 per share again. It is much more reasonable, in my opinion, that New Street’s current price target on the stock is simply stale, following AAPL’s 25% rally in the past six months.</p>\n<p>Therefore, I would not be surprised to see Wall Street’s last AAPL bear eventually (soon?) give in on his downside convictions, at least in what pertains to his current price target.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Bear Attack: Could Apple Stock Really Drop 40%?</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nBear Attack: Could Apple Stock Really Drop 40%?\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-09-02 22:07 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.thestreet.com/apple/stock/bear-attack-could-apple-stock-really-drop-40><strong>Thestreet</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>One of two Wall Street analysts that had a sell rating on Apple stock threw in the towel. The other still thinks that AAPL shares could drop 40%. Is the sizable downside risk realistic?\nOn the first ...</p>\n\n<a href=\"https://www.thestreet.com/apple/stock/bear-attack-could-apple-stock-really-drop-40\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"AAPL":"苹果"},"source_url":"https://www.thestreet.com/apple/stock/bear-attack-could-apple-stock-really-drop-40","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1131318558","content_text":"One of two Wall Street analysts that had a sell rating on Apple stock threw in the towel. The other still thinks that AAPL shares could drop 40%. Is the sizable downside risk realistic?\nOn the first day of September, one of the rare Wall Street bears on Apple stock (AAPL) finally gave in and dropped his sell rating. The last remaining one still sees shares dropping to a price target of $90, representing risk of loss of around 40%.\nCould New Street’s Pierre Ferragu, the last remaining Apple bear on Wall Street, be right about his downside call? The Apple Maven looks a bit closer at the argument.\nWhy bearish on Apple?\nThe core of Pierre’s bearish argument seems to be the iPhone. The analyst has called the upcoming device launch a “12S cycle”, arguing that the best of Apple’s iPhone upgrade wave,the so-called 5G super cycle, has been left in the rearview mirror.\nNew Street subscribes to the view that the strong iPhone 12 cycle has pulled forward smartphone sales, leaving a gap in demand going forward. Interestingly, this is exactly the opposite opinion of bullish Wedbush analyst Dan Ives, who said the following during an interview with the Apple Maven:\n\n “What the Street underestimates is how massive and elongated this super cycle is. […] 5G does not get fully embraced for the next two or three years, until the networks are built out. In China [where the 5G infrastructure is further ahead], the iPhone 12, especially the larger Pro versions, really sold extremely well.”\n\nStill on the iPhone, Mr. Ferragu laid out his expectations for 2022 back in April (I am unaware of revisions since then). He believes that iPhone shipments will reach 190 million units, suggesting segment revenues of around $150 billion – a modest annual increase of 5% from COVID-19 levels.\nCould AAPL sink 40%?\nNow, let’s put pen to paper. For Apple stock to be valued at $90 apiece, one of two things would need to happen: either financial performance would need to lag consensus expectations, or valuations would need to contract (or a combination of both).\nOn results,Wall Street currently sees fiscal 2022 EPS landing at $5.63, roughly flat against a 2021 that has been impressive so far. For AAPL to drop 40% in price, therefore, next-year earnings would need to miss consensus substantially, by at least a couple of dollars. I find this highly unlikely.\nOn valuations, AAPL currently trades at a fiscal 2021 earnings multiple of 27 times. Assuming consensus-matching results in the future, this multiple would need to drop to about 16 times for AAPL shares to sink to $90. The stock’s forward P/E has not been this low in years.\nThe Apple Maven’s take\nI find it very improbable, if not virtually impossible, for Apple to ever be valued at $90 per share again. It is much more reasonable, in my opinion, that New Street’s current price target on the stock is simply stale, following AAPL’s 25% rally in the past six months.\nTherefore, I would not be surprised to see Wall Street’s last AAPL bear eventually (soon?) give in on his downside convictions, at least in what pertains to his current price target.","news_type":1},"isVote":1,"tweetType":1,"viewCount":201,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":145705906,"gmtCreate":1626242963805,"gmtModify":1633928685242,"author":{"id":"4087711343938000","authorId":"4087711343938000","name":"ZeeJay","avatar":"https://static.tigerbbs.com/36dbec811e59c06f4aea5df6c06ea26f","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4087711343938000","authorIdStr":"4087711343938000"},"themes":[],"htmlText":"Feels too speculative for comfort..&nbsp;","listText":"Feels too speculative for comfort..&nbsp;","text":"Feels too speculative for comfort..","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/145705906","repostId":"2151565201","repostType":4,"repost":{"id":"2151565201","kind":"highlight","weMediaInfo":{"introduction":"The leading daily newsletter for the latest financial and business news. 33Yrs Helping Stock Investors with Investing Insights, Tools, News & More.","home_visible":0,"media_name":"Investors","id":"1085713068","head_image":"https://static.tigerbbs.com/608dd68a89ed486e18f64efe3136266c"},"pubTimestamp":1626177299,"share":"https://www.laohu8.com/m/news/2151565201?lang=&edition=full","pubTime":"2021-07-13 19:54","market":"us","language":"en","title":"10 Companies Are About To Post Blowout 1,000%+ Profit Growth","url":"https://stock-news.laohu8.com/highlight/detail?id=2151565201","media":"Investors","summary":"S&P 500 investors are waiting for banner profit reports to kick off this week. And some companies' profit gains are likely to be enormous.","content":"<p>S&amp;P 500 investors are waiting for banner profit reports to kick off this week. And some companies' profit gains are likely to be more enormous than others.</p>\n<p>Analysts expect 10 S&amp;P 500 companies, including health care <b>Zimmer Biomet</b>, energy firm <b>Freeport-McMoRan</b> and consumer discretionary firm <b>Chipotle Mexican Grill</b>, to post massive adjusted profit per share growth of 1,000% or much more for the second quarter. And that would make these companies S&amp;P 500 standouts in a quarter already expected to be a massive <a href=\"https://laohu8.com/S/AONE\">one</a> for profit growth, says an Investor's Business Daily analysis of data from S&amp;P Global Market Intelligence and MarketSmith.</p>\n<p>\"We ran out of superlatives to describe corporate America's stunning performance during first-quarter earnings season,\" said Jeff Buchbinder, equity strategist at LPL Financial. \"So what will companies do for an encore? We expect more good news this quarter as more of the economy has opened up, while also acknowledging the second quarter will almost certainly end up being the peak in earnings growth for this cycle.\"</p>\n<p>Profit reports kick off this week with the banks. And what a peak it'll be for S&amp;P 50o profit.</p>\n<h2>S&amp;P 500 Headed To Amazing Quarterly Profit</h2>\n<p>Companies in the S&amp;P 500 are expected to post moonshot quarterly profit growth of 64% in the second quarter, says John Butters, earnings analyst at FactSet. If that's right, it would be the largest quarterly profit posted by the S&amp;P 500 in more than a decade, Butters says.</p>\n<p>Profits are soaring back as the U.S. economy is reopening, jobs are plentiful and companies and consumers have lots of money to spend. And the speed of the economy's rebound surprised most people. Analysts bumped up their profit forecasts for the quarter 7.2% since the end of March through June 30. That's the largest upward profit growth forecast boost since FactSet has tracked it going back to 2002, Butters says.</p>\n<p>Skeptics might think this is just wishful thinking. But early indications show there's reason to be optimistic. Already 66 S&amp;P 500 companies, also a record, said second-quarter profit will top their earlier targets.</p>\n<p>So how you stand out when most companies' profits are booming? Just ask 10 S&amp;P 500 outliers.</p>\n<h2>Putting Up 1,000% Or More Profit Growth</h2>\n<p>Scanning the S&amp;P 500, Zimmer Biomet is the company to beat in terms of profit growth. Analysts think it will earn $1.86 a share on an adjusted basis in the second quarter. That's up more than 3,600% from what it earned in the same period a year ago.</p>\n<p>The company makes a variety of orthopedic products like hip and knee replacements. Demand for such goods is expected to be strong as many people now get the optional procedures they put off during the pandemic. Zimmer Biomet reports its second quarter profit on Aug. 3. Shares are only up 3.8% this year so far.</p>\n<p>Energy, though, is an area where profits and share prices are booming. Shares of copper miner Freeport-McMoRan are up more than 40% as investors anticipate an amazing quarter for profits. Analysts are calling for the company to earn nearly 74 cents a share in the second quarter, up more than 2,350% from the same year-ago period. Such strong fundamentals paired with a rising stock price explain the lofty 93 IBD Composite Rating. The company reports on July 22.</p>\n<p>And when it comes to a high Composite Rating, look at Chipotle. The burrito chain sports a near perfect IBD Composite Rating of 98. Shares are up 16.5% this year, roughly in line with the S&amp;P 500. But get ready for a hot-red quarter of profit growth. Analysts think it will report second-quarter profit growth of more than 1,517% or $6.47 a share. Chipotle reports on July 20.</p>\n<p>So while it's going to be a powerful period of growth for the S&amp;P 500, it's still possible to beat the average.</p>\n<h2>A Bonanza Of Profit Is Coming</h2>\n<p><i>Analysts see 1,000% or more profit growth from these S&amp;P 500 companies in the second quarter</i></p>\n<table>\n <thead>\n  <tr>\n   <th>Company</th>\n   <th>Ticker</th>\n   <th>Q2 EPS % Ch.</th>\n   <th>Primary Sector</th>\n   <th>Composite Rating</th>\n   <th>% stock YTD ch.</th>\n  </tr>\n </thead>\n <tbody>\n  <tr>\n   <td>Zimmer Biomet</td>\n   <td></td>\n   <td><b>3,620.0%</b></td>\n   <td>Health Care</td>\n   <td>39</td>\n   <td>3.8%</td>\n  </tr>\n  <tr>\n   <td>Freeport-McMoRan</td>\n   <td></td>\n   <td><b>2,353.3%</b></td>\n   <td>Materials</td>\n   <td>93</td>\n   <td>40.4%</td>\n  </tr>\n  <tr>\n   <td>Hasbro</td>\n   <td></td>\n   <td><b>2,285.0%</b></td>\n   <td>Consumer Discretionary</td>\n   <td>67</td>\n   <td>4.9%</td>\n  </tr>\n  <tr>\n   <td><a href=\"https://laohu8.com/S/SYF\">Synchrony Financial</a></td>\n   <td></td>\n   <td><b>2,150.0%</b></td>\n   <td>Financials</td>\n   <td>88</td>\n   <td>40.4%</td>\n  </tr>\n  <tr>\n   <td>W. R. Berkley</td>\n   <td></td>\n   <td><b>1,525.0%</b></td>\n   <td>Financials</td>\n   <td>71</td>\n   <td>14.8%</td>\n  </tr>\n  <tr>\n   <td>Chipotle Mexican Grill</td>\n   <td></td>\n   <td><b>1,517.5%</b></td>\n   <td>Consumer Discretionary</td>\n   <td>98</td>\n   <td>16.5%</td>\n  </tr>\n  <tr>\n   <td>Ross Stores</td>\n   <td></td>\n   <td><b>1,460.0%</b></td>\n   <td>Consumer Discretionary</td>\n   <td>72</td>\n   <td>1.1%</td>\n  </tr>\n  <tr>\n   <td><a href=\"https://laohu8.com/S/FANG\">Diamondback Energy</a></td>\n   <td></td>\n   <td><b>1,306.7%</b></td>\n   <td>Energy</td>\n   <td>97</td>\n   <td>85.6%</td>\n  </tr>\n  <tr>\n   <td>Nucor</td>\n   <td></td>\n   <td><b>1,179.6%</b></td>\n   <td>Materials</td>\n   <td>98</td>\n   <td>83.8%</td>\n  </tr>\n  <tr>\n   <td>Weyerhaeuser</td>\n   <td></td>\n   <td><b>1,109.1%</b></td>\n   <td>Real Estate</td>\n   <td>87</td>\n   <td>6.3%</td>\n  </tr>\n </tbody>\n</table>\n<h5>Sources: IBD, S&amp;P Global Market Intelligence</h5>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>10 Companies Are About To Post Blowout 1,000%+ Profit Growth</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n10 Companies Are About To Post Blowout 1,000%+ Profit Growth\n</h2>\n\n<h4 class=\"meta\">\n\n\n<div class=\"head\" \">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/608dd68a89ed486e18f64efe3136266c);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Investors </p>\n<p class=\"h-time\">2021-07-13 19:54</p>\n</div>\n\n</div>\n\n\n</h4>\n\n</header>\n<article>\n<p>S&amp;P 500 investors are waiting for banner profit reports to kick off this week. And some companies' profit gains are likely to be more enormous than others.</p>\n<p>Analysts expect 10 S&amp;P 500 companies, including health care <b>Zimmer Biomet</b>, energy firm <b>Freeport-McMoRan</b> and consumer discretionary firm <b>Chipotle Mexican Grill</b>, to post massive adjusted profit per share growth of 1,000% or much more for the second quarter. And that would make these companies S&amp;P 500 standouts in a quarter already expected to be a massive <a href=\"https://laohu8.com/S/AONE\">one</a> for profit growth, says an Investor's Business Daily analysis of data from S&amp;P Global Market Intelligence and MarketSmith.</p>\n<p>\"We ran out of superlatives to describe corporate America's stunning performance during first-quarter earnings season,\" said Jeff Buchbinder, equity strategist at LPL Financial. \"So what will companies do for an encore? We expect more good news this quarter as more of the economy has opened up, while also acknowledging the second quarter will almost certainly end up being the peak in earnings growth for this cycle.\"</p>\n<p>Profit reports kick off this week with the banks. And what a peak it'll be for S&amp;P 50o profit.</p>\n<h2>S&amp;P 500 Headed To Amazing Quarterly Profit</h2>\n<p>Companies in the S&amp;P 500 are expected to post moonshot quarterly profit growth of 64% in the second quarter, says John Butters, earnings analyst at FactSet. If that's right, it would be the largest quarterly profit posted by the S&amp;P 500 in more than a decade, Butters says.</p>\n<p>Profits are soaring back as the U.S. economy is reopening, jobs are plentiful and companies and consumers have lots of money to spend. And the speed of the economy's rebound surprised most people. Analysts bumped up their profit forecasts for the quarter 7.2% since the end of March through June 30. That's the largest upward profit growth forecast boost since FactSet has tracked it going back to 2002, Butters says.</p>\n<p>Skeptics might think this is just wishful thinking. But early indications show there's reason to be optimistic. Already 66 S&amp;P 500 companies, also a record, said second-quarter profit will top their earlier targets.</p>\n<p>So how you stand out when most companies' profits are booming? Just ask 10 S&amp;P 500 outliers.</p>\n<h2>Putting Up 1,000% Or More Profit Growth</h2>\n<p>Scanning the S&amp;P 500, Zimmer Biomet is the company to beat in terms of profit growth. Analysts think it will earn $1.86 a share on an adjusted basis in the second quarter. That's up more than 3,600% from what it earned in the same period a year ago.</p>\n<p>The company makes a variety of orthopedic products like hip and knee replacements. Demand for such goods is expected to be strong as many people now get the optional procedures they put off during the pandemic. Zimmer Biomet reports its second quarter profit on Aug. 3. Shares are only up 3.8% this year so far.</p>\n<p>Energy, though, is an area where profits and share prices are booming. Shares of copper miner Freeport-McMoRan are up more than 40% as investors anticipate an amazing quarter for profits. Analysts are calling for the company to earn nearly 74 cents a share in the second quarter, up more than 2,350% from the same year-ago period. Such strong fundamentals paired with a rising stock price explain the lofty 93 IBD Composite Rating. The company reports on July 22.</p>\n<p>And when it comes to a high Composite Rating, look at Chipotle. The burrito chain sports a near perfect IBD Composite Rating of 98. Shares are up 16.5% this year, roughly in line with the S&amp;P 500. But get ready for a hot-red quarter of profit growth. Analysts think it will report second-quarter profit growth of more than 1,517% or $6.47 a share. Chipotle reports on July 20.</p>\n<p>So while it's going to be a powerful period of growth for the S&amp;P 500, it's still possible to beat the average.</p>\n<h2>A Bonanza Of Profit Is Coming</h2>\n<p><i>Analysts see 1,000% or more profit growth from these S&amp;P 500 companies in the second quarter</i></p>\n<table>\n <thead>\n  <tr>\n   <th>Company</th>\n   <th>Ticker</th>\n   <th>Q2 EPS % Ch.</th>\n   <th>Primary Sector</th>\n   <th>Composite Rating</th>\n   <th>% stock YTD ch.</th>\n  </tr>\n </thead>\n <tbody>\n  <tr>\n   <td>Zimmer Biomet</td>\n   <td></td>\n   <td><b>3,620.0%</b></td>\n   <td>Health Care</td>\n   <td>39</td>\n   <td>3.8%</td>\n  </tr>\n  <tr>\n   <td>Freeport-McMoRan</td>\n   <td></td>\n   <td><b>2,353.3%</b></td>\n   <td>Materials</td>\n   <td>93</td>\n   <td>40.4%</td>\n  </tr>\n  <tr>\n   <td>Hasbro</td>\n   <td></td>\n   <td><b>2,285.0%</b></td>\n   <td>Consumer Discretionary</td>\n   <td>67</td>\n   <td>4.9%</td>\n  </tr>\n  <tr>\n   <td><a href=\"https://laohu8.com/S/SYF\">Synchrony Financial</a></td>\n   <td></td>\n   <td><b>2,150.0%</b></td>\n   <td>Financials</td>\n   <td>88</td>\n   <td>40.4%</td>\n  </tr>\n  <tr>\n   <td>W. R. Berkley</td>\n   <td></td>\n   <td><b>1,525.0%</b></td>\n   <td>Financials</td>\n   <td>71</td>\n   <td>14.8%</td>\n  </tr>\n  <tr>\n   <td>Chipotle Mexican Grill</td>\n   <td></td>\n   <td><b>1,517.5%</b></td>\n   <td>Consumer Discretionary</td>\n   <td>98</td>\n   <td>16.5%</td>\n  </tr>\n  <tr>\n   <td>Ross Stores</td>\n   <td></td>\n   <td><b>1,460.0%</b></td>\n   <td>Consumer Discretionary</td>\n   <td>72</td>\n   <td>1.1%</td>\n  </tr>\n  <tr>\n   <td><a href=\"https://laohu8.com/S/FANG\">Diamondback Energy</a></td>\n   <td></td>\n   <td><b>1,306.7%</b></td>\n   <td>Energy</td>\n   <td>97</td>\n   <td>85.6%</td>\n  </tr>\n  <tr>\n   <td>Nucor</td>\n   <td></td>\n   <td><b>1,179.6%</b></td>\n   <td>Materials</td>\n   <td>98</td>\n   <td>83.8%</td>\n  </tr>\n  <tr>\n   <td>Weyerhaeuser</td>\n   <td></td>\n   <td><b>1,109.1%</b></td>\n   <td>Real Estate</td>\n   <td>87</td>\n   <td>6.3%</td>\n  </tr>\n </tbody>\n</table>\n<h5>Sources: IBD, S&amp;P Global Market Intelligence</h5>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"CMG":"墨式烧烤","ZBH":"齐默巴奥米特控股","FCX":"麦克莫兰铜金","POST":"Post Holdings"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2151565201","content_text":"S&P 500 investors are waiting for banner profit reports to kick off this week. And some companies' profit gains are likely to be more enormous than others.\nAnalysts expect 10 S&P 500 companies, including health care Zimmer Biomet, energy firm Freeport-McMoRan and consumer discretionary firm Chipotle Mexican Grill, to post massive adjusted profit per share growth of 1,000% or much more for the second quarter. And that would make these companies S&P 500 standouts in a quarter already expected to be a massive one for profit growth, says an Investor's Business Daily analysis of data from S&P Global Market Intelligence and MarketSmith.\n\"We ran out of superlatives to describe corporate America's stunning performance during first-quarter earnings season,\" said Jeff Buchbinder, equity strategist at LPL Financial. \"So what will companies do for an encore? We expect more good news this quarter as more of the economy has opened up, while also acknowledging the second quarter will almost certainly end up being the peak in earnings growth for this cycle.\"\nProfit reports kick off this week with the banks. And what a peak it'll be for S&P 50o profit.\nS&P 500 Headed To Amazing Quarterly Profit\nCompanies in the S&P 500 are expected to post moonshot quarterly profit growth of 64% in the second quarter, says John Butters, earnings analyst at FactSet. If that's right, it would be the largest quarterly profit posted by the S&P 500 in more than a decade, Butters says.\nProfits are soaring back as the U.S. economy is reopening, jobs are plentiful and companies and consumers have lots of money to spend. And the speed of the economy's rebound surprised most people. Analysts bumped up their profit forecasts for the quarter 7.2% since the end of March through June 30. That's the largest upward profit growth forecast boost since FactSet has tracked it going back to 2002, Butters says.\nSkeptics might think this is just wishful thinking. But early indications show there's reason to be optimistic. Already 66 S&P 500 companies, also a record, said second-quarter profit will top their earlier targets.\nSo how you stand out when most companies' profits are booming? Just ask 10 S&P 500 outliers.\nPutting Up 1,000% Or More Profit Growth\nScanning the S&P 500, Zimmer Biomet is the company to beat in terms of profit growth. Analysts think it will earn $1.86 a share on an adjusted basis in the second quarter. That's up more than 3,600% from what it earned in the same period a year ago.\nThe company makes a variety of orthopedic products like hip and knee replacements. Demand for such goods is expected to be strong as many people now get the optional procedures they put off during the pandemic. Zimmer Biomet reports its second quarter profit on Aug. 3. Shares are only up 3.8% this year so far.\nEnergy, though, is an area where profits and share prices are booming. Shares of copper miner Freeport-McMoRan are up more than 40% as investors anticipate an amazing quarter for profits. Analysts are calling for the company to earn nearly 74 cents a share in the second quarter, up more than 2,350% from the same year-ago period. Such strong fundamentals paired with a rising stock price explain the lofty 93 IBD Composite Rating. The company reports on July 22.\nAnd when it comes to a high Composite Rating, look at Chipotle. The burrito chain sports a near perfect IBD Composite Rating of 98. Shares are up 16.5% this year, roughly in line with the S&P 500. But get ready for a hot-red quarter of profit growth. Analysts think it will report second-quarter profit growth of more than 1,517% or $6.47 a share. Chipotle reports on July 20.\nSo while it's going to be a powerful period of growth for the S&P 500, it's still possible to beat the average.\nA Bonanza Of Profit Is Coming\nAnalysts see 1,000% or more profit growth from these S&P 500 companies in the second quarter\n\n\n\nCompany\nTicker\nQ2 EPS % Ch.\nPrimary Sector\nComposite Rating\n% stock YTD ch.\n\n\n\n\nZimmer Biomet\n\n3,620.0%\nHealth Care\n39\n3.8%\n\n\nFreeport-McMoRan\n\n2,353.3%\nMaterials\n93\n40.4%\n\n\nHasbro\n\n2,285.0%\nConsumer Discretionary\n67\n4.9%\n\n\nSynchrony Financial\n\n2,150.0%\nFinancials\n88\n40.4%\n\n\nW. R. Berkley\n\n1,525.0%\nFinancials\n71\n14.8%\n\n\nChipotle Mexican Grill\n\n1,517.5%\nConsumer Discretionary\n98\n16.5%\n\n\nRoss Stores\n\n1,460.0%\nConsumer Discretionary\n72\n1.1%\n\n\nDiamondback Energy\n\n1,306.7%\nEnergy\n97\n85.6%\n\n\nNucor\n\n1,179.6%\nMaterials\n98\n83.8%\n\n\nWeyerhaeuser\n\n1,109.1%\nReal Estate\n87\n6.3%\n\n\n\nSources: IBD, S&P Global Market Intelligence","news_type":1},"isVote":1,"tweetType":1,"viewCount":258,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":149346119,"gmtCreate":1625706735431,"gmtModify":1631883983184,"author":{"id":"4087711343938000","authorId":"4087711343938000","name":"ZeeJay","avatar":"https://static.tigerbbs.com/36dbec811e59c06f4aea5df6c06ea26f","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4087711343938000","authorIdStr":"4087711343938000"},"themes":[],"htmlText":"Another one riding on a high..","listText":"Another one riding on a high..","text":"Another one riding on a high..","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/149346119","repostId":"2149697283","repostType":4,"isVote":1,"tweetType":1,"viewCount":339,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":149341537,"gmtCreate":1625706681929,"gmtModify":1633938178521,"author":{"id":"4087711343938000","authorId":"4087711343938000","name":"ZeeJay","avatar":"https://static.tigerbbs.com/36dbec811e59c06f4aea5df6c06ea26f","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4087711343938000","authorIdStr":"4087711343938000"},"themes":[],"htmlText":"Too much speculation on healthcare and biotech.. Wait fornsome stability before plunging.","listText":"Too much speculation on healthcare and biotech.. Wait fornsome stability before plunging.","text":"Too much speculation on healthcare and biotech.. Wait fornsome stability before plunging.","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/149341537","repostId":"2149365051","repostType":4,"repost":{"id":"2149365051","kind":"highlight","pubTimestamp":1625648700,"share":"https://www.laohu8.com/m/news/2149365051?lang=&edition=full","pubTime":"2021-07-07 17:05","market":"us","language":"en","title":"3 Biotechs to Avoid Like the Plague in July","url":"https://stock-news.laohu8.com/highlight/detail?id=2149365051","media":"Motley Fool","summary":"Generally speaking, biotech is a pretty innovative industry -- with a few notable bad apples.","content":"<p>Biotech is an industry that has deeply enriched investors' pockets and helped numerous patients alike -- most recently in the form of coronavirus vaccine companies working to contain the once-in-a-lifetime pandemic. The sector is not without its risks, however. A few small-cap players using questionable science have sold investors on false dreams of miracle drugs that could become game-changers in their field, and in these cases, that couldn't be further from the truth.&nbsp;</p>\n<p>Avoiding bad investments is just as important as making good ones. So let's look at the dark side of investing in biotech and which companies to stay well away from.&nbsp;</p>\n<p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/6bccd5c36f3f76148be467937b9b6293\" tg-width=\"700\" tg-height=\"466\" referrerpolicy=\"no-referrer\"><span>Image source: Getty Images.</span></p>\n<h2>1. Cel-Sci</h2>\n<p>Sometimes, <a href=\"https://laohu8.com/S/AONE\">one</a> is dealt a bad hand in life and will need to bluff. However, it's a whole different story to double down on a bluff after <a href=\"https://laohu8.com/S/AONE.U\">one</a>'s cover is blown.&nbsp;</p>\n<p>Take the case of&nbsp;<b>Cel-Sci&nbsp;</b>(NYSEMKT:CVM), a small-cap biotech with a single late-stage immunotherapy candidate (Multikine) for treating head and neck cancer. On June 28, Cel-Sci announced that Multikine failed to achieve the primary endpoint of boosting patient survival by 10% compared to standard-of-care treatments in a decade-long phase 3 trial. As a result, the stock lost 66% of its value within four days, to $8.65.</p>\n<p>It's pretty hard to walk away from a giant bluff when there's just too much in the pot. In a conference call to investors on July 1, CEO Geert Kersten heralded the study as a \"success,\" saying that a cohort of patients who received Multikine plus surgery plus radiotherapy \"met the primary endpoint,\" and that Cel-Sci plans to file for regulatory approval. Later on in the call, chief scientific officer Taylor Eval denied all allegations the company was data-mining the study. On a side note, Kersten said he will \"not be releasing the [full] data to shareholders.\"</p>\n<p>The data that management is referring to is from a subgroup of patients in the Multikine cohort who did not receive chemotherapy in the study. This group of patients survived 14.3% longer after five years than the group who received no Multikine at all -- but that does not mean Multikine works on patients without chemotherapy. It has nothing to do with the study's primary endpoint (which includes both patients who did and did not receive chemotherapy). So the data-mining here is, in fact, pretty evident.</p>\n<p>It's also very easy to see how the drug could have a placebo effect. In clinical trials, Multikine was injected in or around the tumor. In case one was wondering, injecting just about anything into a tumor causes the cancer cells to die off -- partly due to needle damage. Moreover, patients in the 9.5-year study received Multikine for just three weeks and were not treated with the drug if their cancer relapsed. So anything (such as lifestyle choices, receiving other immunotherapies post-relapse, etc.) could have been behind the survival difference in the subgroups.</p>\n<p>Before the results came out (which took over a year), Cel-Sci bagged $31.7 million in cash by selling new stock to retail investors, resulting in heavy losses for shareholders less than three weeks after the deal closed. Overall, given the failure of its flagship candidate, the less than $50 million in assets on its books, and questionable conduct from management, this is definitely a biotech you don't want to be holding anytime soon (if not ever).&nbsp;</p>\n<h2>2. CytoDyn&nbsp;</h2>\n<p><b>CytoDyn</b> (OTC:CYDY) is a biotech known for developing leronlimab, an antibody that failed two phase 3 clinical studies for treating COVID-19. In May, the U.S. Food and Drug Administration (FDA) even released a rare statement saying that the drug did not meet the primary endpoints in these studies.&nbsp;</p>\n<p>In response, CEO Nader Pourhassan has adopted a \"catch me if you can\" type of strategy. In other words, CytoDyn simply moved outside of the FDA's jurisdiction and began commercializing the drug in countries like the Philippines.&nbsp;</p>\n<p>It's perplexing as to why the company would risk its relationship with the FDA like this. Aside from the COVID-19 indication, leronlimab is also under investigation for the treatment of HIV. In one study, leronlimab reduced viral load to negligible levels in 83% of patients with HIV.</p>\n<p>I wouldn't be surprised if the rivalry between Pourhassan and the FDA has gone down to the personal level. Last July, the FDA rejected CytoDyn's Biologic License Application (BLA) filing for leronlimab's approval for treating HIV. But the agency did not ask for another clinical trial; it just wanted additional information about the drug and a meeting with company management. CytoDyn has just begun the process to resubmit its BLA on July 1, almost a year later.</p>\n<p>At the end of the day, biotechs with sketchy science and management woes shouldn't be trading at a $1 billion market cap. Take note that CytoDyn has less than $150 million in total assets, leaving shareholders with little recourse in case of further blunders.&nbsp;</p>\n<h2>3. Northwest Biotherapeutics&nbsp;</h2>\n<p><b>Northwest Biotherapeutics</b>&nbsp;(OTC:NWBO) is a company that closely mirrors Cel-Sci in terms of both its science and stock price. Its management is also even more \"audacious\" than that of the previous companies.&nbsp;</p>\n<p>The company's flagship candidate is an immunotherapy known as DCVax-L, which is under investigation for the treatment of glioblastoma multiforme, the most deadly form of brain cancer. The phase 3 study has been going on since December 2006 (almost 15 years now). It was originally a phase 2 study, but the company \"phase-shifted\" it to 3, citing difficulty in finding patients who are comfortable taking a placebo for the deadly illness.</p>\n<p>The study had numerous red flags from the start. Northwest was supposed to conduct two interim analyses of the trial data starting in December 2013. Yes, you read that right, December of 2013. By August 2014, however, the company had released a statement claiming that \"no interim analysis of efficacy in the Phase III trial [had] been done.\" What's more, the FDA halted the DCVax-L clinical trial in August 2015 before lifting it two years later. To this day, Northwest's management has never explained the reasons behind the trial halt.</p>\n<p>The company did eventually perform the interim analyses in 2017 and 2018, but released the results unblinded. When it comes to deadly diseases with significant unmet needs, clinical trials can be stopped early if the experimental drug meets the primary endpoint for ethical reasons. That did not happen with DCVax-L on both occasions.</p>\n<p>Last October, Northwest finally announced that the trial was coming to its end and that data was to be sent for statistical analysis. It's been more than nine months since the announcement, and no news. But, again, from an ethical endpoint, if DCVax-L was working, it doesn't make sense that Northwest wouldn't release top-line data and rush the drug to approval to save lives.</p>\n<p>Shareholders should be expecting a lot of pain ahead, as the company inexplicably has a market cap of $1.27 billion -- with an unpromising candidate and less than $35 million in total assets. All of this makes Northwest's fate look eerily similar to that of Cel-Sci -- and a stock to stay away from for good.&nbsp;</p>","source":"fool_stock","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>3 Biotechs to Avoid Like the Plague in July</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n3 Biotechs to Avoid Like the Plague in July\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-07-07 17:05 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.fool.com/investing/2021/07/06/3-biotechs-to-avoid-like-the-plague-in-july/><strong>Motley Fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Biotech is an industry that has deeply enriched investors' pockets and helped numerous patients alike -- most recently in the form of coronavirus vaccine companies working to contain the once-in-a-...</p>\n\n<a href=\"https://www.fool.com/investing/2021/07/06/3-biotechs-to-avoid-like-the-plague-in-july/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"CVM":"CEL-SCI Corp","CYDY":"CytoDyn Inc.","NWBO":"西北生物疗法"},"source_url":"https://www.fool.com/investing/2021/07/06/3-biotechs-to-avoid-like-the-plague-in-july/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2149365051","content_text":"Biotech is an industry that has deeply enriched investors' pockets and helped numerous patients alike -- most recently in the form of coronavirus vaccine companies working to contain the once-in-a-lifetime pandemic. The sector is not without its risks, however. A few small-cap players using questionable science have sold investors on false dreams of miracle drugs that could become game-changers in their field, and in these cases, that couldn't be further from the truth. \nAvoiding bad investments is just as important as making good ones. So let's look at the dark side of investing in biotech and which companies to stay well away from. \nImage source: Getty Images.\n1. Cel-Sci\nSometimes, one is dealt a bad hand in life and will need to bluff. However, it's a whole different story to double down on a bluff after one's cover is blown. \nTake the case of Cel-Sci (NYSEMKT:CVM), a small-cap biotech with a single late-stage immunotherapy candidate (Multikine) for treating head and neck cancer. On June 28, Cel-Sci announced that Multikine failed to achieve the primary endpoint of boosting patient survival by 10% compared to standard-of-care treatments in a decade-long phase 3 trial. As a result, the stock lost 66% of its value within four days, to $8.65.\nIt's pretty hard to walk away from a giant bluff when there's just too much in the pot. In a conference call to investors on July 1, CEO Geert Kersten heralded the study as a \"success,\" saying that a cohort of patients who received Multikine plus surgery plus radiotherapy \"met the primary endpoint,\" and that Cel-Sci plans to file for regulatory approval. Later on in the call, chief scientific officer Taylor Eval denied all allegations the company was data-mining the study. On a side note, Kersten said he will \"not be releasing the [full] data to shareholders.\"\nThe data that management is referring to is from a subgroup of patients in the Multikine cohort who did not receive chemotherapy in the study. This group of patients survived 14.3% longer after five years than the group who received no Multikine at all -- but that does not mean Multikine works on patients without chemotherapy. It has nothing to do with the study's primary endpoint (which includes both patients who did and did not receive chemotherapy). So the data-mining here is, in fact, pretty evident.\nIt's also very easy to see how the drug could have a placebo effect. In clinical trials, Multikine was injected in or around the tumor. In case one was wondering, injecting just about anything into a tumor causes the cancer cells to die off -- partly due to needle damage. Moreover, patients in the 9.5-year study received Multikine for just three weeks and were not treated with the drug if their cancer relapsed. So anything (such as lifestyle choices, receiving other immunotherapies post-relapse, etc.) could have been behind the survival difference in the subgroups.\nBefore the results came out (which took over a year), Cel-Sci bagged $31.7 million in cash by selling new stock to retail investors, resulting in heavy losses for shareholders less than three weeks after the deal closed. Overall, given the failure of its flagship candidate, the less than $50 million in assets on its books, and questionable conduct from management, this is definitely a biotech you don't want to be holding anytime soon (if not ever). \n2. CytoDyn \nCytoDyn (OTC:CYDY) is a biotech known for developing leronlimab, an antibody that failed two phase 3 clinical studies for treating COVID-19. In May, the U.S. Food and Drug Administration (FDA) even released a rare statement saying that the drug did not meet the primary endpoints in these studies. \nIn response, CEO Nader Pourhassan has adopted a \"catch me if you can\" type of strategy. In other words, CytoDyn simply moved outside of the FDA's jurisdiction and began commercializing the drug in countries like the Philippines. \nIt's perplexing as to why the company would risk its relationship with the FDA like this. Aside from the COVID-19 indication, leronlimab is also under investigation for the treatment of HIV. In one study, leronlimab reduced viral load to negligible levels in 83% of patients with HIV.\nI wouldn't be surprised if the rivalry between Pourhassan and the FDA has gone down to the personal level. Last July, the FDA rejected CytoDyn's Biologic License Application (BLA) filing for leronlimab's approval for treating HIV. But the agency did not ask for another clinical trial; it just wanted additional information about the drug and a meeting with company management. CytoDyn has just begun the process to resubmit its BLA on July 1, almost a year later.\nAt the end of the day, biotechs with sketchy science and management woes shouldn't be trading at a $1 billion market cap. Take note that CytoDyn has less than $150 million in total assets, leaving shareholders with little recourse in case of further blunders. \n3. Northwest Biotherapeutics \nNorthwest Biotherapeutics (OTC:NWBO) is a company that closely mirrors Cel-Sci in terms of both its science and stock price. Its management is also even more \"audacious\" than that of the previous companies. \nThe company's flagship candidate is an immunotherapy known as DCVax-L, which is under investigation for the treatment of glioblastoma multiforme, the most deadly form of brain cancer. The phase 3 study has been going on since December 2006 (almost 15 years now). It was originally a phase 2 study, but the company \"phase-shifted\" it to 3, citing difficulty in finding patients who are comfortable taking a placebo for the deadly illness.\nThe study had numerous red flags from the start. Northwest was supposed to conduct two interim analyses of the trial data starting in December 2013. Yes, you read that right, December of 2013. By August 2014, however, the company had released a statement claiming that \"no interim analysis of efficacy in the Phase III trial [had] been done.\" What's more, the FDA halted the DCVax-L clinical trial in August 2015 before lifting it two years later. To this day, Northwest's management has never explained the reasons behind the trial halt.\nThe company did eventually perform the interim analyses in 2017 and 2018, but released the results unblinded. When it comes to deadly diseases with significant unmet needs, clinical trials can be stopped early if the experimental drug meets the primary endpoint for ethical reasons. That did not happen with DCVax-L on both occasions.\nLast October, Northwest finally announced that the trial was coming to its end and that data was to be sent for statistical analysis. It's been more than nine months since the announcement, and no news. But, again, from an ethical endpoint, if DCVax-L was working, it doesn't make sense that Northwest wouldn't release top-line data and rush the drug to approval to save lives.\nShareholders should be expecting a lot of pain ahead, as the company inexplicably has a market cap of $1.27 billion -- with an unpromising candidate and less than $35 million in total assets. All of this makes Northwest's fate look eerily similar to that of Cel-Sci -- and a stock to stay away from for good.","news_type":1},"isVote":1,"tweetType":1,"viewCount":253,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":157988300,"gmtCreate":1625559877500,"gmtModify":1633939646570,"author":{"id":"4087711343938000","authorId":"4087711343938000","name":"ZeeJay","avatar":"https://static.tigerbbs.com/36dbec811e59c06f4aea5df6c06ea26f","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4087711343938000","authorIdStr":"4087711343938000"},"themes":[],"htmlText":"Risk of Chinese mobile app businesses..&nbsp;","listText":"Risk of Chinese mobile app businesses..&nbsp;","text":"Risk of Chinese mobile app businesses..","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/157988300","repostId":"1145795655","repostType":4,"isVote":1,"tweetType":1,"viewCount":332,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":152510412,"gmtCreate":1625309792436,"gmtModify":1631884322698,"author":{"id":"4087711343938000","authorId":"4087711343938000","name":"ZeeJay","avatar":"https://static.tigerbbs.com/36dbec811e59c06f4aea5df6c06ea26f","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4087711343938000","authorIdStr":"4087711343938000"},"themes":[],"htmlText":"Hope its real tips..&nbsp;","listText":"Hope its real tips..&nbsp;","text":"Hope its real tips..","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/152510412","repostId":"2148725958","repostType":4,"repost":{"id":"2148725958","kind":"highlight","pubTimestamp":1625227829,"share":"https://www.laohu8.com/m/news/2148725958?lang=&edition=full","pubTime":"2021-07-02 20:10","market":"us","language":"en","title":"3 Stocks Cathie Wood Is Selling That Could Still Make You Rich","url":"https://stock-news.laohu8.com/highlight/detail?id=2148725958","media":"Motley Fool","summary":"It's not always the best move to copy what the successful investor does.","content":"<p>L.A. Lakers star Lebron James doesn't make every shot he takes. Tennis great Serena Williams doesn't win every match she plays. And successful investor Cathie Wood sometimes makes the wrong call on a stock.</p>\n<p>I think Wood does a great job with her ARK Invest ETFs. The proof is in the fantastic performance she's achieved over the years. However, I also view some of the recent moves to sell certain stocks in the ARK ETFs as short-sighted. Here are three stocks Wood is selling that I believe could still make you rich over the long run.</p>\n<p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/519578e90d4a7c02b89d60c8b46b0a43\" tg-width=\"700\" tg-height=\"525\"><span>Image source: Getty Images.</span></p>\n<h2>Pinterest</h2>\n<p>Wood's <b>ARK Fintech Revolution ETF</b> (NYSEMKT:ARKF) sold more than 320,000 shares of&nbsp;<b>Pinterest</b> (NYSE:PINS) in recent weeks. However, the social media stock still ranks in the top 10 holdings of the ETF.</p>\n<p>My Motley Fool colleague Danny Vena views Pinterest as <a href=\"https://laohu8.com/S/AONE\">one</a> of the three top e-commerce stocks to buy right now. I agree with Danny's take on Pinterest (and his other two picks, for that matter).</p>\n<p>Some might be concerned that Pinterest's monthly average user growth rate is slipping a little. Not me. I think that's to be expected after the pandemic-fueled growth of 2020.</p>\n<p>I fully expect that Pinterest will continue to attract more users, including men (the company's customer base currently largely consists of women.) I also look for the company to boost its monetization in international markets as well as in the U.S. Pinterest could easily double its current market cap of $50 billion over the next few years, in my view.</p>\n<h2>Sea Limited</h2>\n<p><a href=\"https://laohu8.com/S/TWOA.U\">Two</a> of Wood's ETFs have sold shares of&nbsp;<b>Sea Limited</b> (NYSE:SE) over the last few weeks -- the ARK Fintech Revolution ETF and the <b><a href=\"https://laohu8.com/S/ARKW\">ARK Next Generation Internet ETF</a></b> (NYSEMKT:ARKW). Still, though, Sea remains the No. 3 holding in the fintech ETF and ranks No. 16 in the internet ETF.</p>\n<p>Sea stands as <a href=\"https://laohu8.com/S/AONE.U\">one</a> of the fastest-growing large-cap stocks on the planet. Its business is expanding on all fronts -- digital entertainment, e-commerce, and digital payments.</p>\n<p>For now, Sea makes most of its money from its digital entertainment unit thanks to the super-popular <i>Free Fire</i> mobile game. It could have even greater growth opportunities over the long term, though, with its Shopee e-commerce platform.</p>\n<p>The company's name reflects an abbreviation for its primary market -- Southeast Asia. However, Sea continues to make solid inroads into the Latin American market. My prediction is that Sea will become a much bigger player in the region, making patient investors a lot of money in the process.</p>\n<h2>Square</h2>\n<p>Three of Wood's ETFs were scooping up shares of&nbsp;<b>Square</b> (NYSE:SQ) in May. That changed in June, though, with the ARK Next Generation Internet ETF selling over 73,500 shares of the fintech stock.</p>\n<p>Don't think that Wood has soured on Square's prospects. The stock remains the No. 1 holding in the ARK Fintech Revolution ETF and is the fourth-biggest position in the <b><a href=\"https://laohu8.com/S/ARKK\">ARK Innovation ETF</a></b> (NYSEMKT:ARKK).</p>\n<p>Sure, Square's valuation seems ridiculously high, with shares trading at close to 170 times expected earnings. However, disruptive companies almost always command steep valuations. And make no mistake about it: Square is a disruptor.</p>\n<p>The company already offers a wide array of services to businesses. Square is positioning itself to also become a full-fledged commercial bank.</p>\n<p>Perhaps Square's greatest opportunity, though, lies in the individual financial services market. The company's Cash App provides a convenient way for consumers to digitally transfer money and buy and sell stocks and <b>Bitcoin</b>.</p>\n<p>It's easy to see Square expanding Cash App to support personal loans and more features in the future. It's also easy to envision this stock making investors much wealthier over the next decade and beyond.</p>","source":"fool_stock","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>3 Stocks Cathie Wood Is Selling That Could Still Make You Rich</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n3 Stocks Cathie Wood Is Selling That Could Still Make You Rich\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-07-02 20:10 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.fool.com/investing/2021/07/02/3-stocks-cathie-wood-is-selling-that-could-still-m/><strong>Motley Fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>L.A. Lakers star Lebron James doesn't make every shot he takes. Tennis great Serena Williams doesn't win every match she plays. And successful investor Cathie Wood sometimes makes the wrong call on a ...</p>\n\n<a href=\"https://www.fool.com/investing/2021/07/02/3-stocks-cathie-wood-is-selling-that-could-still-m/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"SQ":"Block","SE":"Sea Ltd","PINS":"Pinterest, Inc."},"source_url":"https://www.fool.com/investing/2021/07/02/3-stocks-cathie-wood-is-selling-that-could-still-m/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2148725958","content_text":"L.A. Lakers star Lebron James doesn't make every shot he takes. Tennis great Serena Williams doesn't win every match she plays. And successful investor Cathie Wood sometimes makes the wrong call on a stock.\nI think Wood does a great job with her ARK Invest ETFs. The proof is in the fantastic performance she's achieved over the years. However, I also view some of the recent moves to sell certain stocks in the ARK ETFs as short-sighted. Here are three stocks Wood is selling that I believe could still make you rich over the long run.\nImage source: Getty Images.\nPinterest\nWood's ARK Fintech Revolution ETF (NYSEMKT:ARKF) sold more than 320,000 shares of Pinterest (NYSE:PINS) in recent weeks. However, the social media stock still ranks in the top 10 holdings of the ETF.\nMy Motley Fool colleague Danny Vena views Pinterest as one of the three top e-commerce stocks to buy right now. I agree with Danny's take on Pinterest (and his other two picks, for that matter).\nSome might be concerned that Pinterest's monthly average user growth rate is slipping a little. Not me. I think that's to be expected after the pandemic-fueled growth of 2020.\nI fully expect that Pinterest will continue to attract more users, including men (the company's customer base currently largely consists of women.) I also look for the company to boost its monetization in international markets as well as in the U.S. Pinterest could easily double its current market cap of $50 billion over the next few years, in my view.\nSea Limited\nTwo of Wood's ETFs have sold shares of Sea Limited (NYSE:SE) over the last few weeks -- the ARK Fintech Revolution ETF and the ARK Next Generation Internet ETF (NYSEMKT:ARKW). Still, though, Sea remains the No. 3 holding in the fintech ETF and ranks No. 16 in the internet ETF.\nSea stands as one of the fastest-growing large-cap stocks on the planet. Its business is expanding on all fronts -- digital entertainment, e-commerce, and digital payments.\nFor now, Sea makes most of its money from its digital entertainment unit thanks to the super-popular Free Fire mobile game. It could have even greater growth opportunities over the long term, though, with its Shopee e-commerce platform.\nThe company's name reflects an abbreviation for its primary market -- Southeast Asia. However, Sea continues to make solid inroads into the Latin American market. My prediction is that Sea will become a much bigger player in the region, making patient investors a lot of money in the process.\nSquare\nThree of Wood's ETFs were scooping up shares of Square (NYSE:SQ) in May. That changed in June, though, with the ARK Next Generation Internet ETF selling over 73,500 shares of the fintech stock.\nDon't think that Wood has soured on Square's prospects. The stock remains the No. 1 holding in the ARK Fintech Revolution ETF and is the fourth-biggest position in the ARK Innovation ETF (NYSEMKT:ARKK).\nSure, Square's valuation seems ridiculously high, with shares trading at close to 170 times expected earnings. However, disruptive companies almost always command steep valuations. And make no mistake about it: Square is a disruptor.\nThe company already offers a wide array of services to businesses. Square is positioning itself to also become a full-fledged commercial bank.\nPerhaps Square's greatest opportunity, though, lies in the individual financial services market. The company's Cash App provides a convenient way for consumers to digitally transfer money and buy and sell stocks and Bitcoin.\nIt's easy to see Square expanding Cash App to support personal loans and more features in the future. It's also easy to envision this stock making investors much wealthier over the next decade and beyond.","news_type":1},"isVote":1,"tweetType":1,"viewCount":289,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":158995929,"gmtCreate":1625119424361,"gmtModify":1633944568012,"author":{"id":"4087711343938000","authorId":"4087711343938000","name":"ZeeJay","avatar":"https://static.tigerbbs.com/36dbec811e59c06f4aea5df6c06ea26f","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4087711343938000","authorIdStr":"4087711343938000"},"themes":[],"htmlText":"Buy buy buy!!","listText":"Buy buy buy!!","text":"Buy buy buy!!","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/158995929","repostId":"2147581409","repostType":4,"repost":{"id":"2147581409","kind":"highlight","pubTimestamp":1625118840,"share":"https://www.laohu8.com/m/news/2147581409?lang=&edition=full","pubTime":"2021-07-01 13:54","market":"us","language":"en","title":"This Dividend King Is About to Get a Big Boost From Reopening","url":"https://stock-news.laohu8.com/highlight/detail?id=2147581409","media":"Motley Fool","summary":"With a unique approach to a vital food-distribution category, this Dividend King is only just starting its recovery.","content":"<p><b>Hormel Foods</b> (NYSE:HRL), with 55 years of annual increases under its belt, doesn't operate like your typical packaged-food maker. The company's unique system was a major headwind during the pandemic-driven shutdowns in 2020. But as the world is starting to reopen again, that difference has already turned into a tailwind. And the benefits aren't over yet. Here's a quick look at what Hormel does differently and why it's set to boost earnings in the quarters ahead.</p>\n<h2>Going direct</h2>\n<p>Hormel is probably best known for its branded-product portfolio, which includes icons like Spam and Skippy. Those are just two of a long list of leading names that can be found across the grocery store. Though it has a heavy focus on protein-related products, the company manages a collection of separate brand-name products. That's worked out fairly well for investors over time; the average annual dividend increase over the past decade was a huge 15%. Looking at that a different way, in 2010 Hormel's full-year dividend was $0.21 per share. In 2020 it was $0.93 per share. That's the magic of compounding.</p>\n<p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/b6d76002a2eb850d37ca108f7f198fcf\" tg-width=\"700\" tg-height=\"333\"><span>Image source: Getty Images.</span></p>\n<p>A key piece of the company's success, meanwhile, has been a balanced portfolio. That includes both the products it offers and the segments into which it sells. For example, the recent acquisition of Planters from <b>Kraft Heinz</b> added not just the famous peanut brand but also a larger exposure to convenience stores. That doubled up the diversification benefit. But <a href=\"https://laohu8.com/S/AONE\">one</a> of the more notable differences between Hormel and most of its peers is that Hormel has a direct-sales staff dedicated to the foodservice industry. Essentially, it has employees who work directly with restaurants and other food locations, like schools and hotels, to promote its products. It even has brands, like Burke and Cafe H, that are only sold into the foodservice space.</p>\n<p>Prior to the coronavirus pandemic, having this direct connection with foodservice customers provided valuable feedback for Hormel that allowed it to differentiate its products. For example, it developed a high-quality, pre-cooked bacon product (Bacon 1) so that the foodservice space could avoid the time, risk, and expense of cooking greasy bacon. But as restaurants and other out-of-home eating locations were shut down in 2020, this business was a major liability. As recently as the fiscal first quarter of 2021, which ended Jan. 24, foodservice segment sales were down by 17%.</p>\n<h2>That was then, this is now</h2>\n<p>That's just <a href=\"https://laohu8.com/S/AONE.U\">one</a> sales avenue for Hormel, with its other business benefiting from more at-home consumption. In that same quarter, U.S. retail sales were up 13%, deli sales increased 7%, and international sales (heavily centered on China) advanced 9%. That left the foodservice business the real standout in a pretty bad way. In the fiscal second quarter, however, foodservice turned around, with sales up 28%.</p>\n<p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/9afe4230b9f9ac9439297f45b32277d7\" tg-width=\"720\" tg-height=\"483\"><span>HRL data by YCharts</span></p>\n<p>To be fair, that was off a low base, given the pandemic, but it more than offset the flat performance during the quarter in the U.S. retail segment (deli and international both saw continued growth). But the really interesting thing here is that compared to the same quarter in 2019, Hormel's foodservice sales were up 1%. So the business not only rebounded from the 2020 hit, it grew just a touch over the two-year period.&nbsp;During Hormel's fiscal second-quarter 2021 earnings conference call, CEO James Snee noted:</p>\n<blockquote>\n We have a very positive outlook on the foodservice business, as we head into the second half of the year. We are well-positioned from an inventory and capacity standpoint to meet the demand from our distributor partners and operators and are confident in our ability to gain share throughout the recovery.\n</blockquote>\n<p>When pressed by an analyst on the matter, CFO James Sheehan added:</p>\n<blockquote>\n Now for us where we see future opportunities in a number of our segments, we haven't seen lodging come back. We really haven't seen college and university fully come back, which is a big part of our Hormel foodservice business. I referenced K-12 for the Jennie-O foodservice business. So, there's still a lot of dynamics at play. And so even as these other segments, these other channels really start to reopen those are going to have a favorable impact on our foodservice business as well.\n</blockquote>\n<p>Put simply, the company's foodservice business is already back to pre-pandemic levels, and it's not even firing on all cylinders. As the reopening continues to move forward, Hormel's foodservice business looks like it will become an increasingly important growth engine.</p>\n<h2>The big takeaway</h2>\n<p>As the pandemic raged, Hormel's foodservice business was a drag that left it trailing packaged-food peers with a heavier focus on grocery stores. Now, however, it looks like Hormel is set to get a big benefit that other packaged-food makers won't as the foodservice channel comes back to life. Make sure you pay close attention to this business when Hormel next reports earnings; it should make for good reading. Indeed, Hormel isn't exactly your normal food maker, but that looks like it will be a very good thing in the quarters ahead.</p>","source":"fool_stock","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>This Dividend King Is About to Get a Big Boost From Reopening</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nThis Dividend King Is About to Get a Big Boost From Reopening\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-07-01 13:54 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.fool.com/investing/2021/06/30/this-dividend-king-is-about-to-get-a-big-boost-fro/><strong>Motley Fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Hormel Foods (NYSE:HRL), with 55 years of annual increases under its belt, doesn't operate like your typical packaged-food maker. The company's unique system was a major headwind during the pandemic-...</p>\n\n<a href=\"https://www.fool.com/investing/2021/06/30/this-dividend-king-is-about-to-get-a-big-boost-fro/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"HRL":"荷美尔"},"source_url":"https://www.fool.com/investing/2021/06/30/this-dividend-king-is-about-to-get-a-big-boost-fro/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2147581409","content_text":"Hormel Foods (NYSE:HRL), with 55 years of annual increases under its belt, doesn't operate like your typical packaged-food maker. The company's unique system was a major headwind during the pandemic-driven shutdowns in 2020. But as the world is starting to reopen again, that difference has already turned into a tailwind. And the benefits aren't over yet. Here's a quick look at what Hormel does differently and why it's set to boost earnings in the quarters ahead.\nGoing direct\nHormel is probably best known for its branded-product portfolio, which includes icons like Spam and Skippy. Those are just two of a long list of leading names that can be found across the grocery store. Though it has a heavy focus on protein-related products, the company manages a collection of separate brand-name products. That's worked out fairly well for investors over time; the average annual dividend increase over the past decade was a huge 15%. Looking at that a different way, in 2010 Hormel's full-year dividend was $0.21 per share. In 2020 it was $0.93 per share. That's the magic of compounding.\nImage source: Getty Images.\nA key piece of the company's success, meanwhile, has been a balanced portfolio. That includes both the products it offers and the segments into which it sells. For example, the recent acquisition of Planters from Kraft Heinz added not just the famous peanut brand but also a larger exposure to convenience stores. That doubled up the diversification benefit. But one of the more notable differences between Hormel and most of its peers is that Hormel has a direct-sales staff dedicated to the foodservice industry. Essentially, it has employees who work directly with restaurants and other food locations, like schools and hotels, to promote its products. It even has brands, like Burke and Cafe H, that are only sold into the foodservice space.\nPrior to the coronavirus pandemic, having this direct connection with foodservice customers provided valuable feedback for Hormel that allowed it to differentiate its products. For example, it developed a high-quality, pre-cooked bacon product (Bacon 1) so that the foodservice space could avoid the time, risk, and expense of cooking greasy bacon. But as restaurants and other out-of-home eating locations were shut down in 2020, this business was a major liability. As recently as the fiscal first quarter of 2021, which ended Jan. 24, foodservice segment sales were down by 17%.\nThat was then, this is now\nThat's just one sales avenue for Hormel, with its other business benefiting from more at-home consumption. In that same quarter, U.S. retail sales were up 13%, deli sales increased 7%, and international sales (heavily centered on China) advanced 9%. That left the foodservice business the real standout in a pretty bad way. In the fiscal second quarter, however, foodservice turned around, with sales up 28%.\nHRL data by YCharts\nTo be fair, that was off a low base, given the pandemic, but it more than offset the flat performance during the quarter in the U.S. retail segment (deli and international both saw continued growth). But the really interesting thing here is that compared to the same quarter in 2019, Hormel's foodservice sales were up 1%. So the business not only rebounded from the 2020 hit, it grew just a touch over the two-year period. During Hormel's fiscal second-quarter 2021 earnings conference call, CEO James Snee noted:\n\n We have a very positive outlook on the foodservice business, as we head into the second half of the year. We are well-positioned from an inventory and capacity standpoint to meet the demand from our distributor partners and operators and are confident in our ability to gain share throughout the recovery.\n\nWhen pressed by an analyst on the matter, CFO James Sheehan added:\n\n Now for us where we see future opportunities in a number of our segments, we haven't seen lodging come back. We really haven't seen college and university fully come back, which is a big part of our Hormel foodservice business. I referenced K-12 for the Jennie-O foodservice business. So, there's still a lot of dynamics at play. And so even as these other segments, these other channels really start to reopen those are going to have a favorable impact on our foodservice business as well.\n\nPut simply, the company's foodservice business is already back to pre-pandemic levels, and it's not even firing on all cylinders. As the reopening continues to move forward, Hormel's foodservice business looks like it will become an increasingly important growth engine.\nThe big takeaway\nAs the pandemic raged, Hormel's foodservice business was a drag that left it trailing packaged-food peers with a heavier focus on grocery stores. Now, however, it looks like Hormel is set to get a big benefit that other packaged-food makers won't as the foodservice channel comes back to life. Make sure you pay close attention to this business when Hormel next reports earnings; it should make for good reading. Indeed, Hormel isn't exactly your normal food maker, but that looks like it will be a very good thing in the quarters ahead.","news_type":1},"isVote":1,"tweetType":1,"viewCount":355,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":159324091,"gmtCreate":1624942919413,"gmtModify":1633946671187,"author":{"id":"4087711343938000","authorId":"4087711343938000","name":"ZeeJay","avatar":"https://static.tigerbbs.com/36dbec811e59c06f4aea5df6c06ea26f","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4087711343938000","authorIdStr":"4087711343938000"},"themes":[],"htmlText":"Robotics with loads of potential ridingnon hype of automation..","listText":"Robotics with loads of potential ridingnon hype of automation..","text":"Robotics with loads of potential ridingnon hype of automation..","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":8,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/159324091","repostId":"2147853075","repostType":4,"isVote":1,"tweetType":1,"viewCount":224,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":127914858,"gmtCreate":1624814145874,"gmtModify":1633948413451,"author":{"id":"4087711343938000","authorId":"4087711343938000","name":"ZeeJay","avatar":"https://static.tigerbbs.com/36dbec811e59c06f4aea5df6c06ea26f","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4087711343938000","authorIdStr":"4087711343938000"},"themes":[],"htmlText":"Buy buy buy","listText":"Buy buy buy","text":"Buy buy buy","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/127914858","repostId":"2146070550","repostType":4,"isVote":1,"tweetType":1,"viewCount":352,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":127914315,"gmtCreate":1624814099137,"gmtModify":1633948413573,"author":{"id":"4087711343938000","authorId":"4087711343938000","name":"ZeeJay","avatar":"https://static.tigerbbs.com/36dbec811e59c06f4aea5df6c06ea26f","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4087711343938000","authorIdStr":"4087711343938000"},"themes":[],"htmlText":"Apple strategies are very short term. Need longer term view for future growth.","listText":"Apple strategies are very short term. Need longer term view for future growth.","text":"Apple strategies are very short term. Need longer term view for future growth.","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/127914315","repostId":"1189436009","repostType":4,"isVote":1,"tweetType":1,"viewCount":238,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":127915279,"gmtCreate":1624813889891,"gmtModify":1633948414305,"author":{"id":"4087711343938000","authorId":"4087711343938000","name":"ZeeJay","avatar":"https://static.tigerbbs.com/36dbec811e59c06f4aea5df6c06ea26f","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4087711343938000","authorIdStr":"4087711343938000"},"themes":[],"htmlText":"NIO","listText":"NIO","text":"NIO","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/127915279","repostId":"1137119316","repostType":4,"repost":{"id":"1137119316","kind":"news","pubTimestamp":1624754401,"share":"https://www.laohu8.com/m/news/1137119316?lang=&edition=full","pubTime":"2021-06-27 08:40","market":"us","language":"en","title":"Ford Or NIO? The Final Verdict","url":"https://stock-news.laohu8.com/highlight/detail?id=1137119316","media":"seekingalpha","summary":"I am comparing Ford against NIO in different categories.The comparison is intended to improve the understanding of Ford's and NIO's growth potential while highlighting differences in market position and opportunities.NIO is growing a lot faster than Ford and the high valuation may be justified.With Ford  launching a major offensive in the market for electric vehicles, Chinese EV maker NIO  will face one more rival competing for sales in the future. Which vehicle maker offers the best deal based ","content":"<p><b>Summary</b></p>\n<ul>\n <li>I am comparing Ford against NIO in different categories.</li>\n <li>The comparison is intended to improve the understanding of Ford's and NIO's growth potential while highlighting differences in market position and opportunities.</li>\n <li>NIO is growing a lot faster than Ford and the high valuation may be justified.</li>\n</ul>\n<p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/5033fa117d7852799244b8275bc1000f\" tg-width=\"1536\" tg-height=\"886\"><span>peterschreiber.media/iStock via Getty Images</span></p>\n<p>With Ford (F) launching a major offensive in the market for electric vehicles, Chinese EV maker NIO (NIO) will face one more rival competing for sales in the future. Which vehicle maker offers the best deal based on market opportunity, scale, revenue model, growth prospects and valuation? I will compare Ford against NIO in each category and issue a final verdict at the end.</p>\n<p><b>Ford vs. NIO: The battle for the global electric vehicle market is heating up</b></p>\n<p>Although there is a world of difference between Ford and NIO, both companies are set to go toe-to-toe in the rapidly growing global electric vehicle market. Ford’s fleet is not yet EV-focused but this is going to change: Feeling that the EV race is heating up, Ford said it is accelerating its electrification plan by investing&nbsp;$30B into its EV manufacturing capabilities until 2025. Ford’s previous capital plan called for a $22B investment in zero-emission vehicles. Ford also set an ambitious sales goal: 40% of its global sales will be electric within the next decade and 33% of pickup truck sales. Electric vehicle sales account for just 1% of Ford's sales today. As Ford is phasing out combustion engines, it is set to evolve into an all-electric vehicle maker by 2040.</p>\n<p><b>Market opportunity</b></p>\n<p>In 2020, 3.2m electric vehicles were sold in the world which represented a small market share of just 4.2%. China, however, was responsible for buying 41% of all electric vehicles in the world in 2020. Chinese buyers purchased 1.3m electric vehicles last year and sales are set to grow fast as Beijing seeks to boost EV adoption. The second largest market for electric vehicles was Europe which accounted for 42% of global EV sales. The US is only the third-largest market for plug-in electric vehicles in the world.</p>\n<p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/b48c23b32134542f51227d9b1b612887\" tg-width=\"1083\" tg-height=\"863\"><span>(Source: Wikipedia)</span></p>\n<p>China, by far, is the fastest growing EV market in the world, although Europe is catching up fast, in part due to a legislative efforts to increase adoption of zero-emission passenger vehicles and because of massive investments in a Europe-wide charging station network. NIO is&nbsp;on the cusp of entering the European market&nbsp;in a bid to grow market share in the world’s second-largest EV market before the competition is ready.</p>\n<p>Beijing is a driver behind the electrification of the Chinese auto industry: The government wants to see a&nbsp;twenty percent share&nbsp;of electric vehicles for new car sales by 2025 which will drive EV penetration in NIO’s home market.</p>\n<p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/9871e44eaf69adb27151425887870ace\" tg-width=\"739\" tg-height=\"454\"><span>(Source:Schroders)</span></p>\n<p>Turning to growth projections.</p>\n<p>With more favorable government policies for EV makers in places like China and Europe, these markets are poised to see the fastest sales growth and the highest EV adoption rates in the world. China is not only the largest market due to population size but is also expected to outperform all other markets in the world in EV sales until 2030.</p>\n<p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/61d19dff2f34e2d8828aca854e85d84a\" tg-width=\"825\" tg-height=\"565\"><span>(Source:McKinsey)</span></p>\n<p>Since China has a larger total market size, a higher EV adoption rate, stronger expected sales growth and a more favorable regulatory framework, the winner here would be: NIO.</p>\n<p><b>Scale and manufacturing competence</b></p>\n<p>Ford has a century’s worth of manufacturing experience. But Ford, so far, has only one all-electric vehicle in its product line-up that compares to NIO: The Mustang Mach-E SUV. In 2022, Ford will begin to sell the all-electric F-150 Lightening which builds on the success of Ford’s best-selling pick-up truck. NIO already has a stronger product catalog including the 5-seater ES6 SUV, the 5-seater coupe SUV EC6 and the ES8, a 6-seater and 7-seater full-sized SUV.</p>\n<p>Since NIO is solely focused on producing EVs and occupies a very small and defined niche, the Chinese firm has an advantage as far as EV-manufacturing expertise goes. The question is how long this advantage can last. Ford has extensive experience in building cars and can leverage a global manufacturing base to ramp up EV production faster than any niche EV maker could ever hope to achieve. This makes Ford a very serious rival not only to Tesla (TSLA) in the US, but also to NIO abroad. Ford is accelerating its electrification plans and it has the resources and the ambition to become a leader in EVs within the next decade. Ford’s proposed $30B spending on the electrification of its fleet will accelerate its transformation and turn Ford into a long term threat to other EV makers.</p>\n<p>Winner here: Ford.</p>\n<p><b>Differentiation and BaaS revenue model</b></p>\n<p>Both Ford and NIO know about the importance of differentiation in a market that will only get more competitive over time, which is why both companies are investing heavily in a related field that can break or solidify dominance in the EV market: Battery technology.</p>\n<p>Ford is&nbsp;forming a joint venture&nbsp;with South Korean battery technology company SK Innovation to secure supply of traction battery cells and array modules. The joint venture is meant to accelerate battery deliveries and will produce approximately 60 GWh annually, enough to cover 25% of Ford’s estimated annual energy demand by 2030. NIO is also investing in battery technology and has&nbsp;formed its own joint venture&nbsp;to secure battery supply.</p>\n<p>The difference to Ford is that NIO’s battery investment strategy revolves around a battery subscription model, also called “battery-as-a-service”, which creates a strong, long term revenue opportunity for the Chinese vehicle maker. Under this “BaaS” model, users who buy a NIO electric vehicle get a 70,000 RMB initial discount, equivalent to $10,800, and can sign up for a monthly subscription to rent a rechargeable 70 kWh battery. Batteries can then be exchanged at one of NIO’s battery-swapping stations which can be found in most big Chinese cities. A battery subscription costs 980 RMB monthly which is the equivalent of $150.</p>\n<p>The BaaS model has a couple of benefits for both the vehicle maker and the user: Purchasing an electric vehicle from NIO gets a lot more affordable due to the up-front discount and the subscription model ensures that users benefit from advancement in battery technology and better performance over time. Decoupling battery costs from vehicle prices creates an entirely new revenue stream on a subscription basis for NIO. Revenues from “BaaS” subscriptions could be used to increase the density of NIO’s network of charging/replacement stations. The battery subscription model also binds customers to NIO, potentially increasing customer lifetime value.</p>\n<p>Ford and NIO are primed to benefit from falling battery costs for electric vehicles as they ramp up capital allocations. As more investments flow into developing more efficient batteries, performance will go up and costs will go down which should drive EV adoption and benefit all EV makers. This is because lower battery prices make EVs more competitive to passenger vehicles with combustion engines. But since NIO is structuring a part of its business model explicitly around battery subscriptions, NIO could benefit more than Ford.</p>\n<p>Battery costs for EVs have decreased 70% since 2014, based on information provided by investment firm Schroders, and are set to decrease more this decade.</p>\n<p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/c42acb75905affe7570a2f399ea3192f\" tg-width=\"758\" tg-height=\"449\"><span>(Source: Schroders)</span></p>\n<p>The “BaaS” model is genius and could develop into a $500M a year revenue opportunity for NIO long term. Although Ford is ramping up its investments in battery technology, the winner in this category is: NIO.</p>\n<p><b>Sales growth and valuation</b></p>\n<p>Ford’s sales in May grew 4.1% Y/Y but electrified vehicle sales (including hybrids) surged 184% Y/Y as Ford sold a record 10,364 EVs/hybrids in May. Escape electrified sales and Explorer Hybrid grew sales at 125% and 132% Y/Y showing strong customer uptake. NIO delivered 6,711 vehicles last month including 3,017 ES6s, 1,412 ES8s and 2,282 EC6s. Total Y/Y delivery growth for May was 95.3%.</p>\n<p>Ford's sales are fifty-four times larger than NIO's which creates more sales growth and revaluation potential for NIO.</p>\n<p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/df5a0a393e44ed74241c5effcdd92350\" tg-width=\"635\" tg-height=\"419\"><span>Data by YCharts</span></p>\n<p>The difference in valuation between Ford and NIO is like the difference between night and day. This is because Ford is still seen as a mature vehicle maker with expected enterprise sales growth in the low-to-mid digits, despite explosive growth in the EV category. Ford is expected to grow revenues by 33% until FY 2025 (base year: FY 2020) and NIO by 808%!</p>\n<p>Due to these differences in sales growth, NIO is the complete opposite of Ford, at least as far as valuation goes. The Chinese EV-maker is expected to see sales and delivery growth close to 100% this year and since NIO is only dealing in EVs, NIO gets a much higher market-cap-to-sales ratio than Ford.</p>\n<p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/817605c6b1e82c03d0473ea570d32b8f\" tg-width=\"506\" tg-height=\"406\"><span>(Source: Author)</span></p>\n<p><b>NIO has larger risks...</b></p>\n<p>NIO is the more risky venture, but also the one that offers the most promise. Government policy favors EV-makers like NIO. The potential for total global sales growth is larger for NIO as it operates from a smaller revenue base compared to Ford. But there are also a few things that work against NIO. For example, recalls due to production defects would be a much bigger challenge for NIO to overcome than for Ford which can rely on a global service and distribution network. NIO’s valuation is also not without risk as an unexpected slowing of sales growth due to production setbacks would leave a much larger dent in the financials.</p>\n<p><b>Final verdict</b></p>\n<p>NIO is definitely the more “sexy” vehicle maker. Strong adoption and sales growth in China and Europe support NIO. Its super smart BaaS model which decouples vehicle purchase prices from battery costs is genius. You pay a high price for this growth but the market opportunity for NIO is immense.</p>\n<p>Ford’s EV sales are booming and the percentage of EV sales will increase as the vehicle maker electrifies its fleet. Ford has a lot of potential in the EV market but since EV sales are still a relatively low percentage of total sales, it will take a long time for Ford to complete its transformation.</p>\n<p>If you believe in the potential of the global EV market, buy NIO. If you believe in the potential of the global EV market and don’t like much risk, buy Ford.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Ford Or NIO? The Final Verdict</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nFord Or NIO? The Final Verdict\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-06-27 08:40 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://seekingalpha.com/article/4436600-ford-or-nio-the-final-verdict><strong>seekingalpha</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Summary\n\nI am comparing Ford against NIO in different categories.\nThe comparison is intended to improve the understanding of Ford's and NIO's growth potential while highlighting differences in market ...</p>\n\n<a href=\"https://seekingalpha.com/article/4436600-ford-or-nio-the-final-verdict\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"F":"福特汽车","NIO":"蔚来"},"source_url":"https://seekingalpha.com/article/4436600-ford-or-nio-the-final-verdict","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1137119316","content_text":"Summary\n\nI am comparing Ford against NIO in different categories.\nThe comparison is intended to improve the understanding of Ford's and NIO's growth potential while highlighting differences in market position and opportunities.\nNIO is growing a lot faster than Ford and the high valuation may be justified.\n\npeterschreiber.media/iStock via Getty Images\nWith Ford (F) launching a major offensive in the market for electric vehicles, Chinese EV maker NIO (NIO) will face one more rival competing for sales in the future. Which vehicle maker offers the best deal based on market opportunity, scale, revenue model, growth prospects and valuation? I will compare Ford against NIO in each category and issue a final verdict at the end.\nFord vs. NIO: The battle for the global electric vehicle market is heating up\nAlthough there is a world of difference between Ford and NIO, both companies are set to go toe-to-toe in the rapidly growing global electric vehicle market. Ford’s fleet is not yet EV-focused but this is going to change: Feeling that the EV race is heating up, Ford said it is accelerating its electrification plan by investing $30B into its EV manufacturing capabilities until 2025. Ford’s previous capital plan called for a $22B investment in zero-emission vehicles. Ford also set an ambitious sales goal: 40% of its global sales will be electric within the next decade and 33% of pickup truck sales. Electric vehicle sales account for just 1% of Ford's sales today. As Ford is phasing out combustion engines, it is set to evolve into an all-electric vehicle maker by 2040.\nMarket opportunity\nIn 2020, 3.2m electric vehicles were sold in the world which represented a small market share of just 4.2%. China, however, was responsible for buying 41% of all electric vehicles in the world in 2020. Chinese buyers purchased 1.3m electric vehicles last year and sales are set to grow fast as Beijing seeks to boost EV adoption. The second largest market for electric vehicles was Europe which accounted for 42% of global EV sales. The US is only the third-largest market for plug-in electric vehicles in the world.\n(Source: Wikipedia)\nChina, by far, is the fastest growing EV market in the world, although Europe is catching up fast, in part due to a legislative efforts to increase adoption of zero-emission passenger vehicles and because of massive investments in a Europe-wide charging station network. NIO is on the cusp of entering the European market in a bid to grow market share in the world’s second-largest EV market before the competition is ready.\nBeijing is a driver behind the electrification of the Chinese auto industry: The government wants to see a twenty percent share of electric vehicles for new car sales by 2025 which will drive EV penetration in NIO’s home market.\n(Source:Schroders)\nTurning to growth projections.\nWith more favorable government policies for EV makers in places like China and Europe, these markets are poised to see the fastest sales growth and the highest EV adoption rates in the world. China is not only the largest market due to population size but is also expected to outperform all other markets in the world in EV sales until 2030.\n(Source:McKinsey)\nSince China has a larger total market size, a higher EV adoption rate, stronger expected sales growth and a more favorable regulatory framework, the winner here would be: NIO.\nScale and manufacturing competence\nFord has a century’s worth of manufacturing experience. But Ford, so far, has only one all-electric vehicle in its product line-up that compares to NIO: The Mustang Mach-E SUV. In 2022, Ford will begin to sell the all-electric F-150 Lightening which builds on the success of Ford’s best-selling pick-up truck. NIO already has a stronger product catalog including the 5-seater ES6 SUV, the 5-seater coupe SUV EC6 and the ES8, a 6-seater and 7-seater full-sized SUV.\nSince NIO is solely focused on producing EVs and occupies a very small and defined niche, the Chinese firm has an advantage as far as EV-manufacturing expertise goes. The question is how long this advantage can last. Ford has extensive experience in building cars and can leverage a global manufacturing base to ramp up EV production faster than any niche EV maker could ever hope to achieve. This makes Ford a very serious rival not only to Tesla (TSLA) in the US, but also to NIO abroad. Ford is accelerating its electrification plans and it has the resources and the ambition to become a leader in EVs within the next decade. Ford’s proposed $30B spending on the electrification of its fleet will accelerate its transformation and turn Ford into a long term threat to other EV makers.\nWinner here: Ford.\nDifferentiation and BaaS revenue model\nBoth Ford and NIO know about the importance of differentiation in a market that will only get more competitive over time, which is why both companies are investing heavily in a related field that can break or solidify dominance in the EV market: Battery technology.\nFord is forming a joint venture with South Korean battery technology company SK Innovation to secure supply of traction battery cells and array modules. The joint venture is meant to accelerate battery deliveries and will produce approximately 60 GWh annually, enough to cover 25% of Ford’s estimated annual energy demand by 2030. NIO is also investing in battery technology and has formed its own joint venture to secure battery supply.\nThe difference to Ford is that NIO’s battery investment strategy revolves around a battery subscription model, also called “battery-as-a-service”, which creates a strong, long term revenue opportunity for the Chinese vehicle maker. Under this “BaaS” model, users who buy a NIO electric vehicle get a 70,000 RMB initial discount, equivalent to $10,800, and can sign up for a monthly subscription to rent a rechargeable 70 kWh battery. Batteries can then be exchanged at one of NIO’s battery-swapping stations which can be found in most big Chinese cities. A battery subscription costs 980 RMB monthly which is the equivalent of $150.\nThe BaaS model has a couple of benefits for both the vehicle maker and the user: Purchasing an electric vehicle from NIO gets a lot more affordable due to the up-front discount and the subscription model ensures that users benefit from advancement in battery technology and better performance over time. Decoupling battery costs from vehicle prices creates an entirely new revenue stream on a subscription basis for NIO. Revenues from “BaaS” subscriptions could be used to increase the density of NIO’s network of charging/replacement stations. The battery subscription model also binds customers to NIO, potentially increasing customer lifetime value.\nFord and NIO are primed to benefit from falling battery costs for electric vehicles as they ramp up capital allocations. As more investments flow into developing more efficient batteries, performance will go up and costs will go down which should drive EV adoption and benefit all EV makers. This is because lower battery prices make EVs more competitive to passenger vehicles with combustion engines. But since NIO is structuring a part of its business model explicitly around battery subscriptions, NIO could benefit more than Ford.\nBattery costs for EVs have decreased 70% since 2014, based on information provided by investment firm Schroders, and are set to decrease more this decade.\n(Source: Schroders)\nThe “BaaS” model is genius and could develop into a $500M a year revenue opportunity for NIO long term. Although Ford is ramping up its investments in battery technology, the winner in this category is: NIO.\nSales growth and valuation\nFord’s sales in May grew 4.1% Y/Y but electrified vehicle sales (including hybrids) surged 184% Y/Y as Ford sold a record 10,364 EVs/hybrids in May. Escape electrified sales and Explorer Hybrid grew sales at 125% and 132% Y/Y showing strong customer uptake. NIO delivered 6,711 vehicles last month including 3,017 ES6s, 1,412 ES8s and 2,282 EC6s. Total Y/Y delivery growth for May was 95.3%.\nFord's sales are fifty-four times larger than NIO's which creates more sales growth and revaluation potential for NIO.\nData by YCharts\nThe difference in valuation between Ford and NIO is like the difference between night and day. This is because Ford is still seen as a mature vehicle maker with expected enterprise sales growth in the low-to-mid digits, despite explosive growth in the EV category. Ford is expected to grow revenues by 33% until FY 2025 (base year: FY 2020) and NIO by 808%!\nDue to these differences in sales growth, NIO is the complete opposite of Ford, at least as far as valuation goes. The Chinese EV-maker is expected to see sales and delivery growth close to 100% this year and since NIO is only dealing in EVs, NIO gets a much higher market-cap-to-sales ratio than Ford.\n(Source: Author)\nNIO has larger risks...\nNIO is the more risky venture, but also the one that offers the most promise. Government policy favors EV-makers like NIO. The potential for total global sales growth is larger for NIO as it operates from a smaller revenue base compared to Ford. But there are also a few things that work against NIO. For example, recalls due to production defects would be a much bigger challenge for NIO to overcome than for Ford which can rely on a global service and distribution network. NIO’s valuation is also not without risk as an unexpected slowing of sales growth due to production setbacks would leave a much larger dent in the financials.\nFinal verdict\nNIO is definitely the more “sexy” vehicle maker. Strong adoption and sales growth in China and Europe support NIO. Its super smart BaaS model which decouples vehicle purchase prices from battery costs is genius. You pay a high price for this growth but the market opportunity for NIO is immense.\nFord’s EV sales are booming and the percentage of EV sales will increase as the vehicle maker electrifies its fleet. Ford has a lot of potential in the EV market but since EV sales are still a relatively low percentage of total sales, it will take a long time for Ford to complete its transformation.\nIf you believe in the potential of the global EV market, buy NIO. If you believe in the potential of the global EV market and don’t like much risk, buy Ford.","news_type":1},"isVote":1,"tweetType":1,"viewCount":70,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":127915387,"gmtCreate":1624813793549,"gmtModify":1633948414648,"author":{"id":"4087711343938000","authorId":"4087711343938000","name":"ZeeJay","avatar":"https://static.tigerbbs.com/36dbec811e59c06f4aea5df6c06ea26f","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4087711343938000","authorIdStr":"4087711343938000"},"themes":[],"htmlText":"Pure speculation","listText":"Pure speculation","text":"Pure speculation","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":5,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/127915387","repostId":"1172710941","repostType":4,"isVote":1,"tweetType":1,"viewCount":401,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0}],"hots":[{"id":842248013,"gmtCreate":1636188538148,"gmtModify":1636188538301,"author":{"id":"4087711343938000","authorId":"4087711343938000","name":"ZeeJay","avatar":"https://static.tigerbbs.com/36dbec811e59c06f4aea5df6c06ea26f","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4087711343938000","authorIdStr":"4087711343938000"},"themes":[],"htmlText":"[Miser]&nbsp;","listText":"[Miser]&nbsp;","text":"[Miser]","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":9,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/842248013","repostId":"1176171748","repostType":4,"repost":{"id":"1176171748","kind":"news","pubTimestamp":1636158392,"share":"https://www.laohu8.com/m/news/1176171748?lang=&edition=full","pubTime":"2021-11-06 08:26","market":"us","language":"en","title":"US IPO Week Ahead: The IPO market quietly revs its engine in an 11 IPO week","url":"https://stock-news.laohu8.com/highlight/detail?id=1176171748","media":"renaissancecap...","summary":"The IPO market is expected to stay busy with 11 IPOs schedule to raise $10.2 billion in the week ahe","content":"<p>The IPO market is expected to stay busy with 11 IPOs schedule to raise $10.2 billion in the week ahead.</p>\n<p>Electric truck developer&nbsp;<b>Rivian Automotive</b>(RIVN) plans to raise $8.0 billion at a $57.1 billion market cap. This founder-led company is developing and manufacturing a portfolio of electric adventure-ready consumer and commercial SUVs, vans, and pickup trucks. Although the company is in very early stages of commercialization, Rivian began its first deliveries in September of 2021 and has an order of 100,000 EDVs from Amazon through 2025.</p>\n<p>OTC-listed&nbsp;<b>Hertz Global Holdings</b>(HTZ) plans to raise $1.0 billion at a $13.9 billion market cap. The company provides vehicle rental services globally primarily through the Hertz, Dollar, and Thrifty brands. Hertz filed for bankruptcy in May of 2020 and emerged this past June. The company is profitable, and revenue growth accelerated to 34% in the 9mo21.</p>\n<p>Outsourced IT services provider&nbsp;<b>CI&amp;T</b>(CINT) plans to raise $350 million at a $2.4 billion market cap. This Brazil-based company provides strategy, design, and software engineering services through a network of over 5,000 employees. Growing and profitable, CI&amp;T’s &nbsp;blue-chip customer base includes Johnson &amp; Johnson, Google, and Itaú Unibanco.</p>\n<p><b><a href=\"https://laohu8.com/S/EXFY\">Expensify</a></b>(EXFY) plans to raise $234 million at a $2.4 billion market cap. Founder-led Expensify provides a mobile-first expense management platform, primarily helping SMBs simplify the expense approval process from initial receipt scan through next-day reimbursement. Addressing a multibillion-dollar opportunity within US SMBs, Expensify saw robust profitability in the 1H21, but its paid member base remains below pre-COVID levels.</p>\n<p>Customer engagement platform&nbsp;<b>Weave Communications</b>(WEAV) plans to raise $133 million at a $1.9 billion market cap. The company provides a customer communication and engagement software platform to SMBs. Fast growing and unprofitable, Weave had more than 21,000 locations under subscription across approximately 20,000 customers in the US and Canada as of 6/30/21.</p>\n<p>Vaccine biotech&nbsp;<b>Vaxxinity</b>(VAXX) plans to raise $101 million at a $2.1 billion market cap. This Phase 2 biotech is developing vaccines therapies for chronic diseases using synthetic peptides. Vaxxinity’s lead candidate, UB-311, is being developed for the treatment of Alzheimer’s Disease and is scheduled to start a Phase 2b efficacy trial in 2022.</p>\n<p>Online fashion retailer&nbsp;<b>Lulu’s Fashion Lounge Holdings</b>(LVLU) plans to raise $101 million at a $654 million market cap. Lulu’s sells apparel and accessories primarily to Millennial and Gen Z women. While its business took a hit during the pandemic, the company returned to profitability in the 1H21, and revenue growth accelerated to 24%.</p>\n<p>Storage cloud platform&nbsp;<b>Backblaze</b>(BLZE) plans to raise $100 million at a $644 million market cap. With over 480,000 customers across 175 countries, Backblaze provides a storage cloud platform to store, use, and protect data. The company has delivered solid growth, and it has maintained profitability on an EBITDA basis.</p>\n<p>Texas bank&nbsp;<b>Third Coast Bank</b>(TCBX) plans to raise $75 million at a $317 million market cap. This commercially-focused bank operates 12 branches, seven of which are in the Greater Houston market. As of 6/30/21, Third Coast Bank had total assets of $2.0 billion, total loans of $1.6 billion, total deposits of $1.8 billion, and total shareholders’ equity of $138 million.</p>\n<p>Laser communications firm&nbsp;<b>Mynaric</b>(MYNA) plans to raise $70 million at a $356 million market cap. Germany-based Mynaric develops and manufactures laser technologies for aerospace communications networks in government and commercial markets. The company is growing but highly unprofitable, with a -258% LTM gross margin.</p>\n<p>Turbine system maker&nbsp;<b>FlexEnergy</b>(FLXE) plans to raise $35 million at a $122 million market cap. This technology company designs, manufactures, and sells turbine systems and heat exchangers. FlexEnergy saw revenue shrink in both 2020 and the 1H21.</p>\n<p></p>","source":"lsy1619493174116","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>US IPO Week Ahead: The IPO market quietly revs its engine in an 11 IPO week</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nUS IPO Week Ahead: The IPO market quietly revs its engine in an 11 IPO week\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-11-06 08:26 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.renaissancecapital.com/IPO-Center/News/88289/US-IPO-Week-Ahead-The-IPO-market-quietly-revs-its-engine-in-an-11-IPO-week><strong>renaissancecap...</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>The IPO market is expected to stay busy with 11 IPOs schedule to raise $10.2 billion in the week ahead.\nElectric truck developer Rivian Automotive(RIVN) plans to raise $8.0 billion at a $57.1 billion ...</p>\n\n<a href=\"https://www.renaissancecapital.com/IPO-Center/News/88289/US-IPO-Week-Ahead-The-IPO-market-quietly-revs-its-engine-in-an-11-IPO-week\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"LVLU":"Lulu's Fashion Lounge Holdings, Inc","WEAV":"Weave Communications, Inc","TCBX":"Third Coast Bancshares, Inc.","EXFY":"Expensify","CINT":"CI&T Inc.","HTZ":"赫兹租车","BLZE":"Backblaze, Inc.","MYNA":"Mynaric AG","VAXX":"Vaxxinity, Inc.","RIVN":"Rivian Automotive, Inc."},"source_url":"https://www.renaissancecapital.com/IPO-Center/News/88289/US-IPO-Week-Ahead-The-IPO-market-quietly-revs-its-engine-in-an-11-IPO-week","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1176171748","content_text":"The IPO market is expected to stay busy with 11 IPOs schedule to raise $10.2 billion in the week ahead.\nElectric truck developer Rivian Automotive(RIVN) plans to raise $8.0 billion at a $57.1 billion market cap. This founder-led company is developing and manufacturing a portfolio of electric adventure-ready consumer and commercial SUVs, vans, and pickup trucks. Although the company is in very early stages of commercialization, Rivian began its first deliveries in September of 2021 and has an order of 100,000 EDVs from Amazon through 2025.\nOTC-listed Hertz Global Holdings(HTZ) plans to raise $1.0 billion at a $13.9 billion market cap. The company provides vehicle rental services globally primarily through the Hertz, Dollar, and Thrifty brands. Hertz filed for bankruptcy in May of 2020 and emerged this past June. The company is profitable, and revenue growth accelerated to 34% in the 9mo21.\nOutsourced IT services provider CI&T(CINT) plans to raise $350 million at a $2.4 billion market cap. This Brazil-based company provides strategy, design, and software engineering services through a network of over 5,000 employees. Growing and profitable, CI&T’s  blue-chip customer base includes Johnson & Johnson, Google, and Itaú Unibanco.\nExpensify(EXFY) plans to raise $234 million at a $2.4 billion market cap. Founder-led Expensify provides a mobile-first expense management platform, primarily helping SMBs simplify the expense approval process from initial receipt scan through next-day reimbursement. Addressing a multibillion-dollar opportunity within US SMBs, Expensify saw robust profitability in the 1H21, but its paid member base remains below pre-COVID levels.\nCustomer engagement platform Weave Communications(WEAV) plans to raise $133 million at a $1.9 billion market cap. The company provides a customer communication and engagement software platform to SMBs. Fast growing and unprofitable, Weave had more than 21,000 locations under subscription across approximately 20,000 customers in the US and Canada as of 6/30/21.\nVaccine biotech Vaxxinity(VAXX) plans to raise $101 million at a $2.1 billion market cap. This Phase 2 biotech is developing vaccines therapies for chronic diseases using synthetic peptides. Vaxxinity’s lead candidate, UB-311, is being developed for the treatment of Alzheimer’s Disease and is scheduled to start a Phase 2b efficacy trial in 2022.\nOnline fashion retailer Lulu’s Fashion Lounge Holdings(LVLU) plans to raise $101 million at a $654 million market cap. Lulu’s sells apparel and accessories primarily to Millennial and Gen Z women. While its business took a hit during the pandemic, the company returned to profitability in the 1H21, and revenue growth accelerated to 24%.\nStorage cloud platform Backblaze(BLZE) plans to raise $100 million at a $644 million market cap. With over 480,000 customers across 175 countries, Backblaze provides a storage cloud platform to store, use, and protect data. The company has delivered solid growth, and it has maintained profitability on an EBITDA basis.\nTexas bank Third Coast Bank(TCBX) plans to raise $75 million at a $317 million market cap. This commercially-focused bank operates 12 branches, seven of which are in the Greater Houston market. As of 6/30/21, Third Coast Bank had total assets of $2.0 billion, total loans of $1.6 billion, total deposits of $1.8 billion, and total shareholders’ equity of $138 million.\nLaser communications firm Mynaric(MYNA) plans to raise $70 million at a $356 million market cap. Germany-based Mynaric develops and manufactures laser technologies for aerospace communications networks in government and commercial markets. The company is growing but highly unprofitable, with a -258% LTM gross margin.\nTurbine system maker FlexEnergy(FLXE) plans to raise $35 million at a $122 million market cap. This technology company designs, manufactures, and sells turbine systems and heat exchangers. FlexEnergy saw revenue shrink in both 2020 and the 1H21.","news_type":1},"isVote":1,"tweetType":1,"viewCount":980,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":159324091,"gmtCreate":1624942919413,"gmtModify":1633946671187,"author":{"id":"4087711343938000","authorId":"4087711343938000","name":"ZeeJay","avatar":"https://static.tigerbbs.com/36dbec811e59c06f4aea5df6c06ea26f","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4087711343938000","authorIdStr":"4087711343938000"},"themes":[],"htmlText":"Robotics with loads of potential ridingnon hype of automation..","listText":"Robotics with loads of potential ridingnon hype of automation..","text":"Robotics with loads of potential ridingnon hype of automation..","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":8,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/159324091","repostId":"2147853075","repostType":4,"isVote":1,"tweetType":1,"viewCount":224,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":127915387,"gmtCreate":1624813793549,"gmtModify":1633948414648,"author":{"id":"4087711343938000","authorId":"4087711343938000","name":"ZeeJay","avatar":"https://static.tigerbbs.com/36dbec811e59c06f4aea5df6c06ea26f","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4087711343938000","authorIdStr":"4087711343938000"},"themes":[],"htmlText":"Pure speculation","listText":"Pure speculation","text":"Pure speculation","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":5,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/127915387","repostId":"1172710941","repostType":4,"isVote":1,"tweetType":1,"viewCount":401,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":815183172,"gmtCreate":1630656079296,"gmtModify":1632468291157,"author":{"id":"4087711343938000","authorId":"4087711343938000","name":"ZeeJay","avatar":"https://static.tigerbbs.com/36dbec811e59c06f4aea5df6c06ea26f","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4087711343938000","authorIdStr":"4087711343938000"},"themes":[],"htmlText":"Apple performces has already plateaued in recents years, so unless some new big thing can reignite sales, never say never..&nbsp;","listText":"Apple performces has already plateaued in recents years, so unless some new big thing can reignite sales, never say never..&nbsp;","text":"Apple performces has already plateaued in recents years, so unless some new big thing can reignite sales, never say never..","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/815183172","repostId":"1131318558","repostType":4,"repost":{"id":"1131318558","kind":"news","pubTimestamp":1630591645,"share":"https://www.laohu8.com/m/news/1131318558?lang=&edition=full","pubTime":"2021-09-02 22:07","market":"us","language":"en","title":"Bear Attack: Could Apple Stock Really Drop 40%?","url":"https://stock-news.laohu8.com/highlight/detail?id=1131318558","media":"Thestreet","summary":"One of two Wall Street analysts that had a sell rating on Apple stock threw in the towel. The other still thinks that AAPL shares could drop 40%. Is the sizable downside risk realistic?On the first day of September, one of the rare Wall Street bears on Apple stock  finally gave in and dropped his sell rating. The last remaining one still sees shares dropping to a price target of $90, representing risk of loss of around 40%.Could New Street’s Pierre Ferragu, the last remaining Apple bear on Wall ","content":"<p>One of two Wall Street analysts that had a sell rating on Apple stock threw in the towel. The other still thinks that AAPL shares could drop 40%. Is the sizable downside risk realistic?</p>\n<p>On the first day of September, one of the rare Wall Street bears on Apple stock&nbsp;(<b>AAPL</b>)&nbsp;finally gave in and dropped his sell rating. The last remaining one still&nbsp;sees&nbsp;shares dropping to a price target of $90, representing risk of loss of around 40%.</p>\n<p>Could New Street’s Pierre Ferragu, the last remaining Apple bear on Wall Street, be right about his downside call? The Apple Maven looks a bit closer at the argument.</p>\n<p><b>Why bearish on Apple?</b></p>\n<p>The core of Pierre’s bearish argument&nbsp;seems to be the iPhone. The analyst has called the upcoming device launch a “12S cycle”, arguing that the best of Apple’s iPhone upgrade wave,the so-called 5G super cycle, has been left in the rearview mirror.</p>\n<p>New Street subscribes to the view that the strong iPhone 12 cycle has pulled forward smartphone sales, leaving a gap in demand going forward. Interestingly, this is exactly the&nbsp;opposite opinion of bullish Wedbush analyst Dan Ives, who said the following during an interview with the Apple Maven:</p>\n<blockquote>\n “What the Street underestimates is how massive and elongated this super cycle is. […] 5G does not get fully embraced for the next two or three years, until the networks are built out. In China [where the 5G infrastructure is further ahead], the iPhone 12, especially the larger Pro versions, really sold extremely well.”\n</blockquote>\n<p>Still on the iPhone, Mr. Ferragu laid out his expectations for 2022 back in April (I am unaware of revisions since then). He believes that iPhone shipments will reach 190 million units, suggesting segment revenues of around $150 billion – a modest annual increase of 5% from COVID-19 levels.</p>\n<p><b>Could AAPL sink 40%?</b></p>\n<p>Now, let’s put pen to paper. For Apple stock to be valued at $90 apiece, one of two things would need to happen: either financial performance would need to lag consensus expectations, or valuations would need to contract (or a combination of both).</p>\n<p>On results,Wall Street currently sees&nbsp;fiscal 2022 EPS landing at $5.63, roughly flat against a 2021 that has been impressive so far. For AAPL to drop 40% in price, therefore, next-year earnings would need to miss consensus substantially, by at least a couple of dollars. I find this highly unlikely.</p>\n<p>On valuations, AAPL currently trades at a fiscal 2021 earnings multiple of 27 times. Assuming consensus-matching results in the future, this multiple would need to drop to about 16 times for AAPL shares to sink to $90. The stock’s forward P/E has not been this low in years.</p>\n<p><b>The Apple Maven’s take</b></p>\n<p>I find it very improbable, if not virtually impossible, for Apple to ever be valued at $90 per share again. It is much more reasonable, in my opinion, that New Street’s current price target on the stock is simply stale, following AAPL’s 25% rally in the past six months.</p>\n<p>Therefore, I would not be surprised to see Wall Street’s last AAPL bear eventually (soon?) give in on his downside convictions, at least in what pertains to his current price target.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Bear Attack: Could Apple Stock Really Drop 40%?</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nBear Attack: Could Apple Stock Really Drop 40%?\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-09-02 22:07 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.thestreet.com/apple/stock/bear-attack-could-apple-stock-really-drop-40><strong>Thestreet</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>One of two Wall Street analysts that had a sell rating on Apple stock threw in the towel. The other still thinks that AAPL shares could drop 40%. Is the sizable downside risk realistic?\nOn the first ...</p>\n\n<a href=\"https://www.thestreet.com/apple/stock/bear-attack-could-apple-stock-really-drop-40\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"AAPL":"苹果"},"source_url":"https://www.thestreet.com/apple/stock/bear-attack-could-apple-stock-really-drop-40","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1131318558","content_text":"One of two Wall Street analysts that had a sell rating on Apple stock threw in the towel. The other still thinks that AAPL shares could drop 40%. Is the sizable downside risk realistic?\nOn the first day of September, one of the rare Wall Street bears on Apple stock (AAPL) finally gave in and dropped his sell rating. The last remaining one still sees shares dropping to a price target of $90, representing risk of loss of around 40%.\nCould New Street’s Pierre Ferragu, the last remaining Apple bear on Wall Street, be right about his downside call? The Apple Maven looks a bit closer at the argument.\nWhy bearish on Apple?\nThe core of Pierre’s bearish argument seems to be the iPhone. The analyst has called the upcoming device launch a “12S cycle”, arguing that the best of Apple’s iPhone upgrade wave,the so-called 5G super cycle, has been left in the rearview mirror.\nNew Street subscribes to the view that the strong iPhone 12 cycle has pulled forward smartphone sales, leaving a gap in demand going forward. Interestingly, this is exactly the opposite opinion of bullish Wedbush analyst Dan Ives, who said the following during an interview with the Apple Maven:\n\n “What the Street underestimates is how massive and elongated this super cycle is. […] 5G does not get fully embraced for the next two or three years, until the networks are built out. In China [where the 5G infrastructure is further ahead], the iPhone 12, especially the larger Pro versions, really sold extremely well.”\n\nStill on the iPhone, Mr. Ferragu laid out his expectations for 2022 back in April (I am unaware of revisions since then). He believes that iPhone shipments will reach 190 million units, suggesting segment revenues of around $150 billion – a modest annual increase of 5% from COVID-19 levels.\nCould AAPL sink 40%?\nNow, let’s put pen to paper. For Apple stock to be valued at $90 apiece, one of two things would need to happen: either financial performance would need to lag consensus expectations, or valuations would need to contract (or a combination of both).\nOn results,Wall Street currently sees fiscal 2022 EPS landing at $5.63, roughly flat against a 2021 that has been impressive so far. For AAPL to drop 40% in price, therefore, next-year earnings would need to miss consensus substantially, by at least a couple of dollars. I find this highly unlikely.\nOn valuations, AAPL currently trades at a fiscal 2021 earnings multiple of 27 times. Assuming consensus-matching results in the future, this multiple would need to drop to about 16 times for AAPL shares to sink to $90. The stock’s forward P/E has not been this low in years.\nThe Apple Maven’s take\nI find it very improbable, if not virtually impossible, for Apple to ever be valued at $90 per share again. It is much more reasonable, in my opinion, that New Street’s current price target on the stock is simply stale, following AAPL’s 25% rally in the past six months.\nTherefore, I would not be surprised to see Wall Street’s last AAPL bear eventually (soon?) give in on his downside convictions, at least in what pertains to his current price target.","news_type":1},"isVote":1,"tweetType":1,"viewCount":201,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":879335689,"gmtCreate":1636681323341,"gmtModify":1636681677573,"author":{"id":"4087711343938000","authorId":"4087711343938000","name":"ZeeJay","avatar":"https://static.tigerbbs.com/36dbec811e59c06f4aea5df6c06ea26f","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4087711343938000","authorIdStr":"4087711343938000"},"themes":[],"htmlText":"[Smile]&nbsp;","listText":"[Smile]&nbsp;","text":"[Smile]","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/879335689","repostId":"2182606257","repostType":2,"repost":{"id":"2182606257","kind":"news","pubTimestamp":1636666860,"share":"https://www.laohu8.com/m/news/2182606257?lang=&edition=full","pubTime":"2021-11-12 05:41","market":"fut","language":"zh","title":"外媒头条：市值突破千亿！Rivian上市次日再度飙升","url":"https://stock-news.laohu8.com/highlight/detail?id=2182606257","media":"新浪财经","summary":"全球财经媒体昨夜今晨共同关注的头条新闻主要有：\n\n1、为什么经济学家低估了美国通胀的爆发力和耐力？\n\n\n2、美债市场遍布地雷 凶险程度达到疫情爆发以来之最\n\n\n3、又一波新冠疫情来袭 美国中西部医院I","content":"<p><b>全球财经媒体昨夜今晨共同关注的头条新闻主要有：</b></p>\n<blockquote>\n <b>1、为什么经济学家低估了美国通胀的爆发力和耐力？</b>\n</blockquote>\n<blockquote>\n <b>2、美债市场遍布地雷 凶险程度达到疫情爆发以来之最</b>\n</blockquote>\n<blockquote>\n <b>3、又一波新冠疫情来袭 美国中西部医院ICU人满为患</b>\n</blockquote>\n<blockquote>\n <b>4、“<a href=\"https://laohu8.com/S/TSLA\">特斯拉</a>杀手”Rivian上市次日再度飙升逾20% 市值突破千亿超越<a href=\"https://laohu8.com/S/GM\">通用汽车</a></b>\n</blockquote>\n<blockquote>\n <b>5、改善居住条件叠加回城上班刚需 推动曼哈顿房租创纪录上涨</b>\n</blockquote>\n<blockquote>\n <b>6、<a href=\"https://laohu8.com/S/DIS\">迪士尼</a>股价创18个月最大跌幅 因流媒体服务业务放缓</b>\n</blockquote>\n<p><img src=\"https://static.tigerbbs.com/5dbc3fa747a5e8746ac0c3f61f34757e\" tg-width=\"550\" tg-height=\"339\" referrerpolicy=\"no-referrer\" width=\"100%\" height=\"auto\"></p>\n<p><b>为什么经济学家低估了美国通胀的爆发力和耐力？</b></p>\n<p>卷土重来的疫情、脆弱的全球供应网络和刺激政策充实的消费者荷包，共同推动美国物价涨幅远超华尔街和决策者的预期。经济学家也明白了该谦虚的时候要谦虚。</p>\n<p>本周三发布的最新通胀数据显示，10月份消费物价同比上涨6.2%，高于所有预测。以前的物价上涨更多因为经济重新开放，而10月的数据却显示了广泛的通胀压力。</p>\n<p><a href=\"https://laohu8.com/S/DB\">德意志银行</a>首席美国经济学家Matthew Luzzetti说，过去一年，预测通胀“非常具有挑战性，”未来也依然很难。“现在这个时候，谁都别以为自己已经考虑了足够的价格压力，通胀前景的风险仍然偏向上行。”</p>\n<p>自年初以来，经济学家被迫提高了对消费价格涨幅的预测。曾经，通胀被视为某种幻觉，是所谓的基期效应扭曲了数字。但结果证明，这是个更加长期的问题。</p>\n<p><img src=\"https://static.tigerbbs.com/0de9807e60befbc92e727c2b27cd2f47\" tg-width=\"550\" tg-height=\"364\" referrerpolicy=\"no-referrer\" width=\"100%\" height=\"auto\"></p>\n<p><b>美债市场遍布地雷 凶险程度达到疫情爆发以来之最</b></p>\n<p>美国国债市场过去一个月已成为雷区。</p>\n<p>随着全球债券交易员努力迫使央行出手应对高通胀，债市异常的震荡让他们自己也损失不小。由此仿佛陷入一个恶性循环，不愿入市令债市流动性减少，价格更易大幅波动，这进而又阻止了人们入市的脚步。</p>\n<p>美国政府证券流动性指数显示，美国国债目前的交易状况为2020年3月以来最糟。该指数衡量收益率偏离公允价值模型的程度。至于预期波动率，跟踪美国国债的ICE<a href=\"https://laohu8.com/S/BAC\">美国银行</a>MOVE指数目前接近2020年4月以来最高水平。</p>\n<p>美联储11月3日宣布计划每月减少购买800亿美元美国国债，目标是到明年年中结束购债行动。主席鲍威尔重申该减码时间表对于加息时间没有指示意义，必要情况下联储会果断对“通胀”采取行动。周三美国公布的10月CPI涨幅超过预期，美债市场遭遇2月以来最大抛盘。</p>\n<p><img src=\"https://static.tigerbbs.com/17bb143298d36f6743808a411697ad14\" tg-width=\"550\" tg-height=\"349\" referrerpolicy=\"no-referrer\" width=\"100%\" height=\"auto\"></p>\n<p><b>又一波新冠疫情来袭 美国中西部医院ICU人满为患</b></p>\n<p>美国部分地区的医院已经开始看到新冠疫情秋季浪潮的影响，这个最新迹象表明，即使是在疫苗接种率相对较高的地区，医疗系统仍然面临来自新冠病毒的巨大压力。</p>\n<p>在12个州，Covid-19患者使用的重症监护床位比两周前有所攀升，这些州大多数位于南起亚利桑那州和新墨西哥州，北至明尼苏达州，跨越北美大平原的连续地带上。在西部几个州，许多医生和护士还没有从上一轮感染高峰中缓过气来。</p>\n<p>“我们已经满负荷运转，（直到几天前）都无法让病人转院，” 科罗拉多州偏远的Moffat县农村地区医院Memorial Hospital的手术副总裁Jennifer Riley说。“很难相信疫情已经持续了这么久。”该医院有大约25张床位。</p>\n<p>美国未来数月面临着不确定性，随着传统的冬季病毒传染高峰期来临，德尔塔变异毒株仍在全国范围内蔓延。美国许多地区也经历了异常温暖的秋季，尚未看到当寒冷的天气促使人们更多呆在室内、病毒更容易传播时会发生什么状况。</p>\n<p><img src=\"https://static.tigerbbs.com/1558ffa4bade529e0653078064a84267\" tg-width=\"550\" tg-height=\"309\" referrerpolicy=\"no-referrer\" width=\"100%\" height=\"auto\"></p>\n<p><b>“特斯拉杀手”Rivian上市次日再度飙升逾20% 市值突破千亿超越通用汽车</b></p>\n<p>电动汽车初创公司Rivian股价周四继续攀升，在上市一天后再度大涨约23%。</p>\n<p>这家<a href=\"https://laohu8.com/S/AMZN\">亚马逊</a>和福特支持的公司的市值已经超过<a href=\"https://laohu8.com/S/F\">福特汽车</a>和通用汽车，目前超过1000亿美元。不过这仍然远远落后于特斯拉逾1万亿美元的市值。</p>\n<p>截至发稿，通用汽车的市值为888亿美元，而福特的市值为776亿美元。</p>\n<p>Rivian当前的市值意味着亚马逊在该公司20%的股份现价值约210亿美元，而福特持有的12%股份价值超过120亿美元。</p>\n<p>鉴于Rivian还没有成熟的商业模式，并预计三季度营收最高仅为100万美元，因此该股两日的涨幅尤其惊人。该公司在招股说明书中表示，预计当季亏损将高达12.8亿美元。</p>\n<p>Rivian凭借全电动皮卡在市场上击败了竞争对手，但尚未大规模生产其车辆。</p>\n<p><img src=\"https://static.tigerbbs.com/703c35767cc066ea313d043ed964d5ae\" tg-width=\"550\" tg-height=\"309\" referrerpolicy=\"no-referrer\" width=\"100%\" height=\"auto\"></p>\n<p><b>改善居住条件叠加回城上班刚需 推动曼哈顿房租创纪录上涨</b></p>\n<p>曼哈顿的公寓租金正在以创纪录速度上涨，因为准备重返办公室的人们纷纷在曼哈顿寻找条件更好的住所。</p>\n<p>评估公司Miller Samuel Inc．和中介公司Douglas Elliman Real Estate在周四的一份报告中表示，10月份租金中位数达到3382美元，同比上涨18%。这是10年前有数据以来最大同比涨幅；不过，租金中位数绝对值仍低于2019年10月的3409美元。</p>\n<p>Miller Samuel总裁Jonathan Miller说，那些无缘在郊区购房的公寓租户发现，他们可以转而在市内租下更好的房子。还有人则在办公室附近找到房子，为最终不得不回办公室上班做准备。</p>\n<p>“越来越多的人理解了自己想要住的地方和雇主希望他们工作的地方之间的关系，”Miller说。</p>\n<p><img src=\"https://static.tigerbbs.com/4a8b70e558184105f6ced2b1ee484691\" tg-width=\"533\" tg-height=\"300\" referrerpolicy=\"no-referrer\" width=\"100%\" height=\"auto\"></p>\n<p><b>迪士尼股价创18个月最大跌幅 因流媒体服务业务放缓</b></p>\n<p>迪士尼股价创疫情爆发以来最大跌幅，之前该公司报告流媒体用户增长低于预期，引发投资者对连续两年火爆之后增长放缓的担忧。</p>\n<p>迪士尼股价周四早盘一度下跌9.2%，为2020年3月以来最大盘中跌幅。此番下跌导致该公司市值低于竞争对手Netflix&nbsp;Inc．。流媒体的不足只是该公司各业务部门当季普遍令人失望的缩影。</p>\n<p>该公司周三公告称，Disney+在第四财季新增210万用户，其用户总数达到1.181亿。接受彭博调查的分析师预测为1.196亿。这是该服务两年前推出以来的最小季度增幅。</p>\n<p>迪士尼已将这个家庭流媒体产品作为未来几年增长的重点，管理层重申了到2024年拥有2.6亿用户的目标。11月12日是月费8美元的Disney+上线两周年纪念日，该公司正在举行庆祝活动，在全公司范围内推出新电影和促销活动。</p>","source":"sina","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>外媒头条：市值突破千亿！Rivian上市次日再度飙升</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n外媒头条：市值突破千亿！Rivian上市次日再度飙升\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-11-12 05:41 北京时间&nbsp;&nbsp;&nbsp;<a href=https://finance.sina.com.cn/stock/usstock/c/2021-11-12/doc-iktzscyy5039074.shtml><strong>新浪财经</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>全球财经媒体昨夜今晨共同关注的头条新闻主要有：\n\n1、为什么经济学家低估了美国通胀的爆发力和耐力？\n\n\n2、美债市场遍布地雷 凶险程度达到疫情爆发以来之最\n\n\n3、又一波新冠疫情来袭 美国中西部医院ICU人满为患\n\n\n4、“特斯拉杀手”Rivian上市次日再度飙升逾20% 市值突破千亿超越通用汽车\n\n\n5、改善居住条件叠加回城上班刚需 推动曼哈顿房租创纪录上涨\n\n\n6、迪士尼股价创18个月最大跌幅...</p>\n\n<a href=\"https://finance.sina.com.cn/stock/usstock/c/2021-11-12/doc-iktzscyy5039074.shtml\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"https://static.tigerbbs.com/37d8ba54faa1a9d08aed79d6e8240d1f","relate_stocks":{"RIVN":"Rivian Automotive, Inc.",".DJI":"道琼斯",".SPX":"S&P 500 Index",".IXIC":"NASDAQ Composite"},"source_url":"https://finance.sina.com.cn/stock/usstock/c/2021-11-12/doc-iktzscyy5039074.shtml","is_english":false,"share_image_url":"https://static.laohu8.com/b0d1b7e8843deea78cc308b15114de44","article_id":"2182606257","content_text":"全球财经媒体昨夜今晨共同关注的头条新闻主要有：\n\n1、为什么经济学家低估了美国通胀的爆发力和耐力？\n\n\n2、美债市场遍布地雷 凶险程度达到疫情爆发以来之最\n\n\n3、又一波新冠疫情来袭 美国中西部医院ICU人满为患\n\n\n4、“特斯拉杀手”Rivian上市次日再度飙升逾20% 市值突破千亿超越通用汽车\n\n\n5、改善居住条件叠加回城上班刚需 推动曼哈顿房租创纪录上涨\n\n\n6、迪士尼股价创18个月最大跌幅 因流媒体服务业务放缓\n\n\n为什么经济学家低估了美国通胀的爆发力和耐力？\n卷土重来的疫情、脆弱的全球供应网络和刺激政策充实的消费者荷包，共同推动美国物价涨幅远超华尔街和决策者的预期。经济学家也明白了该谦虚的时候要谦虚。\n本周三发布的最新通胀数据显示，10月份消费物价同比上涨6.2%，高于所有预测。以前的物价上涨更多因为经济重新开放，而10月的数据却显示了广泛的通胀压力。\n德意志银行首席美国经济学家Matthew Luzzetti说，过去一年，预测通胀“非常具有挑战性，”未来也依然很难。“现在这个时候，谁都别以为自己已经考虑了足够的价格压力，通胀前景的风险仍然偏向上行。”\n自年初以来，经济学家被迫提高了对消费价格涨幅的预测。曾经，通胀被视为某种幻觉，是所谓的基期效应扭曲了数字。但结果证明，这是个更加长期的问题。\n\n美债市场遍布地雷 凶险程度达到疫情爆发以来之最\n美国国债市场过去一个月已成为雷区。\n随着全球债券交易员努力迫使央行出手应对高通胀，债市异常的震荡让他们自己也损失不小。由此仿佛陷入一个恶性循环，不愿入市令债市流动性减少，价格更易大幅波动，这进而又阻止了人们入市的脚步。\n美国政府证券流动性指数显示，美国国债目前的交易状况为2020年3月以来最糟。该指数衡量收益率偏离公允价值模型的程度。至于预期波动率，跟踪美国国债的ICE美国银行MOVE指数目前接近2020年4月以来最高水平。\n美联储11月3日宣布计划每月减少购买800亿美元美国国债，目标是到明年年中结束购债行动。主席鲍威尔重申该减码时间表对于加息时间没有指示意义，必要情况下联储会果断对“通胀”采取行动。周三美国公布的10月CPI涨幅超过预期，美债市场遭遇2月以来最大抛盘。\n\n又一波新冠疫情来袭 美国中西部医院ICU人满为患\n美国部分地区的医院已经开始看到新冠疫情秋季浪潮的影响，这个最新迹象表明，即使是在疫苗接种率相对较高的地区，医疗系统仍然面临来自新冠病毒的巨大压力。\n在12个州，Covid-19患者使用的重症监护床位比两周前有所攀升，这些州大多数位于南起亚利桑那州和新墨西哥州，北至明尼苏达州，跨越北美大平原的连续地带上。在西部几个州，许多医生和护士还没有从上一轮感染高峰中缓过气来。\n“我们已经满负荷运转，（直到几天前）都无法让病人转院，” 科罗拉多州偏远的Moffat县农村地区医院Memorial Hospital的手术副总裁Jennifer Riley说。“很难相信疫情已经持续了这么久。”该医院有大约25张床位。\n美国未来数月面临着不确定性，随着传统的冬季病毒传染高峰期来临，德尔塔变异毒株仍在全国范围内蔓延。美国许多地区也经历了异常温暖的秋季，尚未看到当寒冷的天气促使人们更多呆在室内、病毒更容易传播时会发生什么状况。\n\n“特斯拉杀手”Rivian上市次日再度飙升逾20% 市值突破千亿超越通用汽车\n电动汽车初创公司Rivian股价周四继续攀升，在上市一天后再度大涨约23%。\n这家亚马逊和福特支持的公司的市值已经超过福特汽车和通用汽车，目前超过1000亿美元。不过这仍然远远落后于特斯拉逾1万亿美元的市值。\n截至发稿，通用汽车的市值为888亿美元，而福特的市值为776亿美元。\nRivian当前的市值意味着亚马逊在该公司20%的股份现价值约210亿美元，而福特持有的12%股份价值超过120亿美元。\n鉴于Rivian还没有成熟的商业模式，并预计三季度营收最高仅为100万美元，因此该股两日的涨幅尤其惊人。该公司在招股说明书中表示，预计当季亏损将高达12.8亿美元。\nRivian凭借全电动皮卡在市场上击败了竞争对手，但尚未大规模生产其车辆。\n\n改善居住条件叠加回城上班刚需 推动曼哈顿房租创纪录上涨\n曼哈顿的公寓租金正在以创纪录速度上涨，因为准备重返办公室的人们纷纷在曼哈顿寻找条件更好的住所。\n评估公司Miller Samuel Inc．和中介公司Douglas Elliman Real Estate在周四的一份报告中表示，10月份租金中位数达到3382美元，同比上涨18%。这是10年前有数据以来最大同比涨幅；不过，租金中位数绝对值仍低于2019年10月的3409美元。\nMiller Samuel总裁Jonathan Miller说，那些无缘在郊区购房的公寓租户发现，他们可以转而在市内租下更好的房子。还有人则在办公室附近找到房子，为最终不得不回办公室上班做准备。\n“越来越多的人理解了自己想要住的地方和雇主希望他们工作的地方之间的关系，”Miller说。\n\n迪士尼股价创18个月最大跌幅 因流媒体服务业务放缓\n迪士尼股价创疫情爆发以来最大跌幅，之前该公司报告流媒体用户增长低于预期，引发投资者对连续两年火爆之后增长放缓的担忧。\n迪士尼股价周四早盘一度下跌9.2%，为2020年3月以来最大盘中跌幅。此番下跌导致该公司市值低于竞争对手Netflix Inc．。流媒体的不足只是该公司各业务部门当季普遍令人失望的缩影。\n该公司周三公告称，Disney+在第四财季新增210万用户，其用户总数达到1.181亿。接受彭博调查的分析师预测为1.196亿。这是该服务两年前推出以来的最小季度增幅。\n迪士尼已将这个家庭流媒体产品作为未来几年增长的重点，管理层重申了到2024年拥有2.6亿用户的目标。11月12日是月费8美元的Disney+上线两周年纪念日，该公司正在举行庆祝活动，在全公司范围内推出新电影和促销活动。","news_type":1},"isVote":1,"tweetType":1,"viewCount":847,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":158995929,"gmtCreate":1625119424361,"gmtModify":1633944568012,"author":{"id":"4087711343938000","authorId":"4087711343938000","name":"ZeeJay","avatar":"https://static.tigerbbs.com/36dbec811e59c06f4aea5df6c06ea26f","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4087711343938000","authorIdStr":"4087711343938000"},"themes":[],"htmlText":"Buy buy buy!!","listText":"Buy buy buy!!","text":"Buy buy buy!!","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/158995929","repostId":"2147581409","repostType":4,"repost":{"id":"2147581409","kind":"highlight","pubTimestamp":1625118840,"share":"https://www.laohu8.com/m/news/2147581409?lang=&edition=full","pubTime":"2021-07-01 13:54","market":"us","language":"en","title":"This Dividend King Is About to Get a Big Boost From Reopening","url":"https://stock-news.laohu8.com/highlight/detail?id=2147581409","media":"Motley Fool","summary":"With a unique approach to a vital food-distribution category, this Dividend King is only just starting its recovery.","content":"<p><b>Hormel Foods</b> (NYSE:HRL), with 55 years of annual increases under its belt, doesn't operate like your typical packaged-food maker. The company's unique system was a major headwind during the pandemic-driven shutdowns in 2020. But as the world is starting to reopen again, that difference has already turned into a tailwind. And the benefits aren't over yet. Here's a quick look at what Hormel does differently and why it's set to boost earnings in the quarters ahead.</p>\n<h2>Going direct</h2>\n<p>Hormel is probably best known for its branded-product portfolio, which includes icons like Spam and Skippy. Those are just two of a long list of leading names that can be found across the grocery store. Though it has a heavy focus on protein-related products, the company manages a collection of separate brand-name products. That's worked out fairly well for investors over time; the average annual dividend increase over the past decade was a huge 15%. Looking at that a different way, in 2010 Hormel's full-year dividend was $0.21 per share. In 2020 it was $0.93 per share. That's the magic of compounding.</p>\n<p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/b6d76002a2eb850d37ca108f7f198fcf\" tg-width=\"700\" tg-height=\"333\"><span>Image source: Getty Images.</span></p>\n<p>A key piece of the company's success, meanwhile, has been a balanced portfolio. That includes both the products it offers and the segments into which it sells. For example, the recent acquisition of Planters from <b>Kraft Heinz</b> added not just the famous peanut brand but also a larger exposure to convenience stores. That doubled up the diversification benefit. But <a href=\"https://laohu8.com/S/AONE\">one</a> of the more notable differences between Hormel and most of its peers is that Hormel has a direct-sales staff dedicated to the foodservice industry. Essentially, it has employees who work directly with restaurants and other food locations, like schools and hotels, to promote its products. It even has brands, like Burke and Cafe H, that are only sold into the foodservice space.</p>\n<p>Prior to the coronavirus pandemic, having this direct connection with foodservice customers provided valuable feedback for Hormel that allowed it to differentiate its products. For example, it developed a high-quality, pre-cooked bacon product (Bacon 1) so that the foodservice space could avoid the time, risk, and expense of cooking greasy bacon. But as restaurants and other out-of-home eating locations were shut down in 2020, this business was a major liability. As recently as the fiscal first quarter of 2021, which ended Jan. 24, foodservice segment sales were down by 17%.</p>\n<h2>That was then, this is now</h2>\n<p>That's just <a href=\"https://laohu8.com/S/AONE.U\">one</a> sales avenue for Hormel, with its other business benefiting from more at-home consumption. In that same quarter, U.S. retail sales were up 13%, deli sales increased 7%, and international sales (heavily centered on China) advanced 9%. That left the foodservice business the real standout in a pretty bad way. In the fiscal second quarter, however, foodservice turned around, with sales up 28%.</p>\n<p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/9afe4230b9f9ac9439297f45b32277d7\" tg-width=\"720\" tg-height=\"483\"><span>HRL data by YCharts</span></p>\n<p>To be fair, that was off a low base, given the pandemic, but it more than offset the flat performance during the quarter in the U.S. retail segment (deli and international both saw continued growth). But the really interesting thing here is that compared to the same quarter in 2019, Hormel's foodservice sales were up 1%. So the business not only rebounded from the 2020 hit, it grew just a touch over the two-year period.&nbsp;During Hormel's fiscal second-quarter 2021 earnings conference call, CEO James Snee noted:</p>\n<blockquote>\n We have a very positive outlook on the foodservice business, as we head into the second half of the year. We are well-positioned from an inventory and capacity standpoint to meet the demand from our distributor partners and operators and are confident in our ability to gain share throughout the recovery.\n</blockquote>\n<p>When pressed by an analyst on the matter, CFO James Sheehan added:</p>\n<blockquote>\n Now for us where we see future opportunities in a number of our segments, we haven't seen lodging come back. We really haven't seen college and university fully come back, which is a big part of our Hormel foodservice business. I referenced K-12 for the Jennie-O foodservice business. So, there's still a lot of dynamics at play. And so even as these other segments, these other channels really start to reopen those are going to have a favorable impact on our foodservice business as well.\n</blockquote>\n<p>Put simply, the company's foodservice business is already back to pre-pandemic levels, and it's not even firing on all cylinders. As the reopening continues to move forward, Hormel's foodservice business looks like it will become an increasingly important growth engine.</p>\n<h2>The big takeaway</h2>\n<p>As the pandemic raged, Hormel's foodservice business was a drag that left it trailing packaged-food peers with a heavier focus on grocery stores. Now, however, it looks like Hormel is set to get a big benefit that other packaged-food makers won't as the foodservice channel comes back to life. Make sure you pay close attention to this business when Hormel next reports earnings; it should make for good reading. Indeed, Hormel isn't exactly your normal food maker, but that looks like it will be a very good thing in the quarters ahead.</p>","source":"fool_stock","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>This Dividend King Is About to Get a Big Boost From Reopening</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nThis Dividend King Is About to Get a Big Boost From Reopening\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-07-01 13:54 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.fool.com/investing/2021/06/30/this-dividend-king-is-about-to-get-a-big-boost-fro/><strong>Motley Fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Hormel Foods (NYSE:HRL), with 55 years of annual increases under its belt, doesn't operate like your typical packaged-food maker. The company's unique system was a major headwind during the pandemic-...</p>\n\n<a href=\"https://www.fool.com/investing/2021/06/30/this-dividend-king-is-about-to-get-a-big-boost-fro/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"HRL":"荷美尔"},"source_url":"https://www.fool.com/investing/2021/06/30/this-dividend-king-is-about-to-get-a-big-boost-fro/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2147581409","content_text":"Hormel Foods (NYSE:HRL), with 55 years of annual increases under its belt, doesn't operate like your typical packaged-food maker. The company's unique system was a major headwind during the pandemic-driven shutdowns in 2020. But as the world is starting to reopen again, that difference has already turned into a tailwind. And the benefits aren't over yet. Here's a quick look at what Hormel does differently and why it's set to boost earnings in the quarters ahead.\nGoing direct\nHormel is probably best known for its branded-product portfolio, which includes icons like Spam and Skippy. Those are just two of a long list of leading names that can be found across the grocery store. Though it has a heavy focus on protein-related products, the company manages a collection of separate brand-name products. That's worked out fairly well for investors over time; the average annual dividend increase over the past decade was a huge 15%. Looking at that a different way, in 2010 Hormel's full-year dividend was $0.21 per share. In 2020 it was $0.93 per share. That's the magic of compounding.\nImage source: Getty Images.\nA key piece of the company's success, meanwhile, has been a balanced portfolio. That includes both the products it offers and the segments into which it sells. For example, the recent acquisition of Planters from Kraft Heinz added not just the famous peanut brand but also a larger exposure to convenience stores. That doubled up the diversification benefit. But one of the more notable differences between Hormel and most of its peers is that Hormel has a direct-sales staff dedicated to the foodservice industry. Essentially, it has employees who work directly with restaurants and other food locations, like schools and hotels, to promote its products. It even has brands, like Burke and Cafe H, that are only sold into the foodservice space.\nPrior to the coronavirus pandemic, having this direct connection with foodservice customers provided valuable feedback for Hormel that allowed it to differentiate its products. For example, it developed a high-quality, pre-cooked bacon product (Bacon 1) so that the foodservice space could avoid the time, risk, and expense of cooking greasy bacon. But as restaurants and other out-of-home eating locations were shut down in 2020, this business was a major liability. As recently as the fiscal first quarter of 2021, which ended Jan. 24, foodservice segment sales were down by 17%.\nThat was then, this is now\nThat's just one sales avenue for Hormel, with its other business benefiting from more at-home consumption. In that same quarter, U.S. retail sales were up 13%, deli sales increased 7%, and international sales (heavily centered on China) advanced 9%. That left the foodservice business the real standout in a pretty bad way. In the fiscal second quarter, however, foodservice turned around, with sales up 28%.\nHRL data by YCharts\nTo be fair, that was off a low base, given the pandemic, but it more than offset the flat performance during the quarter in the U.S. retail segment (deli and international both saw continued growth). But the really interesting thing here is that compared to the same quarter in 2019, Hormel's foodservice sales were up 1%. So the business not only rebounded from the 2020 hit, it grew just a touch over the two-year period. During Hormel's fiscal second-quarter 2021 earnings conference call, CEO James Snee noted:\n\n We have a very positive outlook on the foodservice business, as we head into the second half of the year. We are well-positioned from an inventory and capacity standpoint to meet the demand from our distributor partners and operators and are confident in our ability to gain share throughout the recovery.\n\nWhen pressed by an analyst on the matter, CFO James Sheehan added:\n\n Now for us where we see future opportunities in a number of our segments, we haven't seen lodging come back. We really haven't seen college and university fully come back, which is a big part of our Hormel foodservice business. I referenced K-12 for the Jennie-O foodservice business. So, there's still a lot of dynamics at play. And so even as these other segments, these other channels really start to reopen those are going to have a favorable impact on our foodservice business as well.\n\nPut simply, the company's foodservice business is already back to pre-pandemic levels, and it's not even firing on all cylinders. As the reopening continues to move forward, Hormel's foodservice business looks like it will become an increasingly important growth engine.\nThe big takeaway\nAs the pandemic raged, Hormel's foodservice business was a drag that left it trailing packaged-food peers with a heavier focus on grocery stores. Now, however, it looks like Hormel is set to get a big benefit that other packaged-food makers won't as the foodservice channel comes back to life. Make sure you pay close attention to this business when Hormel next reports earnings; it should make for good reading. Indeed, Hormel isn't exactly your normal food maker, but that looks like it will be a very good thing in the quarters ahead.","news_type":1},"isVote":1,"tweetType":1,"viewCount":355,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":127915279,"gmtCreate":1624813889891,"gmtModify":1633948414305,"author":{"id":"4087711343938000","authorId":"4087711343938000","name":"ZeeJay","avatar":"https://static.tigerbbs.com/36dbec811e59c06f4aea5df6c06ea26f","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4087711343938000","authorIdStr":"4087711343938000"},"themes":[],"htmlText":"NIO","listText":"NIO","text":"NIO","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/127915279","repostId":"1137119316","repostType":4,"repost":{"id":"1137119316","kind":"news","pubTimestamp":1624754401,"share":"https://www.laohu8.com/m/news/1137119316?lang=&edition=full","pubTime":"2021-06-27 08:40","market":"us","language":"en","title":"Ford Or NIO? The Final Verdict","url":"https://stock-news.laohu8.com/highlight/detail?id=1137119316","media":"seekingalpha","summary":"I am comparing Ford against NIO in different categories.The comparison is intended to improve the understanding of Ford's and NIO's growth potential while highlighting differences in market position and opportunities.NIO is growing a lot faster than Ford and the high valuation may be justified.With Ford  launching a major offensive in the market for electric vehicles, Chinese EV maker NIO  will face one more rival competing for sales in the future. Which vehicle maker offers the best deal based ","content":"<p><b>Summary</b></p>\n<ul>\n <li>I am comparing Ford against NIO in different categories.</li>\n <li>The comparison is intended to improve the understanding of Ford's and NIO's growth potential while highlighting differences in market position and opportunities.</li>\n <li>NIO is growing a lot faster than Ford and the high valuation may be justified.</li>\n</ul>\n<p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/5033fa117d7852799244b8275bc1000f\" tg-width=\"1536\" tg-height=\"886\"><span>peterschreiber.media/iStock via Getty Images</span></p>\n<p>With Ford (F) launching a major offensive in the market for electric vehicles, Chinese EV maker NIO (NIO) will face one more rival competing for sales in the future. Which vehicle maker offers the best deal based on market opportunity, scale, revenue model, growth prospects and valuation? I will compare Ford against NIO in each category and issue a final verdict at the end.</p>\n<p><b>Ford vs. NIO: The battle for the global electric vehicle market is heating up</b></p>\n<p>Although there is a world of difference between Ford and NIO, both companies are set to go toe-to-toe in the rapidly growing global electric vehicle market. Ford’s fleet is not yet EV-focused but this is going to change: Feeling that the EV race is heating up, Ford said it is accelerating its electrification plan by investing&nbsp;$30B into its EV manufacturing capabilities until 2025. Ford’s previous capital plan called for a $22B investment in zero-emission vehicles. Ford also set an ambitious sales goal: 40% of its global sales will be electric within the next decade and 33% of pickup truck sales. Electric vehicle sales account for just 1% of Ford's sales today. As Ford is phasing out combustion engines, it is set to evolve into an all-electric vehicle maker by 2040.</p>\n<p><b>Market opportunity</b></p>\n<p>In 2020, 3.2m electric vehicles were sold in the world which represented a small market share of just 4.2%. China, however, was responsible for buying 41% of all electric vehicles in the world in 2020. Chinese buyers purchased 1.3m electric vehicles last year and sales are set to grow fast as Beijing seeks to boost EV adoption. The second largest market for electric vehicles was Europe which accounted for 42% of global EV sales. The US is only the third-largest market for plug-in electric vehicles in the world.</p>\n<p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/b48c23b32134542f51227d9b1b612887\" tg-width=\"1083\" tg-height=\"863\"><span>(Source: Wikipedia)</span></p>\n<p>China, by far, is the fastest growing EV market in the world, although Europe is catching up fast, in part due to a legislative efforts to increase adoption of zero-emission passenger vehicles and because of massive investments in a Europe-wide charging station network. NIO is&nbsp;on the cusp of entering the European market&nbsp;in a bid to grow market share in the world’s second-largest EV market before the competition is ready.</p>\n<p>Beijing is a driver behind the electrification of the Chinese auto industry: The government wants to see a&nbsp;twenty percent share&nbsp;of electric vehicles for new car sales by 2025 which will drive EV penetration in NIO’s home market.</p>\n<p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/9871e44eaf69adb27151425887870ace\" tg-width=\"739\" tg-height=\"454\"><span>(Source:Schroders)</span></p>\n<p>Turning to growth projections.</p>\n<p>With more favorable government policies for EV makers in places like China and Europe, these markets are poised to see the fastest sales growth and the highest EV adoption rates in the world. China is not only the largest market due to population size but is also expected to outperform all other markets in the world in EV sales until 2030.</p>\n<p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/61d19dff2f34e2d8828aca854e85d84a\" tg-width=\"825\" tg-height=\"565\"><span>(Source:McKinsey)</span></p>\n<p>Since China has a larger total market size, a higher EV adoption rate, stronger expected sales growth and a more favorable regulatory framework, the winner here would be: NIO.</p>\n<p><b>Scale and manufacturing competence</b></p>\n<p>Ford has a century’s worth of manufacturing experience. But Ford, so far, has only one all-electric vehicle in its product line-up that compares to NIO: The Mustang Mach-E SUV. In 2022, Ford will begin to sell the all-electric F-150 Lightening which builds on the success of Ford’s best-selling pick-up truck. NIO already has a stronger product catalog including the 5-seater ES6 SUV, the 5-seater coupe SUV EC6 and the ES8, a 6-seater and 7-seater full-sized SUV.</p>\n<p>Since NIO is solely focused on producing EVs and occupies a very small and defined niche, the Chinese firm has an advantage as far as EV-manufacturing expertise goes. The question is how long this advantage can last. Ford has extensive experience in building cars and can leverage a global manufacturing base to ramp up EV production faster than any niche EV maker could ever hope to achieve. This makes Ford a very serious rival not only to Tesla (TSLA) in the US, but also to NIO abroad. Ford is accelerating its electrification plans and it has the resources and the ambition to become a leader in EVs within the next decade. Ford’s proposed $30B spending on the electrification of its fleet will accelerate its transformation and turn Ford into a long term threat to other EV makers.</p>\n<p>Winner here: Ford.</p>\n<p><b>Differentiation and BaaS revenue model</b></p>\n<p>Both Ford and NIO know about the importance of differentiation in a market that will only get more competitive over time, which is why both companies are investing heavily in a related field that can break or solidify dominance in the EV market: Battery technology.</p>\n<p>Ford is&nbsp;forming a joint venture&nbsp;with South Korean battery technology company SK Innovation to secure supply of traction battery cells and array modules. The joint venture is meant to accelerate battery deliveries and will produce approximately 60 GWh annually, enough to cover 25% of Ford’s estimated annual energy demand by 2030. NIO is also investing in battery technology and has&nbsp;formed its own joint venture&nbsp;to secure battery supply.</p>\n<p>The difference to Ford is that NIO’s battery investment strategy revolves around a battery subscription model, also called “battery-as-a-service”, which creates a strong, long term revenue opportunity for the Chinese vehicle maker. Under this “BaaS” model, users who buy a NIO electric vehicle get a 70,000 RMB initial discount, equivalent to $10,800, and can sign up for a monthly subscription to rent a rechargeable 70 kWh battery. Batteries can then be exchanged at one of NIO’s battery-swapping stations which can be found in most big Chinese cities. A battery subscription costs 980 RMB monthly which is the equivalent of $150.</p>\n<p>The BaaS model has a couple of benefits for both the vehicle maker and the user: Purchasing an electric vehicle from NIO gets a lot more affordable due to the up-front discount and the subscription model ensures that users benefit from advancement in battery technology and better performance over time. Decoupling battery costs from vehicle prices creates an entirely new revenue stream on a subscription basis for NIO. Revenues from “BaaS” subscriptions could be used to increase the density of NIO’s network of charging/replacement stations. The battery subscription model also binds customers to NIO, potentially increasing customer lifetime value.</p>\n<p>Ford and NIO are primed to benefit from falling battery costs for electric vehicles as they ramp up capital allocations. As more investments flow into developing more efficient batteries, performance will go up and costs will go down which should drive EV adoption and benefit all EV makers. This is because lower battery prices make EVs more competitive to passenger vehicles with combustion engines. But since NIO is structuring a part of its business model explicitly around battery subscriptions, NIO could benefit more than Ford.</p>\n<p>Battery costs for EVs have decreased 70% since 2014, based on information provided by investment firm Schroders, and are set to decrease more this decade.</p>\n<p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/c42acb75905affe7570a2f399ea3192f\" tg-width=\"758\" tg-height=\"449\"><span>(Source: Schroders)</span></p>\n<p>The “BaaS” model is genius and could develop into a $500M a year revenue opportunity for NIO long term. Although Ford is ramping up its investments in battery technology, the winner in this category is: NIO.</p>\n<p><b>Sales growth and valuation</b></p>\n<p>Ford’s sales in May grew 4.1% Y/Y but electrified vehicle sales (including hybrids) surged 184% Y/Y as Ford sold a record 10,364 EVs/hybrids in May. Escape electrified sales and Explorer Hybrid grew sales at 125% and 132% Y/Y showing strong customer uptake. NIO delivered 6,711 vehicles last month including 3,017 ES6s, 1,412 ES8s and 2,282 EC6s. Total Y/Y delivery growth for May was 95.3%.</p>\n<p>Ford's sales are fifty-four times larger than NIO's which creates more sales growth and revaluation potential for NIO.</p>\n<p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/df5a0a393e44ed74241c5effcdd92350\" tg-width=\"635\" tg-height=\"419\"><span>Data by YCharts</span></p>\n<p>The difference in valuation between Ford and NIO is like the difference between night and day. This is because Ford is still seen as a mature vehicle maker with expected enterprise sales growth in the low-to-mid digits, despite explosive growth in the EV category. Ford is expected to grow revenues by 33% until FY 2025 (base year: FY 2020) and NIO by 808%!</p>\n<p>Due to these differences in sales growth, NIO is the complete opposite of Ford, at least as far as valuation goes. The Chinese EV-maker is expected to see sales and delivery growth close to 100% this year and since NIO is only dealing in EVs, NIO gets a much higher market-cap-to-sales ratio than Ford.</p>\n<p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/817605c6b1e82c03d0473ea570d32b8f\" tg-width=\"506\" tg-height=\"406\"><span>(Source: Author)</span></p>\n<p><b>NIO has larger risks...</b></p>\n<p>NIO is the more risky venture, but also the one that offers the most promise. Government policy favors EV-makers like NIO. The potential for total global sales growth is larger for NIO as it operates from a smaller revenue base compared to Ford. But there are also a few things that work against NIO. For example, recalls due to production defects would be a much bigger challenge for NIO to overcome than for Ford which can rely on a global service and distribution network. NIO’s valuation is also not without risk as an unexpected slowing of sales growth due to production setbacks would leave a much larger dent in the financials.</p>\n<p><b>Final verdict</b></p>\n<p>NIO is definitely the more “sexy” vehicle maker. Strong adoption and sales growth in China and Europe support NIO. Its super smart BaaS model which decouples vehicle purchase prices from battery costs is genius. You pay a high price for this growth but the market opportunity for NIO is immense.</p>\n<p>Ford’s EV sales are booming and the percentage of EV sales will increase as the vehicle maker electrifies its fleet. Ford has a lot of potential in the EV market but since EV sales are still a relatively low percentage of total sales, it will take a long time for Ford to complete its transformation.</p>\n<p>If you believe in the potential of the global EV market, buy NIO. If you believe in the potential of the global EV market and don’t like much risk, buy Ford.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Ford Or NIO? The Final Verdict</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nFord Or NIO? The Final Verdict\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-06-27 08:40 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://seekingalpha.com/article/4436600-ford-or-nio-the-final-verdict><strong>seekingalpha</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Summary\n\nI am comparing Ford against NIO in different categories.\nThe comparison is intended to improve the understanding of Ford's and NIO's growth potential while highlighting differences in market ...</p>\n\n<a href=\"https://seekingalpha.com/article/4436600-ford-or-nio-the-final-verdict\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"F":"福特汽车","NIO":"蔚来"},"source_url":"https://seekingalpha.com/article/4436600-ford-or-nio-the-final-verdict","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1137119316","content_text":"Summary\n\nI am comparing Ford against NIO in different categories.\nThe comparison is intended to improve the understanding of Ford's and NIO's growth potential while highlighting differences in market position and opportunities.\nNIO is growing a lot faster than Ford and the high valuation may be justified.\n\npeterschreiber.media/iStock via Getty Images\nWith Ford (F) launching a major offensive in the market for electric vehicles, Chinese EV maker NIO (NIO) will face one more rival competing for sales in the future. Which vehicle maker offers the best deal based on market opportunity, scale, revenue model, growth prospects and valuation? I will compare Ford against NIO in each category and issue a final verdict at the end.\nFord vs. NIO: The battle for the global electric vehicle market is heating up\nAlthough there is a world of difference between Ford and NIO, both companies are set to go toe-to-toe in the rapidly growing global electric vehicle market. Ford’s fleet is not yet EV-focused but this is going to change: Feeling that the EV race is heating up, Ford said it is accelerating its electrification plan by investing $30B into its EV manufacturing capabilities until 2025. Ford’s previous capital plan called for a $22B investment in zero-emission vehicles. Ford also set an ambitious sales goal: 40% of its global sales will be electric within the next decade and 33% of pickup truck sales. Electric vehicle sales account for just 1% of Ford's sales today. As Ford is phasing out combustion engines, it is set to evolve into an all-electric vehicle maker by 2040.\nMarket opportunity\nIn 2020, 3.2m electric vehicles were sold in the world which represented a small market share of just 4.2%. China, however, was responsible for buying 41% of all electric vehicles in the world in 2020. Chinese buyers purchased 1.3m electric vehicles last year and sales are set to grow fast as Beijing seeks to boost EV adoption. The second largest market for electric vehicles was Europe which accounted for 42% of global EV sales. The US is only the third-largest market for plug-in electric vehicles in the world.\n(Source: Wikipedia)\nChina, by far, is the fastest growing EV market in the world, although Europe is catching up fast, in part due to a legislative efforts to increase adoption of zero-emission passenger vehicles and because of massive investments in a Europe-wide charging station network. NIO is on the cusp of entering the European market in a bid to grow market share in the world’s second-largest EV market before the competition is ready.\nBeijing is a driver behind the electrification of the Chinese auto industry: The government wants to see a twenty percent share of electric vehicles for new car sales by 2025 which will drive EV penetration in NIO’s home market.\n(Source:Schroders)\nTurning to growth projections.\nWith more favorable government policies for EV makers in places like China and Europe, these markets are poised to see the fastest sales growth and the highest EV adoption rates in the world. China is not only the largest market due to population size but is also expected to outperform all other markets in the world in EV sales until 2030.\n(Source:McKinsey)\nSince China has a larger total market size, a higher EV adoption rate, stronger expected sales growth and a more favorable regulatory framework, the winner here would be: NIO.\nScale and manufacturing competence\nFord has a century’s worth of manufacturing experience. But Ford, so far, has only one all-electric vehicle in its product line-up that compares to NIO: The Mustang Mach-E SUV. In 2022, Ford will begin to sell the all-electric F-150 Lightening which builds on the success of Ford’s best-selling pick-up truck. NIO already has a stronger product catalog including the 5-seater ES6 SUV, the 5-seater coupe SUV EC6 and the ES8, a 6-seater and 7-seater full-sized SUV.\nSince NIO is solely focused on producing EVs and occupies a very small and defined niche, the Chinese firm has an advantage as far as EV-manufacturing expertise goes. The question is how long this advantage can last. Ford has extensive experience in building cars and can leverage a global manufacturing base to ramp up EV production faster than any niche EV maker could ever hope to achieve. This makes Ford a very serious rival not only to Tesla (TSLA) in the US, but also to NIO abroad. Ford is accelerating its electrification plans and it has the resources and the ambition to become a leader in EVs within the next decade. Ford’s proposed $30B spending on the electrification of its fleet will accelerate its transformation and turn Ford into a long term threat to other EV makers.\nWinner here: Ford.\nDifferentiation and BaaS revenue model\nBoth Ford and NIO know about the importance of differentiation in a market that will only get more competitive over time, which is why both companies are investing heavily in a related field that can break or solidify dominance in the EV market: Battery technology.\nFord is forming a joint venture with South Korean battery technology company SK Innovation to secure supply of traction battery cells and array modules. The joint venture is meant to accelerate battery deliveries and will produce approximately 60 GWh annually, enough to cover 25% of Ford’s estimated annual energy demand by 2030. NIO is also investing in battery technology and has formed its own joint venture to secure battery supply.\nThe difference to Ford is that NIO’s battery investment strategy revolves around a battery subscription model, also called “battery-as-a-service”, which creates a strong, long term revenue opportunity for the Chinese vehicle maker. Under this “BaaS” model, users who buy a NIO electric vehicle get a 70,000 RMB initial discount, equivalent to $10,800, and can sign up for a monthly subscription to rent a rechargeable 70 kWh battery. Batteries can then be exchanged at one of NIO’s battery-swapping stations which can be found in most big Chinese cities. A battery subscription costs 980 RMB monthly which is the equivalent of $150.\nThe BaaS model has a couple of benefits for both the vehicle maker and the user: Purchasing an electric vehicle from NIO gets a lot more affordable due to the up-front discount and the subscription model ensures that users benefit from advancement in battery technology and better performance over time. Decoupling battery costs from vehicle prices creates an entirely new revenue stream on a subscription basis for NIO. Revenues from “BaaS” subscriptions could be used to increase the density of NIO’s network of charging/replacement stations. The battery subscription model also binds customers to NIO, potentially increasing customer lifetime value.\nFord and NIO are primed to benefit from falling battery costs for electric vehicles as they ramp up capital allocations. As more investments flow into developing more efficient batteries, performance will go up and costs will go down which should drive EV adoption and benefit all EV makers. This is because lower battery prices make EVs more competitive to passenger vehicles with combustion engines. But since NIO is structuring a part of its business model explicitly around battery subscriptions, NIO could benefit more than Ford.\nBattery costs for EVs have decreased 70% since 2014, based on information provided by investment firm Schroders, and are set to decrease more this decade.\n(Source: Schroders)\nThe “BaaS” model is genius and could develop into a $500M a year revenue opportunity for NIO long term. Although Ford is ramping up its investments in battery technology, the winner in this category is: NIO.\nSales growth and valuation\nFord’s sales in May grew 4.1% Y/Y but electrified vehicle sales (including hybrids) surged 184% Y/Y as Ford sold a record 10,364 EVs/hybrids in May. Escape electrified sales and Explorer Hybrid grew sales at 125% and 132% Y/Y showing strong customer uptake. NIO delivered 6,711 vehicles last month including 3,017 ES6s, 1,412 ES8s and 2,282 EC6s. Total Y/Y delivery growth for May was 95.3%.\nFord's sales are fifty-four times larger than NIO's which creates more sales growth and revaluation potential for NIO.\nData by YCharts\nThe difference in valuation between Ford and NIO is like the difference between night and day. This is because Ford is still seen as a mature vehicle maker with expected enterprise sales growth in the low-to-mid digits, despite explosive growth in the EV category. Ford is expected to grow revenues by 33% until FY 2025 (base year: FY 2020) and NIO by 808%!\nDue to these differences in sales growth, NIO is the complete opposite of Ford, at least as far as valuation goes. The Chinese EV-maker is expected to see sales and delivery growth close to 100% this year and since NIO is only dealing in EVs, NIO gets a much higher market-cap-to-sales ratio than Ford.\n(Source: Author)\nNIO has larger risks...\nNIO is the more risky venture, but also the one that offers the most promise. Government policy favors EV-makers like NIO. The potential for total global sales growth is larger for NIO as it operates from a smaller revenue base compared to Ford. But there are also a few things that work against NIO. For example, recalls due to production defects would be a much bigger challenge for NIO to overcome than for Ford which can rely on a global service and distribution network. NIO’s valuation is also not without risk as an unexpected slowing of sales growth due to production setbacks would leave a much larger dent in the financials.\nFinal verdict\nNIO is definitely the more “sexy” vehicle maker. Strong adoption and sales growth in China and Europe support NIO. Its super smart BaaS model which decouples vehicle purchase prices from battery costs is genius. You pay a high price for this growth but the market opportunity for NIO is immense.\nFord’s EV sales are booming and the percentage of EV sales will increase as the vehicle maker electrifies its fleet. Ford has a lot of potential in the EV market but since EV sales are still a relatively low percentage of total sales, it will take a long time for Ford to complete its transformation.\nIf you believe in the potential of the global EV market, buy NIO. If you believe in the potential of the global EV market and don’t like much risk, buy Ford.","news_type":1},"isVote":1,"tweetType":1,"viewCount":70,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":145705906,"gmtCreate":1626242963805,"gmtModify":1633928685242,"author":{"id":"4087711343938000","authorId":"4087711343938000","name":"ZeeJay","avatar":"https://static.tigerbbs.com/36dbec811e59c06f4aea5df6c06ea26f","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4087711343938000","authorIdStr":"4087711343938000"},"themes":[],"htmlText":"Feels too speculative for comfort..&nbsp;","listText":"Feels too speculative for comfort..&nbsp;","text":"Feels too speculative for comfort..","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/145705906","repostId":"2151565201","repostType":4,"repost":{"id":"2151565201","kind":"highlight","weMediaInfo":{"introduction":"The leading daily newsletter for the latest financial and business news. 33Yrs Helping Stock Investors with Investing Insights, Tools, News & More.","home_visible":0,"media_name":"Investors","id":"1085713068","head_image":"https://static.tigerbbs.com/608dd68a89ed486e18f64efe3136266c"},"pubTimestamp":1626177299,"share":"https://www.laohu8.com/m/news/2151565201?lang=&edition=full","pubTime":"2021-07-13 19:54","market":"us","language":"en","title":"10 Companies Are About To Post Blowout 1,000%+ Profit Growth","url":"https://stock-news.laohu8.com/highlight/detail?id=2151565201","media":"Investors","summary":"S&P 500 investors are waiting for banner profit reports to kick off this week. And some companies' profit gains are likely to be enormous.","content":"<p>S&amp;P 500 investors are waiting for banner profit reports to kick off this week. And some companies' profit gains are likely to be more enormous than others.</p>\n<p>Analysts expect 10 S&amp;P 500 companies, including health care <b>Zimmer Biomet</b>, energy firm <b>Freeport-McMoRan</b> and consumer discretionary firm <b>Chipotle Mexican Grill</b>, to post massive adjusted profit per share growth of 1,000% or much more for the second quarter. And that would make these companies S&amp;P 500 standouts in a quarter already expected to be a massive <a href=\"https://laohu8.com/S/AONE\">one</a> for profit growth, says an Investor's Business Daily analysis of data from S&amp;P Global Market Intelligence and MarketSmith.</p>\n<p>\"We ran out of superlatives to describe corporate America's stunning performance during first-quarter earnings season,\" said Jeff Buchbinder, equity strategist at LPL Financial. \"So what will companies do for an encore? We expect more good news this quarter as more of the economy has opened up, while also acknowledging the second quarter will almost certainly end up being the peak in earnings growth for this cycle.\"</p>\n<p>Profit reports kick off this week with the banks. And what a peak it'll be for S&amp;P 50o profit.</p>\n<h2>S&amp;P 500 Headed To Amazing Quarterly Profit</h2>\n<p>Companies in the S&amp;P 500 are expected to post moonshot quarterly profit growth of 64% in the second quarter, says John Butters, earnings analyst at FactSet. If that's right, it would be the largest quarterly profit posted by the S&amp;P 500 in more than a decade, Butters says.</p>\n<p>Profits are soaring back as the U.S. economy is reopening, jobs are plentiful and companies and consumers have lots of money to spend. And the speed of the economy's rebound surprised most people. Analysts bumped up their profit forecasts for the quarter 7.2% since the end of March through June 30. That's the largest upward profit growth forecast boost since FactSet has tracked it going back to 2002, Butters says.</p>\n<p>Skeptics might think this is just wishful thinking. But early indications show there's reason to be optimistic. Already 66 S&amp;P 500 companies, also a record, said second-quarter profit will top their earlier targets.</p>\n<p>So how you stand out when most companies' profits are booming? Just ask 10 S&amp;P 500 outliers.</p>\n<h2>Putting Up 1,000% Or More Profit Growth</h2>\n<p>Scanning the S&amp;P 500, Zimmer Biomet is the company to beat in terms of profit growth. Analysts think it will earn $1.86 a share on an adjusted basis in the second quarter. That's up more than 3,600% from what it earned in the same period a year ago.</p>\n<p>The company makes a variety of orthopedic products like hip and knee replacements. Demand for such goods is expected to be strong as many people now get the optional procedures they put off during the pandemic. Zimmer Biomet reports its second quarter profit on Aug. 3. Shares are only up 3.8% this year so far.</p>\n<p>Energy, though, is an area where profits and share prices are booming. Shares of copper miner Freeport-McMoRan are up more than 40% as investors anticipate an amazing quarter for profits. Analysts are calling for the company to earn nearly 74 cents a share in the second quarter, up more than 2,350% from the same year-ago period. Such strong fundamentals paired with a rising stock price explain the lofty 93 IBD Composite Rating. The company reports on July 22.</p>\n<p>And when it comes to a high Composite Rating, look at Chipotle. The burrito chain sports a near perfect IBD Composite Rating of 98. Shares are up 16.5% this year, roughly in line with the S&amp;P 500. But get ready for a hot-red quarter of profit growth. Analysts think it will report second-quarter profit growth of more than 1,517% or $6.47 a share. Chipotle reports on July 20.</p>\n<p>So while it's going to be a powerful period of growth for the S&amp;P 500, it's still possible to beat the average.</p>\n<h2>A Bonanza Of Profit Is Coming</h2>\n<p><i>Analysts see 1,000% or more profit growth from these S&amp;P 500 companies in the second quarter</i></p>\n<table>\n <thead>\n  <tr>\n   <th>Company</th>\n   <th>Ticker</th>\n   <th>Q2 EPS % Ch.</th>\n   <th>Primary Sector</th>\n   <th>Composite Rating</th>\n   <th>% stock YTD ch.</th>\n  </tr>\n </thead>\n <tbody>\n  <tr>\n   <td>Zimmer Biomet</td>\n   <td></td>\n   <td><b>3,620.0%</b></td>\n   <td>Health Care</td>\n   <td>39</td>\n   <td>3.8%</td>\n  </tr>\n  <tr>\n   <td>Freeport-McMoRan</td>\n   <td></td>\n   <td><b>2,353.3%</b></td>\n   <td>Materials</td>\n   <td>93</td>\n   <td>40.4%</td>\n  </tr>\n  <tr>\n   <td>Hasbro</td>\n   <td></td>\n   <td><b>2,285.0%</b></td>\n   <td>Consumer Discretionary</td>\n   <td>67</td>\n   <td>4.9%</td>\n  </tr>\n  <tr>\n   <td><a href=\"https://laohu8.com/S/SYF\">Synchrony Financial</a></td>\n   <td></td>\n   <td><b>2,150.0%</b></td>\n   <td>Financials</td>\n   <td>88</td>\n   <td>40.4%</td>\n  </tr>\n  <tr>\n   <td>W. R. Berkley</td>\n   <td></td>\n   <td><b>1,525.0%</b></td>\n   <td>Financials</td>\n   <td>71</td>\n   <td>14.8%</td>\n  </tr>\n  <tr>\n   <td>Chipotle Mexican Grill</td>\n   <td></td>\n   <td><b>1,517.5%</b></td>\n   <td>Consumer Discretionary</td>\n   <td>98</td>\n   <td>16.5%</td>\n  </tr>\n  <tr>\n   <td>Ross Stores</td>\n   <td></td>\n   <td><b>1,460.0%</b></td>\n   <td>Consumer Discretionary</td>\n   <td>72</td>\n   <td>1.1%</td>\n  </tr>\n  <tr>\n   <td><a href=\"https://laohu8.com/S/FANG\">Diamondback Energy</a></td>\n   <td></td>\n   <td><b>1,306.7%</b></td>\n   <td>Energy</td>\n   <td>97</td>\n   <td>85.6%</td>\n  </tr>\n  <tr>\n   <td>Nucor</td>\n   <td></td>\n   <td><b>1,179.6%</b></td>\n   <td>Materials</td>\n   <td>98</td>\n   <td>83.8%</td>\n  </tr>\n  <tr>\n   <td>Weyerhaeuser</td>\n   <td></td>\n   <td><b>1,109.1%</b></td>\n   <td>Real Estate</td>\n   <td>87</td>\n   <td>6.3%</td>\n  </tr>\n </tbody>\n</table>\n<h5>Sources: IBD, S&amp;P Global Market Intelligence</h5>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>10 Companies Are About To Post Blowout 1,000%+ Profit Growth</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n10 Companies Are About To Post Blowout 1,000%+ Profit Growth\n</h2>\n\n<h4 class=\"meta\">\n\n\n<div class=\"head\" \">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/608dd68a89ed486e18f64efe3136266c);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Investors </p>\n<p class=\"h-time\">2021-07-13 19:54</p>\n</div>\n\n</div>\n\n\n</h4>\n\n</header>\n<article>\n<p>S&amp;P 500 investors are waiting for banner profit reports to kick off this week. And some companies' profit gains are likely to be more enormous than others.</p>\n<p>Analysts expect 10 S&amp;P 500 companies, including health care <b>Zimmer Biomet</b>, energy firm <b>Freeport-McMoRan</b> and consumer discretionary firm <b>Chipotle Mexican Grill</b>, to post massive adjusted profit per share growth of 1,000% or much more for the second quarter. And that would make these companies S&amp;P 500 standouts in a quarter already expected to be a massive <a href=\"https://laohu8.com/S/AONE\">one</a> for profit growth, says an Investor's Business Daily analysis of data from S&amp;P Global Market Intelligence and MarketSmith.</p>\n<p>\"We ran out of superlatives to describe corporate America's stunning performance during first-quarter earnings season,\" said Jeff Buchbinder, equity strategist at LPL Financial. \"So what will companies do for an encore? We expect more good news this quarter as more of the economy has opened up, while also acknowledging the second quarter will almost certainly end up being the peak in earnings growth for this cycle.\"</p>\n<p>Profit reports kick off this week with the banks. And what a peak it'll be for S&amp;P 50o profit.</p>\n<h2>S&amp;P 500 Headed To Amazing Quarterly Profit</h2>\n<p>Companies in the S&amp;P 500 are expected to post moonshot quarterly profit growth of 64% in the second quarter, says John Butters, earnings analyst at FactSet. If that's right, it would be the largest quarterly profit posted by the S&amp;P 500 in more than a decade, Butters says.</p>\n<p>Profits are soaring back as the U.S. economy is reopening, jobs are plentiful and companies and consumers have lots of money to spend. And the speed of the economy's rebound surprised most people. Analysts bumped up their profit forecasts for the quarter 7.2% since the end of March through June 30. That's the largest upward profit growth forecast boost since FactSet has tracked it going back to 2002, Butters says.</p>\n<p>Skeptics might think this is just wishful thinking. But early indications show there's reason to be optimistic. Already 66 S&amp;P 500 companies, also a record, said second-quarter profit will top their earlier targets.</p>\n<p>So how you stand out when most companies' profits are booming? Just ask 10 S&amp;P 500 outliers.</p>\n<h2>Putting Up 1,000% Or More Profit Growth</h2>\n<p>Scanning the S&amp;P 500, Zimmer Biomet is the company to beat in terms of profit growth. Analysts think it will earn $1.86 a share on an adjusted basis in the second quarter. That's up more than 3,600% from what it earned in the same period a year ago.</p>\n<p>The company makes a variety of orthopedic products like hip and knee replacements. Demand for such goods is expected to be strong as many people now get the optional procedures they put off during the pandemic. Zimmer Biomet reports its second quarter profit on Aug. 3. Shares are only up 3.8% this year so far.</p>\n<p>Energy, though, is an area where profits and share prices are booming. Shares of copper miner Freeport-McMoRan are up more than 40% as investors anticipate an amazing quarter for profits. Analysts are calling for the company to earn nearly 74 cents a share in the second quarter, up more than 2,350% from the same year-ago period. Such strong fundamentals paired with a rising stock price explain the lofty 93 IBD Composite Rating. The company reports on July 22.</p>\n<p>And when it comes to a high Composite Rating, look at Chipotle. The burrito chain sports a near perfect IBD Composite Rating of 98. Shares are up 16.5% this year, roughly in line with the S&amp;P 500. But get ready for a hot-red quarter of profit growth. Analysts think it will report second-quarter profit growth of more than 1,517% or $6.47 a share. Chipotle reports on July 20.</p>\n<p>So while it's going to be a powerful period of growth for the S&amp;P 500, it's still possible to beat the average.</p>\n<h2>A Bonanza Of Profit Is Coming</h2>\n<p><i>Analysts see 1,000% or more profit growth from these S&amp;P 500 companies in the second quarter</i></p>\n<table>\n <thead>\n  <tr>\n   <th>Company</th>\n   <th>Ticker</th>\n   <th>Q2 EPS % Ch.</th>\n   <th>Primary Sector</th>\n   <th>Composite Rating</th>\n   <th>% stock YTD ch.</th>\n  </tr>\n </thead>\n <tbody>\n  <tr>\n   <td>Zimmer Biomet</td>\n   <td></td>\n   <td><b>3,620.0%</b></td>\n   <td>Health Care</td>\n   <td>39</td>\n   <td>3.8%</td>\n  </tr>\n  <tr>\n   <td>Freeport-McMoRan</td>\n   <td></td>\n   <td><b>2,353.3%</b></td>\n   <td>Materials</td>\n   <td>93</td>\n   <td>40.4%</td>\n  </tr>\n  <tr>\n   <td>Hasbro</td>\n   <td></td>\n   <td><b>2,285.0%</b></td>\n   <td>Consumer Discretionary</td>\n   <td>67</td>\n   <td>4.9%</td>\n  </tr>\n  <tr>\n   <td><a href=\"https://laohu8.com/S/SYF\">Synchrony Financial</a></td>\n   <td></td>\n   <td><b>2,150.0%</b></td>\n   <td>Financials</td>\n   <td>88</td>\n   <td>40.4%</td>\n  </tr>\n  <tr>\n   <td>W. R. Berkley</td>\n   <td></td>\n   <td><b>1,525.0%</b></td>\n   <td>Financials</td>\n   <td>71</td>\n   <td>14.8%</td>\n  </tr>\n  <tr>\n   <td>Chipotle Mexican Grill</td>\n   <td></td>\n   <td><b>1,517.5%</b></td>\n   <td>Consumer Discretionary</td>\n   <td>98</td>\n   <td>16.5%</td>\n  </tr>\n  <tr>\n   <td>Ross Stores</td>\n   <td></td>\n   <td><b>1,460.0%</b></td>\n   <td>Consumer Discretionary</td>\n   <td>72</td>\n   <td>1.1%</td>\n  </tr>\n  <tr>\n   <td><a href=\"https://laohu8.com/S/FANG\">Diamondback Energy</a></td>\n   <td></td>\n   <td><b>1,306.7%</b></td>\n   <td>Energy</td>\n   <td>97</td>\n   <td>85.6%</td>\n  </tr>\n  <tr>\n   <td>Nucor</td>\n   <td></td>\n   <td><b>1,179.6%</b></td>\n   <td>Materials</td>\n   <td>98</td>\n   <td>83.8%</td>\n  </tr>\n  <tr>\n   <td>Weyerhaeuser</td>\n   <td></td>\n   <td><b>1,109.1%</b></td>\n   <td>Real Estate</td>\n   <td>87</td>\n   <td>6.3%</td>\n  </tr>\n </tbody>\n</table>\n<h5>Sources: IBD, S&amp;P Global Market Intelligence</h5>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"CMG":"墨式烧烤","ZBH":"齐默巴奥米特控股","FCX":"麦克莫兰铜金","POST":"Post Holdings"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2151565201","content_text":"S&P 500 investors are waiting for banner profit reports to kick off this week. And some companies' profit gains are likely to be more enormous than others.\nAnalysts expect 10 S&P 500 companies, including health care Zimmer Biomet, energy firm Freeport-McMoRan and consumer discretionary firm Chipotle Mexican Grill, to post massive adjusted profit per share growth of 1,000% or much more for the second quarter. And that would make these companies S&P 500 standouts in a quarter already expected to be a massive one for profit growth, says an Investor's Business Daily analysis of data from S&P Global Market Intelligence and MarketSmith.\n\"We ran out of superlatives to describe corporate America's stunning performance during first-quarter earnings season,\" said Jeff Buchbinder, equity strategist at LPL Financial. \"So what will companies do for an encore? We expect more good news this quarter as more of the economy has opened up, while also acknowledging the second quarter will almost certainly end up being the peak in earnings growth for this cycle.\"\nProfit reports kick off this week with the banks. And what a peak it'll be for S&P 50o profit.\nS&P 500 Headed To Amazing Quarterly Profit\nCompanies in the S&P 500 are expected to post moonshot quarterly profit growth of 64% in the second quarter, says John Butters, earnings analyst at FactSet. If that's right, it would be the largest quarterly profit posted by the S&P 500 in more than a decade, Butters says.\nProfits are soaring back as the U.S. economy is reopening, jobs are plentiful and companies and consumers have lots of money to spend. And the speed of the economy's rebound surprised most people. Analysts bumped up their profit forecasts for the quarter 7.2% since the end of March through June 30. That's the largest upward profit growth forecast boost since FactSet has tracked it going back to 2002, Butters says.\nSkeptics might think this is just wishful thinking. But early indications show there's reason to be optimistic. Already 66 S&P 500 companies, also a record, said second-quarter profit will top their earlier targets.\nSo how you stand out when most companies' profits are booming? Just ask 10 S&P 500 outliers.\nPutting Up 1,000% Or More Profit Growth\nScanning the S&P 500, Zimmer Biomet is the company to beat in terms of profit growth. Analysts think it will earn $1.86 a share on an adjusted basis in the second quarter. That's up more than 3,600% from what it earned in the same period a year ago.\nThe company makes a variety of orthopedic products like hip and knee replacements. Demand for such goods is expected to be strong as many people now get the optional procedures they put off during the pandemic. Zimmer Biomet reports its second quarter profit on Aug. 3. Shares are only up 3.8% this year so far.\nEnergy, though, is an area where profits and share prices are booming. Shares of copper miner Freeport-McMoRan are up more than 40% as investors anticipate an amazing quarter for profits. Analysts are calling for the company to earn nearly 74 cents a share in the second quarter, up more than 2,350% from the same year-ago period. Such strong fundamentals paired with a rising stock price explain the lofty 93 IBD Composite Rating. The company reports on July 22.\nAnd when it comes to a high Composite Rating, look at Chipotle. The burrito chain sports a near perfect IBD Composite Rating of 98. Shares are up 16.5% this year, roughly in line with the S&P 500. But get ready for a hot-red quarter of profit growth. Analysts think it will report second-quarter profit growth of more than 1,517% or $6.47 a share. Chipotle reports on July 20.\nSo while it's going to be a powerful period of growth for the S&P 500, it's still possible to beat the average.\nA Bonanza Of Profit Is Coming\nAnalysts see 1,000% or more profit growth from these S&P 500 companies in the second quarter\n\n\n\nCompany\nTicker\nQ2 EPS % Ch.\nPrimary Sector\nComposite Rating\n% stock YTD ch.\n\n\n\n\nZimmer Biomet\n\n3,620.0%\nHealth Care\n39\n3.8%\n\n\nFreeport-McMoRan\n\n2,353.3%\nMaterials\n93\n40.4%\n\n\nHasbro\n\n2,285.0%\nConsumer Discretionary\n67\n4.9%\n\n\nSynchrony Financial\n\n2,150.0%\nFinancials\n88\n40.4%\n\n\nW. R. Berkley\n\n1,525.0%\nFinancials\n71\n14.8%\n\n\nChipotle Mexican Grill\n\n1,517.5%\nConsumer Discretionary\n98\n16.5%\n\n\nRoss Stores\n\n1,460.0%\nConsumer Discretionary\n72\n1.1%\n\n\nDiamondback Energy\n\n1,306.7%\nEnergy\n97\n85.6%\n\n\nNucor\n\n1,179.6%\nMaterials\n98\n83.8%\n\n\nWeyerhaeuser\n\n1,109.1%\nReal Estate\n87\n6.3%\n\n\n\nSources: IBD, S&P Global Market Intelligence","news_type":1},"isVote":1,"tweetType":1,"viewCount":258,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":149341537,"gmtCreate":1625706681929,"gmtModify":1633938178521,"author":{"id":"4087711343938000","authorId":"4087711343938000","name":"ZeeJay","avatar":"https://static.tigerbbs.com/36dbec811e59c06f4aea5df6c06ea26f","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4087711343938000","authorIdStr":"4087711343938000"},"themes":[],"htmlText":"Too much speculation on healthcare and biotech.. Wait fornsome stability before plunging.","listText":"Too much speculation on healthcare and biotech.. Wait fornsome stability before plunging.","text":"Too much speculation on healthcare and biotech.. Wait fornsome stability before plunging.","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/149341537","repostId":"2149365051","repostType":4,"repost":{"id":"2149365051","kind":"highlight","pubTimestamp":1625648700,"share":"https://www.laohu8.com/m/news/2149365051?lang=&edition=full","pubTime":"2021-07-07 17:05","market":"us","language":"en","title":"3 Biotechs to Avoid Like the Plague in July","url":"https://stock-news.laohu8.com/highlight/detail?id=2149365051","media":"Motley Fool","summary":"Generally speaking, biotech is a pretty innovative industry -- with a few notable bad apples.","content":"<p>Biotech is an industry that has deeply enriched investors' pockets and helped numerous patients alike -- most recently in the form of coronavirus vaccine companies working to contain the once-in-a-lifetime pandemic. The sector is not without its risks, however. A few small-cap players using questionable science have sold investors on false dreams of miracle drugs that could become game-changers in their field, and in these cases, that couldn't be further from the truth.&nbsp;</p>\n<p>Avoiding bad investments is just as important as making good ones. So let's look at the dark side of investing in biotech and which companies to stay well away from.&nbsp;</p>\n<p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/6bccd5c36f3f76148be467937b9b6293\" tg-width=\"700\" tg-height=\"466\" referrerpolicy=\"no-referrer\"><span>Image source: Getty Images.</span></p>\n<h2>1. Cel-Sci</h2>\n<p>Sometimes, <a href=\"https://laohu8.com/S/AONE\">one</a> is dealt a bad hand in life and will need to bluff. However, it's a whole different story to double down on a bluff after <a href=\"https://laohu8.com/S/AONE.U\">one</a>'s cover is blown.&nbsp;</p>\n<p>Take the case of&nbsp;<b>Cel-Sci&nbsp;</b>(NYSEMKT:CVM), a small-cap biotech with a single late-stage immunotherapy candidate (Multikine) for treating head and neck cancer. On June 28, Cel-Sci announced that Multikine failed to achieve the primary endpoint of boosting patient survival by 10% compared to standard-of-care treatments in a decade-long phase 3 trial. As a result, the stock lost 66% of its value within four days, to $8.65.</p>\n<p>It's pretty hard to walk away from a giant bluff when there's just too much in the pot. In a conference call to investors on July 1, CEO Geert Kersten heralded the study as a \"success,\" saying that a cohort of patients who received Multikine plus surgery plus radiotherapy \"met the primary endpoint,\" and that Cel-Sci plans to file for regulatory approval. Later on in the call, chief scientific officer Taylor Eval denied all allegations the company was data-mining the study. On a side note, Kersten said he will \"not be releasing the [full] data to shareholders.\"</p>\n<p>The data that management is referring to is from a subgroup of patients in the Multikine cohort who did not receive chemotherapy in the study. This group of patients survived 14.3% longer after five years than the group who received no Multikine at all -- but that does not mean Multikine works on patients without chemotherapy. It has nothing to do with the study's primary endpoint (which includes both patients who did and did not receive chemotherapy). So the data-mining here is, in fact, pretty evident.</p>\n<p>It's also very easy to see how the drug could have a placebo effect. In clinical trials, Multikine was injected in or around the tumor. In case one was wondering, injecting just about anything into a tumor causes the cancer cells to die off -- partly due to needle damage. Moreover, patients in the 9.5-year study received Multikine for just three weeks and were not treated with the drug if their cancer relapsed. So anything (such as lifestyle choices, receiving other immunotherapies post-relapse, etc.) could have been behind the survival difference in the subgroups.</p>\n<p>Before the results came out (which took over a year), Cel-Sci bagged $31.7 million in cash by selling new stock to retail investors, resulting in heavy losses for shareholders less than three weeks after the deal closed. Overall, given the failure of its flagship candidate, the less than $50 million in assets on its books, and questionable conduct from management, this is definitely a biotech you don't want to be holding anytime soon (if not ever).&nbsp;</p>\n<h2>2. CytoDyn&nbsp;</h2>\n<p><b>CytoDyn</b> (OTC:CYDY) is a biotech known for developing leronlimab, an antibody that failed two phase 3 clinical studies for treating COVID-19. In May, the U.S. Food and Drug Administration (FDA) even released a rare statement saying that the drug did not meet the primary endpoints in these studies.&nbsp;</p>\n<p>In response, CEO Nader Pourhassan has adopted a \"catch me if you can\" type of strategy. In other words, CytoDyn simply moved outside of the FDA's jurisdiction and began commercializing the drug in countries like the Philippines.&nbsp;</p>\n<p>It's perplexing as to why the company would risk its relationship with the FDA like this. Aside from the COVID-19 indication, leronlimab is also under investigation for the treatment of HIV. In one study, leronlimab reduced viral load to negligible levels in 83% of patients with HIV.</p>\n<p>I wouldn't be surprised if the rivalry between Pourhassan and the FDA has gone down to the personal level. Last July, the FDA rejected CytoDyn's Biologic License Application (BLA) filing for leronlimab's approval for treating HIV. But the agency did not ask for another clinical trial; it just wanted additional information about the drug and a meeting with company management. CytoDyn has just begun the process to resubmit its BLA on July 1, almost a year later.</p>\n<p>At the end of the day, biotechs with sketchy science and management woes shouldn't be trading at a $1 billion market cap. Take note that CytoDyn has less than $150 million in total assets, leaving shareholders with little recourse in case of further blunders.&nbsp;</p>\n<h2>3. Northwest Biotherapeutics&nbsp;</h2>\n<p><b>Northwest Biotherapeutics</b>&nbsp;(OTC:NWBO) is a company that closely mirrors Cel-Sci in terms of both its science and stock price. Its management is also even more \"audacious\" than that of the previous companies.&nbsp;</p>\n<p>The company's flagship candidate is an immunotherapy known as DCVax-L, which is under investigation for the treatment of glioblastoma multiforme, the most deadly form of brain cancer. The phase 3 study has been going on since December 2006 (almost 15 years now). It was originally a phase 2 study, but the company \"phase-shifted\" it to 3, citing difficulty in finding patients who are comfortable taking a placebo for the deadly illness.</p>\n<p>The study had numerous red flags from the start. Northwest was supposed to conduct two interim analyses of the trial data starting in December 2013. Yes, you read that right, December of 2013. By August 2014, however, the company had released a statement claiming that \"no interim analysis of efficacy in the Phase III trial [had] been done.\" What's more, the FDA halted the DCVax-L clinical trial in August 2015 before lifting it two years later. To this day, Northwest's management has never explained the reasons behind the trial halt.</p>\n<p>The company did eventually perform the interim analyses in 2017 and 2018, but released the results unblinded. When it comes to deadly diseases with significant unmet needs, clinical trials can be stopped early if the experimental drug meets the primary endpoint for ethical reasons. That did not happen with DCVax-L on both occasions.</p>\n<p>Last October, Northwest finally announced that the trial was coming to its end and that data was to be sent for statistical analysis. It's been more than nine months since the announcement, and no news. But, again, from an ethical endpoint, if DCVax-L was working, it doesn't make sense that Northwest wouldn't release top-line data and rush the drug to approval to save lives.</p>\n<p>Shareholders should be expecting a lot of pain ahead, as the company inexplicably has a market cap of $1.27 billion -- with an unpromising candidate and less than $35 million in total assets. All of this makes Northwest's fate look eerily similar to that of Cel-Sci -- and a stock to stay away from for good.&nbsp;</p>","source":"fool_stock","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>3 Biotechs to Avoid Like the Plague in July</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n3 Biotechs to Avoid Like the Plague in July\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-07-07 17:05 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.fool.com/investing/2021/07/06/3-biotechs-to-avoid-like-the-plague-in-july/><strong>Motley Fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Biotech is an industry that has deeply enriched investors' pockets and helped numerous patients alike -- most recently in the form of coronavirus vaccine companies working to contain the once-in-a-...</p>\n\n<a href=\"https://www.fool.com/investing/2021/07/06/3-biotechs-to-avoid-like-the-plague-in-july/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"CVM":"CEL-SCI Corp","CYDY":"CytoDyn Inc.","NWBO":"西北生物疗法"},"source_url":"https://www.fool.com/investing/2021/07/06/3-biotechs-to-avoid-like-the-plague-in-july/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2149365051","content_text":"Biotech is an industry that has deeply enriched investors' pockets and helped numerous patients alike -- most recently in the form of coronavirus vaccine companies working to contain the once-in-a-lifetime pandemic. The sector is not without its risks, however. A few small-cap players using questionable science have sold investors on false dreams of miracle drugs that could become game-changers in their field, and in these cases, that couldn't be further from the truth. \nAvoiding bad investments is just as important as making good ones. So let's look at the dark side of investing in biotech and which companies to stay well away from. \nImage source: Getty Images.\n1. Cel-Sci\nSometimes, one is dealt a bad hand in life and will need to bluff. However, it's a whole different story to double down on a bluff after one's cover is blown. \nTake the case of Cel-Sci (NYSEMKT:CVM), a small-cap biotech with a single late-stage immunotherapy candidate (Multikine) for treating head and neck cancer. On June 28, Cel-Sci announced that Multikine failed to achieve the primary endpoint of boosting patient survival by 10% compared to standard-of-care treatments in a decade-long phase 3 trial. As a result, the stock lost 66% of its value within four days, to $8.65.\nIt's pretty hard to walk away from a giant bluff when there's just too much in the pot. In a conference call to investors on July 1, CEO Geert Kersten heralded the study as a \"success,\" saying that a cohort of patients who received Multikine plus surgery plus radiotherapy \"met the primary endpoint,\" and that Cel-Sci plans to file for regulatory approval. Later on in the call, chief scientific officer Taylor Eval denied all allegations the company was data-mining the study. On a side note, Kersten said he will \"not be releasing the [full] data to shareholders.\"\nThe data that management is referring to is from a subgroup of patients in the Multikine cohort who did not receive chemotherapy in the study. This group of patients survived 14.3% longer after five years than the group who received no Multikine at all -- but that does not mean Multikine works on patients without chemotherapy. It has nothing to do with the study's primary endpoint (which includes both patients who did and did not receive chemotherapy). So the data-mining here is, in fact, pretty evident.\nIt's also very easy to see how the drug could have a placebo effect. In clinical trials, Multikine was injected in or around the tumor. In case one was wondering, injecting just about anything into a tumor causes the cancer cells to die off -- partly due to needle damage. Moreover, patients in the 9.5-year study received Multikine for just three weeks and were not treated with the drug if their cancer relapsed. So anything (such as lifestyle choices, receiving other immunotherapies post-relapse, etc.) could have been behind the survival difference in the subgroups.\nBefore the results came out (which took over a year), Cel-Sci bagged $31.7 million in cash by selling new stock to retail investors, resulting in heavy losses for shareholders less than three weeks after the deal closed. Overall, given the failure of its flagship candidate, the less than $50 million in assets on its books, and questionable conduct from management, this is definitely a biotech you don't want to be holding anytime soon (if not ever). \n2. CytoDyn \nCytoDyn (OTC:CYDY) is a biotech known for developing leronlimab, an antibody that failed two phase 3 clinical studies for treating COVID-19. In May, the U.S. Food and Drug Administration (FDA) even released a rare statement saying that the drug did not meet the primary endpoints in these studies. \nIn response, CEO Nader Pourhassan has adopted a \"catch me if you can\" type of strategy. In other words, CytoDyn simply moved outside of the FDA's jurisdiction and began commercializing the drug in countries like the Philippines. \nIt's perplexing as to why the company would risk its relationship with the FDA like this. Aside from the COVID-19 indication, leronlimab is also under investigation for the treatment of HIV. In one study, leronlimab reduced viral load to negligible levels in 83% of patients with HIV.\nI wouldn't be surprised if the rivalry between Pourhassan and the FDA has gone down to the personal level. Last July, the FDA rejected CytoDyn's Biologic License Application (BLA) filing for leronlimab's approval for treating HIV. But the agency did not ask for another clinical trial; it just wanted additional information about the drug and a meeting with company management. CytoDyn has just begun the process to resubmit its BLA on July 1, almost a year later.\nAt the end of the day, biotechs with sketchy science and management woes shouldn't be trading at a $1 billion market cap. Take note that CytoDyn has less than $150 million in total assets, leaving shareholders with little recourse in case of further blunders. \n3. Northwest Biotherapeutics \nNorthwest Biotherapeutics (OTC:NWBO) is a company that closely mirrors Cel-Sci in terms of both its science and stock price. Its management is also even more \"audacious\" than that of the previous companies. \nThe company's flagship candidate is an immunotherapy known as DCVax-L, which is under investigation for the treatment of glioblastoma multiforme, the most deadly form of brain cancer. The phase 3 study has been going on since December 2006 (almost 15 years now). It was originally a phase 2 study, but the company \"phase-shifted\" it to 3, citing difficulty in finding patients who are comfortable taking a placebo for the deadly illness.\nThe study had numerous red flags from the start. Northwest was supposed to conduct two interim analyses of the trial data starting in December 2013. Yes, you read that right, December of 2013. By August 2014, however, the company had released a statement claiming that \"no interim analysis of efficacy in the Phase III trial [had] been done.\" What's more, the FDA halted the DCVax-L clinical trial in August 2015 before lifting it two years later. To this day, Northwest's management has never explained the reasons behind the trial halt.\nThe company did eventually perform the interim analyses in 2017 and 2018, but released the results unblinded. When it comes to deadly diseases with significant unmet needs, clinical trials can be stopped early if the experimental drug meets the primary endpoint for ethical reasons. That did not happen with DCVax-L on both occasions.\nLast October, Northwest finally announced that the trial was coming to its end and that data was to be sent for statistical analysis. It's been more than nine months since the announcement, and no news. But, again, from an ethical endpoint, if DCVax-L was working, it doesn't make sense that Northwest wouldn't release top-line data and rush the drug to approval to save lives.\nShareholders should be expecting a lot of pain ahead, as the company inexplicably has a market cap of $1.27 billion -- with an unpromising candidate and less than $35 million in total assets. All of this makes Northwest's fate look eerily similar to that of Cel-Sci -- and a stock to stay away from for good.","news_type":1},"isVote":1,"tweetType":1,"viewCount":253,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":841700354,"gmtCreate":1635939499588,"gmtModify":1635939749648,"author":{"id":"4087711343938000","authorId":"4087711343938000","name":"ZeeJay","avatar":"https://static.tigerbbs.com/36dbec811e59c06f4aea5df6c06ea26f","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4087711343938000","authorIdStr":"4087711343938000"},"themes":[],"htmlText":"🤧","listText":"🤧","text":"🤧","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/841700354","repostId":"1115803721","repostType":4,"repost":{"id":"1115803721","kind":"news","pubTimestamp":1635863791,"share":"https://www.laohu8.com/m/news/1115803721?lang=&edition=full","pubTime":"2021-11-02 22:36","market":"us","language":"en","title":"Hertz Says It’s Already Receiving Teslas; Doesn’t Address Musk Tweet","url":"https://stock-news.laohu8.com/highlight/detail?id=1115803721","media":"Bloomberg","summary":"Hertz Global Holdings Inc. said it’s already receiving cars under its plan to add 100,000 Tesla elec","content":"<p>Hertz Global Holdings Inc.&nbsp;said it’s already receiving cars under its plan to add 100,000 Tesla electric vehicles through 2022, without responding directly to a market-moving tweet from billionaire Elon Musk that said there’s been no signed contract between the companies yet.</p>\n<p>The rental-car company unveiled its EV initiative last week, a deal with potential to change the industry and speed consumers’ adoption of EVs. Shares of&nbsp;Tesla Inc.&nbsp;fell in early trading Tuesday after Musk, its chief executive officer, tweeted there was no contract yet and reiterated that Hertz wouldn’t get any special pricing.</p>\n<p>“As we announced last week, Hertz has made an initial order of 100,000 Tesla electric vehicles and is investing in new EV charging infrastructure across the company’s global operations,” Hertz said in an emailed statement Tuesday. “Deliveries of the Teslas already have started. We are seeing very strong early demand for Teslas in our rental fleet, which reflects market demand for Tesla vehicles.”</p>\n<p>Hertz, which trades over the counter ahead of a re-listing on the Nasdaq Stock Market, climbed 38% through Monday since Bloomberg News first reported the Tesla-rental plan on Oct. 25. The plan has pushed up the Estero, Florida-based rental company’s market valuation to about $16.1 billion -- just four months out of bankruptcy.</p>\n<p>In his Monday night tweet, Musk said that because Tesla has demand for more vehicles than it can produce, the deal with Hertz “has zero effect on our economics.” Teslasharesslumped as much as 6.9% before the start of regular trading Tuesday, after soaring 56% during the past month to give the EV-maker a market valuation above $1 trillion.</p>","source":"lsy1584095487587","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Hertz Says It’s Already Receiving Teslas; Doesn’t Address Musk Tweet</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nHertz Says It’s Already Receiving Teslas; Doesn’t Address Musk Tweet\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-11-02 22:36 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.bloomberg.com/news/articles/2021-11-02/hertz-says-already-receiving-teslas-doesn-t-address-musk-tweet><strong>Bloomberg</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Hertz Global Holdings Inc. said it’s already receiving cars under its plan to add 100,000 Tesla electric vehicles through 2022, without responding directly to a market-moving tweet from billionaire ...</p>\n\n<a href=\"https://www.bloomberg.com/news/articles/2021-11-02/hertz-says-already-receiving-teslas-doesn-t-address-musk-tweet\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"TSLA":"特斯拉","HTZ":"赫兹租车","HTZZ":"Hertz Global Holdings, Inc."},"source_url":"https://www.bloomberg.com/news/articles/2021-11-02/hertz-says-already-receiving-teslas-doesn-t-address-musk-tweet","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1115803721","content_text":"Hertz Global Holdings Inc. said it’s already receiving cars under its plan to add 100,000 Tesla electric vehicles through 2022, without responding directly to a market-moving tweet from billionaire Elon Musk that said there’s been no signed contract between the companies yet.\nThe rental-car company unveiled its EV initiative last week, a deal with potential to change the industry and speed consumers’ adoption of EVs. Shares of Tesla Inc. fell in early trading Tuesday after Musk, its chief executive officer, tweeted there was no contract yet and reiterated that Hertz wouldn’t get any special pricing.\n“As we announced last week, Hertz has made an initial order of 100,000 Tesla electric vehicles and is investing in new EV charging infrastructure across the company’s global operations,” Hertz said in an emailed statement Tuesday. “Deliveries of the Teslas already have started. We are seeing very strong early demand for Teslas in our rental fleet, which reflects market demand for Tesla vehicles.”\nHertz, which trades over the counter ahead of a re-listing on the Nasdaq Stock Market, climbed 38% through Monday since Bloomberg News first reported the Tesla-rental plan on Oct. 25. The plan has pushed up the Estero, Florida-based rental company’s market valuation to about $16.1 billion -- just four months out of bankruptcy.\nIn his Monday night tweet, Musk said that because Tesla has demand for more vehicles than it can produce, the deal with Hertz “has zero effect on our economics.” Teslasharesslumped as much as 6.9% before the start of regular trading Tuesday, after soaring 56% during the past month to give the EV-maker a market valuation above $1 trillion.","news_type":1},"isVote":1,"tweetType":1,"viewCount":964,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":149346119,"gmtCreate":1625706735431,"gmtModify":1631883983184,"author":{"id":"4087711343938000","authorId":"4087711343938000","name":"ZeeJay","avatar":"https://static.tigerbbs.com/36dbec811e59c06f4aea5df6c06ea26f","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4087711343938000","authorIdStr":"4087711343938000"},"themes":[],"htmlText":"Another one riding on a high..","listText":"Another one riding on a high..","text":"Another one riding on a high..","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/149346119","repostId":"2149697283","repostType":4,"isVote":1,"tweetType":1,"viewCount":339,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":157988300,"gmtCreate":1625559877500,"gmtModify":1633939646570,"author":{"id":"4087711343938000","authorId":"4087711343938000","name":"ZeeJay","avatar":"https://static.tigerbbs.com/36dbec811e59c06f4aea5df6c06ea26f","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4087711343938000","authorIdStr":"4087711343938000"},"themes":[],"htmlText":"Risk of Chinese mobile app businesses..&nbsp;","listText":"Risk of Chinese mobile app businesses..&nbsp;","text":"Risk of Chinese mobile app businesses..","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/157988300","repostId":"1145795655","repostType":4,"isVote":1,"tweetType":1,"viewCount":332,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":152510412,"gmtCreate":1625309792436,"gmtModify":1631884322698,"author":{"id":"4087711343938000","authorId":"4087711343938000","name":"ZeeJay","avatar":"https://static.tigerbbs.com/36dbec811e59c06f4aea5df6c06ea26f","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4087711343938000","authorIdStr":"4087711343938000"},"themes":[],"htmlText":"Hope its real tips..&nbsp;","listText":"Hope its real tips..&nbsp;","text":"Hope its real tips..","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/152510412","repostId":"2148725958","repostType":4,"repost":{"id":"2148725958","kind":"highlight","pubTimestamp":1625227829,"share":"https://www.laohu8.com/m/news/2148725958?lang=&edition=full","pubTime":"2021-07-02 20:10","market":"us","language":"en","title":"3 Stocks Cathie Wood Is Selling That Could Still Make You Rich","url":"https://stock-news.laohu8.com/highlight/detail?id=2148725958","media":"Motley Fool","summary":"It's not always the best move to copy what the successful investor does.","content":"<p>L.A. Lakers star Lebron James doesn't make every shot he takes. Tennis great Serena Williams doesn't win every match she plays. And successful investor Cathie Wood sometimes makes the wrong call on a stock.</p>\n<p>I think Wood does a great job with her ARK Invest ETFs. The proof is in the fantastic performance she's achieved over the years. However, I also view some of the recent moves to sell certain stocks in the ARK ETFs as short-sighted. Here are three stocks Wood is selling that I believe could still make you rich over the long run.</p>\n<p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/519578e90d4a7c02b89d60c8b46b0a43\" tg-width=\"700\" tg-height=\"525\"><span>Image source: Getty Images.</span></p>\n<h2>Pinterest</h2>\n<p>Wood's <b>ARK Fintech Revolution ETF</b> (NYSEMKT:ARKF) sold more than 320,000 shares of&nbsp;<b>Pinterest</b> (NYSE:PINS) in recent weeks. However, the social media stock still ranks in the top 10 holdings of the ETF.</p>\n<p>My Motley Fool colleague Danny Vena views Pinterest as <a href=\"https://laohu8.com/S/AONE\">one</a> of the three top e-commerce stocks to buy right now. I agree with Danny's take on Pinterest (and his other two picks, for that matter).</p>\n<p>Some might be concerned that Pinterest's monthly average user growth rate is slipping a little. Not me. I think that's to be expected after the pandemic-fueled growth of 2020.</p>\n<p>I fully expect that Pinterest will continue to attract more users, including men (the company's customer base currently largely consists of women.) I also look for the company to boost its monetization in international markets as well as in the U.S. Pinterest could easily double its current market cap of $50 billion over the next few years, in my view.</p>\n<h2>Sea Limited</h2>\n<p><a href=\"https://laohu8.com/S/TWOA.U\">Two</a> of Wood's ETFs have sold shares of&nbsp;<b>Sea Limited</b> (NYSE:SE) over the last few weeks -- the ARK Fintech Revolution ETF and the <b><a href=\"https://laohu8.com/S/ARKW\">ARK Next Generation Internet ETF</a></b> (NYSEMKT:ARKW). Still, though, Sea remains the No. 3 holding in the fintech ETF and ranks No. 16 in the internet ETF.</p>\n<p>Sea stands as <a href=\"https://laohu8.com/S/AONE.U\">one</a> of the fastest-growing large-cap stocks on the planet. Its business is expanding on all fronts -- digital entertainment, e-commerce, and digital payments.</p>\n<p>For now, Sea makes most of its money from its digital entertainment unit thanks to the super-popular <i>Free Fire</i> mobile game. It could have even greater growth opportunities over the long term, though, with its Shopee e-commerce platform.</p>\n<p>The company's name reflects an abbreviation for its primary market -- Southeast Asia. However, Sea continues to make solid inroads into the Latin American market. My prediction is that Sea will become a much bigger player in the region, making patient investors a lot of money in the process.</p>\n<h2>Square</h2>\n<p>Three of Wood's ETFs were scooping up shares of&nbsp;<b>Square</b> (NYSE:SQ) in May. That changed in June, though, with the ARK Next Generation Internet ETF selling over 73,500 shares of the fintech stock.</p>\n<p>Don't think that Wood has soured on Square's prospects. The stock remains the No. 1 holding in the ARK Fintech Revolution ETF and is the fourth-biggest position in the <b><a href=\"https://laohu8.com/S/ARKK\">ARK Innovation ETF</a></b> (NYSEMKT:ARKK).</p>\n<p>Sure, Square's valuation seems ridiculously high, with shares trading at close to 170 times expected earnings. However, disruptive companies almost always command steep valuations. And make no mistake about it: Square is a disruptor.</p>\n<p>The company already offers a wide array of services to businesses. Square is positioning itself to also become a full-fledged commercial bank.</p>\n<p>Perhaps Square's greatest opportunity, though, lies in the individual financial services market. The company's Cash App provides a convenient way for consumers to digitally transfer money and buy and sell stocks and <b>Bitcoin</b>.</p>\n<p>It's easy to see Square expanding Cash App to support personal loans and more features in the future. It's also easy to envision this stock making investors much wealthier over the next decade and beyond.</p>","source":"fool_stock","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>3 Stocks Cathie Wood Is Selling That Could Still Make You Rich</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n3 Stocks Cathie Wood Is Selling That Could Still Make You Rich\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-07-02 20:10 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.fool.com/investing/2021/07/02/3-stocks-cathie-wood-is-selling-that-could-still-m/><strong>Motley Fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>L.A. Lakers star Lebron James doesn't make every shot he takes. Tennis great Serena Williams doesn't win every match she plays. And successful investor Cathie Wood sometimes makes the wrong call on a ...</p>\n\n<a href=\"https://www.fool.com/investing/2021/07/02/3-stocks-cathie-wood-is-selling-that-could-still-m/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"SQ":"Block","SE":"Sea Ltd","PINS":"Pinterest, Inc."},"source_url":"https://www.fool.com/investing/2021/07/02/3-stocks-cathie-wood-is-selling-that-could-still-m/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2148725958","content_text":"L.A. Lakers star Lebron James doesn't make every shot he takes. Tennis great Serena Williams doesn't win every match she plays. And successful investor Cathie Wood sometimes makes the wrong call on a stock.\nI think Wood does a great job with her ARK Invest ETFs. The proof is in the fantastic performance she's achieved over the years. However, I also view some of the recent moves to sell certain stocks in the ARK ETFs as short-sighted. Here are three stocks Wood is selling that I believe could still make you rich over the long run.\nImage source: Getty Images.\nPinterest\nWood's ARK Fintech Revolution ETF (NYSEMKT:ARKF) sold more than 320,000 shares of Pinterest (NYSE:PINS) in recent weeks. However, the social media stock still ranks in the top 10 holdings of the ETF.\nMy Motley Fool colleague Danny Vena views Pinterest as one of the three top e-commerce stocks to buy right now. I agree with Danny's take on Pinterest (and his other two picks, for that matter).\nSome might be concerned that Pinterest's monthly average user growth rate is slipping a little. Not me. I think that's to be expected after the pandemic-fueled growth of 2020.\nI fully expect that Pinterest will continue to attract more users, including men (the company's customer base currently largely consists of women.) I also look for the company to boost its monetization in international markets as well as in the U.S. Pinterest could easily double its current market cap of $50 billion over the next few years, in my view.\nSea Limited\nTwo of Wood's ETFs have sold shares of Sea Limited (NYSE:SE) over the last few weeks -- the ARK Fintech Revolution ETF and the ARK Next Generation Internet ETF (NYSEMKT:ARKW). Still, though, Sea remains the No. 3 holding in the fintech ETF and ranks No. 16 in the internet ETF.\nSea stands as one of the fastest-growing large-cap stocks on the planet. Its business is expanding on all fronts -- digital entertainment, e-commerce, and digital payments.\nFor now, Sea makes most of its money from its digital entertainment unit thanks to the super-popular Free Fire mobile game. It could have even greater growth opportunities over the long term, though, with its Shopee e-commerce platform.\nThe company's name reflects an abbreviation for its primary market -- Southeast Asia. However, Sea continues to make solid inroads into the Latin American market. My prediction is that Sea will become a much bigger player in the region, making patient investors a lot of money in the process.\nSquare\nThree of Wood's ETFs were scooping up shares of Square (NYSE:SQ) in May. That changed in June, though, with the ARK Next Generation Internet ETF selling over 73,500 shares of the fintech stock.\nDon't think that Wood has soured on Square's prospects. The stock remains the No. 1 holding in the ARK Fintech Revolution ETF and is the fourth-biggest position in the ARK Innovation ETF (NYSEMKT:ARKK).\nSure, Square's valuation seems ridiculously high, with shares trading at close to 170 times expected earnings. However, disruptive companies almost always command steep valuations. And make no mistake about it: Square is a disruptor.\nThe company already offers a wide array of services to businesses. Square is positioning itself to also become a full-fledged commercial bank.\nPerhaps Square's greatest opportunity, though, lies in the individual financial services market. The company's Cash App provides a convenient way for consumers to digitally transfer money and buy and sell stocks and Bitcoin.\nIt's easy to see Square expanding Cash App to support personal loans and more features in the future. It's also easy to envision this stock making investors much wealthier over the next decade and beyond.","news_type":1},"isVote":1,"tweetType":1,"viewCount":289,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":127914858,"gmtCreate":1624814145874,"gmtModify":1633948413451,"author":{"id":"4087711343938000","authorId":"4087711343938000","name":"ZeeJay","avatar":"https://static.tigerbbs.com/36dbec811e59c06f4aea5df6c06ea26f","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4087711343938000","authorIdStr":"4087711343938000"},"themes":[],"htmlText":"Buy buy buy","listText":"Buy buy buy","text":"Buy buy buy","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/127914858","repostId":"2146070550","repostType":4,"isVote":1,"tweetType":1,"viewCount":352,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":127914315,"gmtCreate":1624814099137,"gmtModify":1633948413573,"author":{"id":"4087711343938000","authorId":"4087711343938000","name":"ZeeJay","avatar":"https://static.tigerbbs.com/36dbec811e59c06f4aea5df6c06ea26f","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4087711343938000","authorIdStr":"4087711343938000"},"themes":[],"htmlText":"Apple strategies are very short term. Need longer term view for future growth.","listText":"Apple strategies are very short term. Need longer term view for future growth.","text":"Apple strategies are very short term. Need longer term view for future growth.","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/127914315","repostId":"1189436009","repostType":4,"repost":{"id":"1189436009","kind":"news","pubTimestamp":1624752667,"share":"https://www.laohu8.com/m/news/1189436009?lang=&edition=full","pubTime":"2021-06-27 08:11","market":"us","language":"en","title":"Apple's TV service faces its biggest test yet as free trials run out","url":"https://stock-news.laohu8.com/highlight/detail?id=1189436009","media":"CNBC","summary":"Starting in July, Apple will no longer provide a free year of the streaming service with purchases. Instead, it will offer 3 months.Also in July, the first subscribers to activate Apple's promotional offer will start to be automatically billed for the service after watching its shows for nearly 21 months for free.Apple still has a much smaller content library than rivals such as Netflix and Disney.The training wheels are about to come off for Apple TV+, the company's streaming video service.Appl","content":"<div>\n<p>KEY POINTS\n\nStarting in July, Apple will no longer provide a free year of the streaming service with purchases. Instead, it will offer 3 months.\nAlso in July, the first subscribers to activate Apple's...</p>\n\n<a href=\"https://www.cnbc.com/2021/06/26/apples-tv-service-faces-its-biggest-test-yet-as-free-trials-run-out.html\">Web Link</a>\n\n</div>\n","source":"cnbc_highlight","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Apple's TV service faces its biggest test yet as free trials run out</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nApple's TV service faces its biggest test yet as free trials run out\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-06-27 08:11 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.cnbc.com/2021/06/26/apples-tv-service-faces-its-biggest-test-yet-as-free-trials-run-out.html><strong>CNBC</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>KEY POINTS\n\nStarting in July, Apple will no longer provide a free year of the streaming service with purchases. Instead, it will offer 3 months.\nAlso in July, the first subscribers to activate Apple's...</p>\n\n<a href=\"https://www.cnbc.com/2021/06/26/apples-tv-service-faces-its-biggest-test-yet-as-free-trials-run-out.html\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"AAPL":"苹果"},"source_url":"https://www.cnbc.com/2021/06/26/apples-tv-service-faces-its-biggest-test-yet-as-free-trials-run-out.html","is_english":true,"share_image_url":"https://static.laohu8.com/72bb72e1b84c09fca865c6dcb1bbcd16","article_id":"1189436009","content_text":"KEY POINTS\n\nStarting in July, Apple will no longer provide a free year of the streaming service with purchases. Instead, it will offer 3 months.\nAlso in July, the first subscribers to activate Apple's promotional offer will start to be automatically billed for the service after watching its shows for nearly 21 months for free.\nApple still has a much smaller content library than rivals such as Netflix and Disney.\n\nThe training wheels are about to come off for Apple TV+, the company's streaming video service.\nApple TV+ costs $4.99 per month. It's also bundled with other Apple services like Music and iCloud in packages called Apple One starting at $14.95 per month. But a lot of subscribers aren't paying.\nApple gave away a huge number of Apple TV+ of subscriptions to get the service off the ground. Starting in September 2019, anyone who bought an Apple product — an iPhone, iPad, Mac, Apple TV, or Apple Watch — got one year of Apple TV+ for free. During the pandemic, Apple extended the offer twice for people whose trial periods were about to expire.\nThe majority of Apple TV+ subscribers are still on the promotional offer, with 62% of current subscribers accessing Apple TV+ through a promotional package, according to survey data by Moffatt Nathanson published in January. Apple hasn't said how many subscribers the service has, but it has sold hundreds of millions of iPhones and other gadgets since late 2019.\nNow Apple is starting to wean Apple TV+ subscribers off the free plan.\nOn July 1, people who buy Apple products will be eligible for only 3 months of free Apple TV+, instead of a year, and people who already cashed on the trial can't get it again. Also during July, the first subscribers to activate the promotional offer will start to be automatically billed for the service after having access to its shows for nearly 21 months for free.\nThis creates a huge test for Apple.\nWill the millions of users currently on a free trial end up signing up for the $5 per month service or an Apple bundle because they can't go without Apple's shows? Or will they cancel?\nOthers may simply forget that they were on the trial and not immediately notice the new charges.\nApple reducing its reliance on free trials for Apple TV+ is a \"critical point\" for the service, said Parks Associates analyst Steve Cason, who follows the streaming industry.\n\"For newer or smaller services, partnerships and promotions are an invaluable customer acquisition tool,\" Cason said. \"A large percentage of folks follow through, they truly love the service and continue it. Or they forget they gave the service their credit card.\"\nFewer TV shows and movies than rivals\nApple TV+ has always had fewer hours of movies and TV compared to other streaming services, which may be a reason why it debuted with a lower price, versus to $8 per month for Disney+ or $8.99 for a standard Netflix plan.\nWhen Apple TV+ was launched in November 2019, it had nine original, Apple-backed shows and movies. Now it has around 87 original TV shows, movies and documentaries. That’s nowhere near what other services offer.\nHulu, for example, has thousands of shows, according to Reelgood data, many of which already have large fanbases because they were broadcast on TV.Netflix and Amazon Prime Video both have more than 1,000 licensed and original shows for customers to watch.\nApple has not licensed any non-exclusive shows for its service, and instead is only offering shows it financially backed. It hasn’t spent to buy media companies to fill out its back catalog, unlike Amazon, which recently agreed to acquire MGM Studios.\nMost of Apple’s shows star big-named producers and actors, such as Oprah and Steven Spielberg. However, talent is not exclusively tied to the company. Oprah’s biggest interview in recent memory, with Prince Harry, was broadcast on CBS. Steven Spielberg recently signed a deal with Netflix, too.\nStreaming ratings are notoriously secretive, and Apple’s never revealed how many viewers any of its shows have.\nWhen Apple executives are asked about the success of its content, they point to award nominations. In a press release last week,Apple said that its original shows have received 112 awards and 389 nominations, including Critics Choice awards, Golden Globes, and Oscars.\n“No matter what device you enjoy it from, it is a milestone period for Apple TV+, racking up many new award nominations and wins, including its first Oscar nominations,” Apple CEO Tim Cook said on a call with analysts in April.\nCook went on to praise one show in particular, “Ted Lasso,” which looks like Apple TV+‘s first big hit. The breezy comedy about an American soccer coach, which was based on an NBC advertisement poking fun at Americans’ ignorance about soccer, found a fanbase with its low-stakes banter.\n“Ted Lasso” season 2 will premier on July 23 and Apple will release new episodes weekly with an aim to get current subscribers on the trial hooked and potentially find new subscribers.\nA promotional email sent to subscribers this week highlights “Ted Lasso” in addition to a second season of “The Morning Show” starring Jennifer Aniston premiering in September. The email also promoted shows that have yet to premier, such as a comedy starring Will Ferrell and Paul Rudd called “The Shrink Next Door” and the sci-fi series “Foundation” based on Issac Asimov’s books.\nStill, “Ted Lasso” is a 30-minute comedy with only 10 episodes currently available, and overall, Apple’s library of content still trails far behind rivals.\n“Apple’s not in a position of strength here,” Moffett Nathanson’s Michael Nathanson said. “Although they have some excellent shows, they lack the scale of new releases, tentpole titles and a deep library to really create a large profitable business at this point.”\nPart of a whole\nIt’s hard to figure out how Apple TV+ stacks up to Disney or Netflix in terms of subscribers because Apple doesn’t release stats.\nNetflix has 208 million subscribers around the world. It would also be surprising if Apple can match Disney+’s 100 million subscribers, which it has built since Apple TV+ debuted.\nAnalysts are reluctant to offer estimates, but based on the number of smartphones Apple sells per year, tens of millions of people could have taken the promotional offer for Apple TV. Apple sold 206 million iPhones globally in 2020,according to an IDC estimate, and that doesn’t include the other Apple products that come with a free trial.\nEleven percent of U.S. households with a high-speed internet connection subscribe to Apple TV+, according to Parks Associates survey data. There are about 103 million households with broadband,according to Census data.\nThe percent of subscribers who could end up churning is also foggy. A Moffett Nathanson analysis of survey data suggests 29% percent of Apple TV+ subscribers don’t plan to renew and 41% aren’t sure yet. Only 30% said they planned to continue subscribing to Apple TV+.\nBut Apple never said it planned to take on Netflix, Cason said, so the total number of subscribers may not be that important to the company. He thinks that Apple TV+ is another one of several services designed to get users hooked on iPhones and Apple services, in line with Apple’s overall corporate strategy.\n“Apple wants to get you into their ecosystem through a device purchase, and once you get in there, they go, ‘We’ll give you Apple TV+. We also have Apple Music, podcasts, news, fitness, you can bundle them or you buy them separate,’” Cason said.\nIn fact, that’s how Apple thinks about its subscriber numbers. It said in April that it has 660 million paid subscribers across its services — but that also includes anyone who’s subscribed to an app through App Store billing.\nApple TV+ gives the company commercial-free content it can use to promote new audio and visual standards it builds into its products. For example, when Apple TV+ shows first debuted, they supported a Dolby HDR standard that produced better image quality when viewed through a supported Apple player. The next year, Apple announced that iPhones can film video using Dolby Vision HDR.\nMore recently, Apple launched a feature called spatial audio that works like advanced surround sound when listening on certain Apple headphones. Apple TV+ shows and movies support spatial audio, giving Apple customers the ability to watch a show in it without the company making sure that supported content is available from rivals.","news_type":1},"isVote":1,"tweetType":1,"viewCount":238,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0}],"lives":[]}